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Aim and outline of the thesis
1.1 Introduction
Compartments of micron and sub-micron dimensions are abundant in Nature in 
the form of for example cells, organelles and viral capsids. These capsules play a 
major role in the protection of the cargo from environmental effects. In addition, 
compartmentalization can also facilitate biological processes, for example cascade 
catalysis, which takes place in cells, and in which a compound is processed to a 
final product via several enzyme conversions in a predetermined order. 
Biomimetic microcapsules based on phospholipids have already been extensively 
studied for more than 40 years and have led to a better understanding of capsule 
formation by self-assembly. Nowadays many different approaches can be followed 
for the creation of synthetic microcapsules. Progress in material sciences has 
allowed production of microcapsules whose structure and composition are 
controlled on the nanoscale. Potential applications for such artificial systems are in 
most cases linked to encapsulation and (controlled) release or protection of agents 
like pharmaceuticals, fragrances, dyes or flavour additives. Microcapsules can thus 
be found in fields as diverse as medicine, cosmetics, food design and coatings of 
textiles and paper. Probably the most dynamic area of artificial microcapsule 
development is related to drug delivery applications.
1.2 Aim and outline
The aim of this thesis is to develop polymeric microcapsules that can be applied in 
a variety of biomedical applications, such as drug delivery, additives for smart 
bone cement or ultrasound contrast agents. Since these different applications have 
different requirements, not all capsules can be prepared using the same procedure 
or from the same material. Capsules which are designed for drug delivery for 
example, have to be prepared from biodegradable polymers or a combination of
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biodegradable and biocompatible polymers. The capsules designed for smart bone 
cement do not need to be degradable, but have to be mechanically robust instead. 
Finally, ultrasound contrast agents have to be filled with a gaseous interior.
The various polymers and the techniques that were used for the preparation of 
these capsules are described in the following chapters, along with their 
applications.
Chapter 2 gives a literature overview of the different techniques that are used for 
the preparation of several different types of capsules ranging in size from less than 
a hundred nanometer to several hundreds of micrometers. These capsules are 
comprised of self-assembled block copolymers, oppositely charged polymers, 
polymer precipitates or they are synthesized via in-situ polymerizations. In the 
second part of this chapter systems are highlighted where a capsule acts as a 
nanoreactor by carefully choosing the polymers, encapsulated compounds and 
reaction conditions.
Chapter 3 describes the efforts to prepare biodegradable polymersomes in both 
aqueous and apolar environments. With the amphiphilic block copolymers of 
poly(ethylene glycol)-poly(L-lactic acid) (PEG-PLLA), poly(ethylene glycol)- 
polycaprolactone (PEG-PCL) and poly(ethylene glycol)-poly(lactic-co-glycolic acid) 
(PEG-PLGA) it was possible to form polymersomes in an aqueous environment by 
the kinetic injection method, but only with the addition of the block copolymer 
poly(ethylene glycol)-polystyrene. This polymer is known to form polymersomes 
on its own and therefore served as a template for the formation of polymersomes 
with the biodegradable block copolymers. It was observed that for decreasing 
lengths of the polyester blocks increasing amounts of the templating polymer were 
needed.
Regular polymersomes are ideal for the encapsulation of hydrophilic compounds. 
However, many drugs are hydrophobic by nature. In order to be able to efficiently 
encapsulate these hydrophobic compounds, reversed polymersomes were 
prepared by injecting a polymer solution of poly(ethylene glycol)-polystyrene with 
a biodegradable block copolymer into an apolar medium. This resulted in the 
formation of spherical aggregates by phase separation. These aggregates proved to 
be stable when redispersed in water after lyophilization. In order to investigate the 
resulting structure of the aggregates after phase separation and to locate the two
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different block copolymers, degradation experiments were conducted. The 
biodegradable polymers were degradated either enzymatically or by a basic buffer. 
This made it possible to determine the position of the biodegradable block 
copolymer in the aggregates and to conclude that distinct domains of each block 
copolymer were formed within the aggregates.
Chapter 4 reports the optimization by design of experiments of the encapsulation 
efficiency and size of biodegradable water-in-oil-in-water (w/o/w) microcapsules 
having a single aqueous core. Several of the parameters that can affect the capsule 
formation process were investigated by combining two different mathematical 
approaches to streamline the number of experiments that needed to be done to 
yield the best microcapsules. First a fractional factorial design was used to screen 
for the most dominant factors influencing the encapsulation efficiency and size of 
these microcapsules. These factors were optimized further by applying a D- 
optimal design. This resulted in microcapsules having a single core, with a size 
below 10 microns and a fairly high encapsulation efficiency of 78%.
Chapter 5 explores the possibility of using biodegradable polymeric microcapsules 
as delivery systems, which can be triggered to deliver their load by an external 
stimulus, namely ultrasound. For using this external trigger, hollow gas-filled 
biodegradable capsules between 1-10 ^m were prepared using an emulsion­
evaporation method. Poly(lactic acid) microcapsules were created with varying 
ratio of the shell thickness to diameter. There proved to be a clear correlation 
between this ratio and the ultrasound pressure needed to rupture the capsules. 
This behavior was identical to the behavior predicted by theory. When mixing 
microcapsules having a low  and a high ratio of shell thickness to diameter, it was 
shown that these capsules could be activated independently from each other in one 
system, thereby opening the way for sequential drug delivery.
Chapter 6 deals with microcapsules, which can be utilized as self-healing agents in 
bone cement. Bone cement is prepared via a free radical polymerization of methyl 
methacrylate, and is used to fixate e.g. hip and knee implants. Implant failure is 
quite often a result of bone cement fatigue which is caused by the presence of 
microcracks. In this chapter microcapsules filled with monomer were mixed 
through the bone cement before curing. The hypothesis was that when a crack 
propagates through the bone cement and ruptures a capsule, it will release the 
encapsulated monomer which will fill up the crack and heal the bone cement by
3
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polymerization via the co-encapsulated initiator. This concept was demonstrated 
by manually applying a mixture of monomer and initiator onto the crack plane, 
which indeed allowed the reconnection of the two parts of the broken bone cement 
sample. Different microcapsules were prepared, with a shell which should be 
brittle enough to rupture and strong enough to survive the mixing process with the 
bone cement. However, when these capsules were tested for their self-healing 
capabilities, it was concluded that none of the prepared capsules were capable of 
restoring mechanical properties.
Chapter 7 describes the possibilities for the preparation of gas filled and liquid­
core biodegradable PLLA capsules with a narrow size distribution using 
microfluidics. With this technique, an oil-in-water emulsion was produced in 
which the polymer, a hydrophobic non-volatile non-solvent and a hydrophobic 
model drug were dissolved in the organic phase. By optimizing the flow speeds of 
the different phases with respect to the molecular weights of the polymers, 
biodegradable microcapsules could be prepared with an organic phase in the core. 
These capsules gave a burst release of this model drug when placed in a slightly 
basic solution. Gas-filled particles were prepared from the same capsules by 
removing the core phase by lyophilization. This approach of using microfluidics to 
prepare biodegradable capsules with a narrow size distribution and with apolar 
compounds encapsulated is of potential interest for the field of drug delivery.
4
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Chapter 2
Summary
Polymer-based capsules have recently emerged as devices for encapsulation 
delivery. They have as main advantage over traditional lipid-based microspheres 
that they have a more stable membrane. This makes them more robust, giving the 
capsule content a better protection against environmental influences. Various 
methods have been developed to prepare polymer-based capsules. They can be 
made by self-assembly, templating, in situ polymerization or precipitation. Their 
application has been explored in various areas such as drug delivery, diagnostics, 
sensors and nano-reactors. Considering the output in this field has substantially 
grown, the application potential of polymer-based capsules is only just starting to 
be explored.
Part o f  this research was published as: Dennis Lensen, Dennis M. Vriezema and Jan C.M. van Hest, 
M acromolecular Bioscience, 2008, 8, 991.
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2.1 Introduction
A typical cell in Nature contains several types of organelles. These compartments, 
which are mostly surrounded by a single bilayer phospholipid membrane, each 
fulfill a unique role within the cellular environment. Different organelles comprise 
different collections of specific enzymes that catalyze requisite chemical reactions. 
Peroxisomes, for example, contain several oxidases, enzymes that use molecular 
oxygen to oxidize fatty acids, in the process forming hydrogen peroxide, which is 
degraded in the vesicle by catalase to water and oxygen.[1] Within the closed 
compartment of lysosomes enzymes work most efficiently at low pH values. The 
acidic pH helps to denature proteins, making them accessible to the action of the 
lysosomal hydrolases.
The process of compartmentalization to ensure the integrity of catalytic pathways 
has inspired chemists to mimic Nature and create artificial environments for 
reactions to take place in. Liposomes, as pioneered by Bangham, were the first 
artificial capsules designed for this purpose.[2-3] These structures are composed of 
phospholipids, which spontaneously assemble into a bilayer membrane 
architecture, similar to natural vesicles. Liposomes have been subject of extensive 
studies for decades already.
In recent years a different type of vesicular architecture, composed of 
macromolecules instead of small organic compounds, has become topic of 
investigation. A wide variety of polymeric capsules has been developed, such as 
polymersomes,[4-28] layer-by-layer capsules,[29-34] and hollow microspheres[35-37 or 
microcapsules.[38-39] The use of polymers instead of organic molecules to construct 
the membrane makes these systems more stable and robust compared to 
liposomes. Additionally, as a vast amount of monomers as well as many different 
techniques to build up the polymeric structures are available, it is better possible to 
tune the properties of polymeric capsules for the desired purpose. Another effect 
of the use of polymers instead of small phospholipids for the build-up of the 
capsule shell is the reduced permeability of the membranes due to the higher 
thickness and the decreased fluidic character. This latter property however can be 
undesired when the capsules are applied for synthetic purposes, since the substrate 
has difficulty reaching the catalytic species inside the capsule.
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The aim of this chapter is to give an overview of the different methodologies that 
can be utilized to form the various polymeric capsules that are known. The focus 
will be on capsules that can perform chemical reactions within their lumen, the so 
called nanoreactors, and the approaches that have been undertaken to increase the 
permeability of the polymeric shell. Other interesting applications of polymeric 
capsules in the field of e.g. biosensors, drug delivery systems and self-healing 
materials are beyond the scope of this review and the reader is referred to some 
excellent reviews on these topics which have been recently published.[38< 40-41]
2.2 Self-assembled systems
2.2.1 Polymersomes
Vesicles that are prepared from macromolecular amphiphiles, or amphiphilic 
copolymers, are commonly named polymersomes. An amphiphilic block 
copolymer consists of a hydrophilic and a hydrophobic block, both of which can 
consist of a wide variety of polymers. For the aggregation of small amphiphiles 
such as phospholipids, Israelachvili developed a model, which is based on the 
geometry of the molecules.[42-43] A packing parameter is defined in this model, 
which is determined by the surface area of the polar headgroup and the length and 
volume of the hydrophobic tails as depicted in Figure 1. This packing parameter 
can predict whether the formation of micelles, vesicles or inverted structures is 
expected.
Packing Parameter:
Figure 1. Different morphologies predicted by the packing parameter. For p < % micelles 
and micellar rods are predicted, vesicles and films are formed when % < p < 1 and inverted 
structures are expected for p > 1J12!
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This theory was adapted by Discher et al. for block copolymers with hydrophilic 
and hydrophobic character. They introduced a theory in which the effective 
interaction energy between hydrophobic blocks is the key to aggregate stability, 
whereas the relative mass or volume fraction of each block is the key to 
morphology (Figure 2)JS] The molecular shape of an amphiphile, whether cylinder, 
wedge or cone shaped, dictates whether membrane, cylindrical, or spherical 
morphologies will respectively form. This shape is simply a reflection of the 
hydrophilic fraction f. Large hydrophilic blocks, f  >> 50%, lead to conically shaped 
amphiphiles, which give micellar structures. When a hydrophilic fraction of 40% > 
f  > 50% is used, wedge shaped amphiphiles are self-assembled into rod-like 
aggregates. For vesicles it is ideal to have a hydrophilic fraction of 25% > f  > 40%, in 
which the amphiphile has a cylindrical shape and assembles into a vesicular 
morphology.
ƒ  dictates aggregate morphology
25- 40% 40- 50% > 50%
Figure 2. Top: Schematic representation of amphiphiles, which self-assemble in either 
vesicles, rod-like structures or micelles. Below: Cryo-TEM images of the respective 
structures.!5!
The most commonly used amphiphiles have a hydrophilic block of poly(acrylic 
acid) (PAA) or poly(ethylene oxide) (PEO) in combination with polystyrene (PS) or 
polybutadiene (PBD) as the hydrophobic block. Ever since the first reports on 
polymersomes a large number of examples have been described concerning the 
formation of these assemblies.14, 7-8 10 44-451 The versatility of vesicle formation using 
amphiphilic block copolymers was demonstrated by Burke et al., who showed that
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for a series of block copolymers with PS as the hydrophobic block a variety of 
different vesicular morphologies could be obtained (Figure 3).[46]
Figure 3. Representative electron micrographs of various types of vesicles: A. small uniform 
vesicles; B. large polydisperse vesicles; C. entrapped vesicles. These structures are 
composed of single or multiple vesicles encased within a larger vesicle; D. hollow concentric 
vesicles. Each layer is an individual vesicle and a vesicle can contain as many as 6 layers 
with a spacing between the walls; E. onions. The layers are lamellar aggregates attached to 
each other and can consist of up to eight layers and F. vesicles with tubes in their wall. These 
vesicles have a bilayer wall composed of hollow tubes as an intermediate in the transition 
between small uniform vesicles and hexagonally packed hollow hoops.!46!
Polymersomes can be prepared by several methods, which will be explained 
briefly below.!7! Three main methods can be distinguished: kinetic trapping, 
thermodynamic trapping and rehydration. Kinetically formed polymersomes are 
produced by first dissolving the block copolymer in an organic solvent that mixes 
well with water. This solution is gently injected in an excess of an aqueous medium  
and solvents are then removed using the appropriate techniques. Recently, 
Marsden et al. have optimized the preparation of polymersomes with a 
controllable diameter using kinetic trapping. They dissolved their block 
copolymers in an organic solvent and rapidly added water to the system. After 
vortexing the mixture the organic solvent was removed under reduced pressure, 
yielding polymersomes with a narrow size distribution.!47! A slightly different 
method is thermodynamic trapping, which uses a similar procedure, although now  
an aqueous medium is added slowly to an organic polymer solution. Here the 
polymers conform in an energetic favorable assembly, since the non-solvent is 
added slowly. The disadvantage of both methods is that it is quite difficult to 
remove all of the organic solvent; this might interfere with biological systems and 
can also fluidize the membrane, leading to destabilization of the polymersomes.
The rehydration method can be performed via several different approaches. The 
film rehydration technique uses a polymer film, which is created on glass or 
roughened Teflon by drying of a polymer solution by means of rotary evaporation,
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high vacuum or a nitrogen flow. This film is then rehydrated using buffer or water 
yielding vesicles upon detachment of the film from the surface. The morphology of 
these aggregates can be influenced by sonication or stirring with an ultraturrax. A 
different approach is to use electroformation to yield homogeneous unilamellar 
giant polymersomes with diameters larger than 1 ^m. The method is similar to the 
film rehydration technique, however, instead of using an inert surface, the film is 
spread on electrodes. After the medium is added to rehydrate the film an electric 
current is applied to facilitate hydration.i48i
2.2.2 Peptide-based vesicles
Besides the well-known vesicles that are composed of synthetic block copolymers, 
vesicles also have been prepared from polypeptides having hydrophilic and 
hydrophobic blocks, or from block copolymers of which one block is comprised of 
a polypeptide structure.
This class of peptide-containing polymersomes has recently drawn much attention, 
since new methods have emerged in which the molecular weight of block 
copolypeptides can be precisely controlled and increasingly complex polypeptides 
can be synthesized yielding polymers having superior properties compared to ill- 
defined homopolypeptides.[13, 15-17 19-20 22, 24-2S]
Deming et al. showed vesicle formation using either poly(L-lysine)-k-poly(L- 
leucine) or poly(L-glutamic add)-k-poly(L-leucine) diblock copolypeptidesJ49 
Vesicles could be prepared with diameters ranging from 50 to 1,000 nm and they 
retained their polar contents without leakage. Recently they reported on a 
polypeptide block copolymer with a small variation to the previously described 
polypeptides. Poly(L-arginine)-k-poly(L-leudne), depicted in Figure 4, has an a- 
helical hydrophobic block which favors the formation of flat membranes, and a 
highly charged hydrophilic segment, which increases membrane fluidity. This 
latter block was also chosen to mimic the arginine-rich segment which is found in 
protein transduction domains (PTD) and could help in the enhancement of 
intracellular delivery of these capsules.!50
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Figure 4. Schematic representation of poly(L-arginine)-b-poly(L-leucine) with 10 mol% 
randomly placed lysine residues in the arginine block, which allows facile attachment of 
fluorescein dyes.[50]
Vesicles could also be prepared from hybrid polymer-polypeptide systems. The 
formation of spherical micelles and large vesicles ("peptosomes") in an aqueous 
solution of a block copolymer of polybutadiene-b-polyglutamate was described by 
Kukula et al.[23] Also Checot et al. reported vesicular aggregates formed by 
polybutadiene-polyglutamate and showed the occurrence of a transition of the 
hydrophilic block from an a-helical to a random coil conformation.!51!
Kataoka et al. developed a new  type of hybrid peptide-based polymer vesicles 
with a polyion complex (PIC) membrane, so called PICsomes.[18, 21] These PICsomes 
(Figure 5) were prepared by mixing the positively charged poly(ethylene glycol)-^- 
poly([5-aminopentyl]-a,|3-aspartamide) (PEG-P(Asp-AP)) with the negatively 
charged poly(ethylene glycol)-b-poly(a,|3-aspartic acid) (PEG-P(Asp)) in a Tris-HCl 
buffer, and subjecting them to sonication. By matching the chain length of block 
copolymer pairs with oppositely charged segments and compensating for the 
counter charge in a stoichiometric manner, semipermeable vesicles were formed.
11
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o
Figure 5. Dark-field microscopy images of PlCsomesJ21
Vriezema et al. developed a vesicular system in which polystyrene-fc-poly(L- 
isocyanoalanine(2-thiophen-3-yl-ethyl)amide) (PS-PIAT) was usedJ48, S2 The polar 
polyisocyanide block formed a rigid rod-like structure due to the helical 
propensity of the polyisocyanides, combined with the hydrogen bonding 
properties of the peptide side chains. These polymersomes have the unique feature 
that they are sufficiently porous due to the coil-like polystyrene part and the rigid 
polyisocyanide block (Figure 6). This allowed for diffusion of small molecules 
across their membranes, while large molecules, such as enzymes, remained 
trapped inside.[S2] These polymersomes, therefore, are well suited for nanoreactor 
applications, as they give protection to (bio)catalysts inside, whereas substrates 
and products can diffuse in and out.
Figure 6. PS-PIAT rod-coil block copolymer which forms porous vesicles.!52!
As an extension of this research a hybrid block copolymer of poly(y-benzyl L- 
glutamate) and a polyisocyanide was reported by Kros et al.[S3] These rod-rod block 
copolymers assembled into ordered layers to yield hollow capsules.
2.3 Layer-by-layer vesicles
In the beginning of the nineteen nineties the Layer-by-Layer technique was 
introduced by Decher and was originally used for sequential adsorption of
12
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oppositely charged polymers, polyelectrolytes, on a charged surface.[S4] When a 
polyelectrolyte is adsorbed on a glass surface, the charge of the polymer 
overcompensates, leading to a reversal of the surface charge, thereby promoting 
the adsorption of the next oppositely charged polyelectrolyte. This procedure is 
schematically illustrated in Figure 7.
Figure 7. A. Schematic representation of the deposition of oppositely charged 
polyelectrolytes. Steps 1 and 3 represent the adsorption of a polyanion and a polycation 
respectively. Steps 2 and 4 represent the washing steps. B. Polyelectrolytes adsorbed on the 
surface following the steps 1-4. C. Chemical structure of poly(styrene sulfonate) (PSS) and 
poly(allylamine hydrochloride) (PAH), which are often used for LbL films.!54!
Currently a large number of components, other than charged polymers, have been 
included in between the multilayers, like DNA, proteins, nanoparticles, lipids and 
viruses, yielding thin films with tailor-made properties. Besides electrostatic 
interactions, other interactions such as H-bonds, covalent bonds, biospecific 
interactions and stereocomplex formation have also been used to build up these 
multilamellar systems.[29]
In the late 1990s Mohwald et al.[55] extended the LBL technique to polymeric 
capsules by depositing polyelectrolytes onto charged colloidal particles as
13
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templates. Various multilayers can be formed with a variety of constituents. The 
process for assembly of these multilayers is depicted in Figure 8.
Figure 8. Schematic representation of layer-by-layer capsules (LbL capsules). a-d. Stepwise 
addition of oppositely charged macromolecules deposited on a template surface, e. 
decomposition of the core and f. hollow LbL capsule.!29!
For the fabrication of hollow polyelectrolyte capsules, a template is used which can 
be removed later. First PS or cross-linked melamine formaldehyde (MF) 
microcapsules were used as core material. However, the MF capsules proved 
difficult to remove after the formation of the multilayer and in case of PS an 
osmotic pressure was built up in the capsule due to the fast dissolution of the 
polymer core, which could destroy the polymeric shell. To overcome these 
problems inorganic substrates such as CaCO3, MnCO3 and CdCO3 are now used  
more frequently.!56-61! These inorganic carbonates have the advantage that upon  
dissolution with an EDTA solution the metal ions are complexed and can pass the 
membrane of the polyelectrolyte shell. These capsules are known for their 
permeability of molecules with a molecular weight below S kDa and should 
therefore have no osmotic stress.[62]
Wang et al. exploited mesoporous silica (MS) as a template to prepare nanoporous 
polymer spheres. Poly(acrylic acid) (PAA) together with poly(allyl amine) (PAH) 
was used as the polyelectrolyte pair.!63! Furthermore they also studied the 
infiltration of PAA into amine-functionalized MS particles as a function of 
molecular weight, nanopore size and solution conditions.[64] Also cross-linking was 
used to selectively form amide bonds between the PAA and the primary amine
14
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groups of the template, thereby stabilizing the adsorbed PAA molecules. The 
particles were then exposed to PAH and cross-linking was again performed to 
bond the carboxylic acid moieties of PAA and the amine groups of PAH. The 
template was then removed and pores of 10-50 nm could be observed using 
electron microscopy.!65]
The layer-by-layer techniques described above use solid particles in an aqueous 
medium. A novel development is the layer-by-layer deposition on a liquid core. 
Grigoriev et al. have recently described a general method for the encapsulation of a 
broad range of emulsions comprised of various hydrophobic substances and oil- 
soluble compounds.[66] To an emulsion of didodecyldimethylammonium bromide 
(DODAB), chloroform and dodecane in water a polyelectrolyte solution was gently 
added. After deposition of a layer, a washing step was carried out, before the next 
layer was deposited, resulting in microcapsules as shown in Figure 9.
Figure 9. A. Schematic representation of several steps during Layer-by-Layer encapsulation 
of a liquid core. Explanation of abbreviations: DODAB: didodecyl dimethyl ammonium 
bromide, PSS: poly(sodium 4-styrene sulfonate), PDADMAC: poly(diallyl dimethyl 
ammonium chloride). B. Layer-by-Layer capsules prepared using a liquid core. Scale bar 
represents 10 |am.[66l
Encapsulation of an oil was also performed using an ultrasonic probe in 
combination with the Layer-by-Layer techniqueJ67] Here a drug was dissolved in 
soybean oil and transferred to a polyglutamate solution containing an emulsifier. 
The emulsion was sonicated to form spheres of the desired size and layers were 
deposited in the same manner as described before.
2.4 Hollow microspheres/microcapsules
The terminology of microspheres or microcapsules is used for capsules which have 
a diameter of 1-1000 microns. The shell of these particles can be hard or soft,
15
Chapter 2
organic or inorganic, depending on the system. Several methods for making these 
particles with a liquid core have been developed during the last couple of decades. 
Most commonly the cores consist of organic solvents, but recently also the first 
reports on capsules with aqueous cores have appeared,[35] although a self-assembly 
method, as described in the previous two paragraphs still seems to be preferred for 
these types of capsules.
2.4.1 Phase separation polymer capsules
The most intensively studied microcapsule production method is based on phase 
separation. An oil-in-water emulsion is used, in which the oil phase consists of a 
mixture of the shell forming polymer, a volatile solvent and a non-volatile non­
solvent. Small polymer-rich droplets are formed by phase separation within the 
emulsion droplets as the good solvent evaporates. These polymer-rich droplets 
will migrate to the interface and engulf under the right conditions the original 
droplet.[68] Further removal of the solvent results in more polymer precipitate 
which migrates to the shell thus forming core-shell microcapsules. This technique 
outlined above is mainly used to encapsulate oil cores. The encapsulation of 
aqueous cores is more difficult, and was recently demonstrated by Atkin et al. for 
the first time (Figure 10).[69] They needed a large amount of acetone as a volatile 
solvent to dissolve the shell-forming polymer in the aqueous phase. While the 
volatile solvent evaporated, the aqueous volume decreased, yielding smaller 
capsules.
Polymer dissolved in Evaporation causes Polymer migrates Complete evaporation
aqueous core with polymer to precipitate and to the interface results in microcapsule
excess volatile solvent droplet shrinks in size formation
Figure 10. Microcapsules formed by solvent extraction and evaporation technique.[69]
A new class of biocapsules, so-called lyophilisomes, was developed by Daamen et 
al.[37] They presented a new precipitation strategy to prepare capsules from a range 
of (large) biomolecules at low temperatures. The preparation of these aggregates 
comprises three stages as depicted in Figure 11.
16
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Figure 11 Proposed mechanism for the preparation of lyophilisomes.[:
The first step is a microphase separation by fast-freezing, resulting in a water 
phase and biomolecule rich phase, which becomes organized into sheets. Secondly, 
annealing rearranges the sheets into spheres, which are transformed into hollow  
capsules in the third step by lyophilization. This final transformation is probably 
due to a three-dimensional coffee stain mechanism.[70]
2.4.2 Microcapsules formed by polymerization
A different approach to forming microcapsules utilizes polymerization of 
dispersed monomers or cross linking of polymers in solution. Several of these 
methods will be discussed in the next sessions.
2.42.1 Colloidosomes
Colloidosomes are microcapsules of which the shell consists of coagulated or 
sintered colloidal particles.[39] The capsule formation process normally starts with 
the formation of an emulsion from an organic phase and an aqueous suspension of 
polymer particles. By stirring this emulsion the polymer particles migrate to the 
oil/water interface and stabilize the water-in-oil droplets. The stability of the 
system is acquired by interlocking the particles using heat. This causes the particles 
to sinter and form a continuous shell. By varying the colloidal particles' size and/or
17
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the degree of sintering good control over the permeability of the resulting capsule 
can be obtained. Alternative shell locking mechanisms include the use of a 
coagulant or polymer adsorption once stabilized. The colloidosomes can be 
redispersed in an external fluid that is similar to the encapsulated environment. A 
similar but alternative method is to use colloidal particles that are initially 
suspended in the organic phase. Velev et al. introduced oil emulsion droplets into 
an aqueous dispersion of micron-sized polystyrene particles, which coat the 
emulsion droplets, thereby stabilizing the droplet.[71] They tailored the interparticle 
interactions by adsorbing surfactants to the particle surface, prior to emulsification.
2.4.22 Polymerization induced phase separation
In a first approach an emulsion of surfactant-stabilized organic droplets containing 
monomer is created.[68, 72] After initiation of the polymerization, the growing 
polymer chains become immiscible with the dispersed phase, leading to phase 
separation. The polymer is deposited on the oil droplet and forms a shell around it 
as depicted in Figure 12.
Figure 12. Shell forming polymer microcapsules with the polymerization induced phase 
separation method.[68]
In a second approach both phases in a water-in-oil emulsion contain monomer, 
which react with each other according to a polycondensation mechanism. These 
monomers meet at the interface and polymerize to form a membrane almost 
instantaneously. After this initial membrane formation the reaction between the 
monomers is decreased, since it is harder to diffuse through the polymer shell. 
Several papers have described the formation of these capsules using either nylon[73- 
74] or polyurethanes.[75-78] This latter class of polymers can also be used for capsule 
formation in oil-in-water systems as was demonstrated by Bouchemal et al.[79]
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A third approach was chosen by White et al.[80] They used an oil-in-water system, 
but in this case all the monomers were dissolved in the water phase and 
poly(ethylene-alt-maleic anhydride) was added as a stabilizer for the oil droplets in 
solution. The formed polymer became immiscible with the water phase, 
precipitated on the interface and was cross-linked. This resulted in microcapsules 
as depicted in Figure 13, which can be tuned in diameter between 10 to 1000 |am.
Figure 13. Microcapsules formed by precipitation polymerization out of the continuous 
aqueous phaseJ80!
All of the techniques described above use emulsifiers, templates or preorganized 
structures. Kim et al. have described an alternative, direct synthesis method of 
polymer nanocapsules by polymerization of cyclodextrins with multiple 
polymerizable groups at the periphery in methanol, using a photo polymerization 
technique (Figure 14) followed by dialysis.[81] This method produced polymer 
nanocapsules with a highly stable structure and relatively narrow size distribution.
Figure 14. Capsules created by polymerization of disk-shaped host molecules at the 
periphery.!81!
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The polymer shell allowed facile tailoring of its surface properties in a noncovalent 
and modular manner due to the unique recognition properties of the accessible 
molecular cavities exposed on the surface.
2.5 Application of polymeric capsules as nanoreactors
In this section we will focus on polymeric capsules for application as nanoreactors. 
This is a relatively new area in which during the last couple of years much 
progress has been madeJ12, 82-83] Nanoscaled reactors have been envisioned ever 
since the discovery by Bangham that isolated phosphatidylcholine self-assembles 
into vesicular aggregates.!2-3] Entrapped enzymes in the inner compartment of these 
vesicles can perform reactions, while substrate molecules are present in the bulk. 
The catalyst can convert these substrates, which first have to cross the membrane 
of the compartment. The set of requirements needed for a bioreactor has been set 
out by Monnard,[84] which can be briefly summarized as follows: (i) efficient 
entrapment of the catalyst within the inner compartment should be possible, (ii) a 
sufficiently robust and stable membrane of the reactor is needed, since the catalytic 
species and other components have to be retained and protected from degradation; 
the membrane though should allow for selective diffusion of the substrate and 
product, (iii) influences from the bulk, like pH, ionic interactions, temperature, 
should not influence the reactor in such a way that the system stops functioning, 
and (iv) the system should not be harmful when used in living systems.
Nanoreactors composed of polymers have the advantage of being very robust, 
which meets the second requirement set by Monnard. In case of polymersomes, the 
increased length and conformational freedom of the polymer chains that constitute 
the polymersome bilayer provide not only a basis for enhanced toughness when  
compared to liposomes, but also leads to reduced permeability of the membrane. 
This latter property is therefore a major disadvantage since it hampers the 
application of polymersomes as nanoreactors. Several solutions however have 
been developed recently to circumvent this problem.
Meier et al. constructed a polymersome nanoreactor using a triblock copolymer of 
poly(2-methyloxazoline)-b-poly(dimethylsiloxane)-b-(2-methyloxazoline), in which 
in the vesicular membrane a mutant of the FhuA protein, the OmpF channel 
protein was inserted. Normally the triblock copolymer forms a vesicle which is 
very robust and does not show permeability. By introducing a channel protein they
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created selective permeability, which was demonstrated by the fact that the 
encapsulated prodrug activating enzyme Trypanosoma vivax Nucleoside Hydrolase 
(TvNH) showed an activity which was determined by the transport of the 
substrate through the OmpF channel. When more channels were introduced, these 
reactors were no longer limited by transport.!85! A similar system was developed  
using a plant-derived acid phosphatase. By variation of the pH of the surrounding 
solution, the nanoreactor was able to change its state of activity as demonstrated 
by producing a water-insoluble fluorescent dye inside the polymeric vesicle. The 
bacterial pores that were integrated into the polymer membrane remained 
functional and allowed the passive diffusion of both protons for activity control of 
the encapsulated acid phosphatase, as well as the diffusion of the non-fluorescent 
substrate into the nanoreactor as depicted in Figure 15.[86]
Figure 15. Nanoreactor with tunable activity using pH.
Onaca et al. modified the FhuA protein chemically and made it a reduction- 
responsive channel.[87] By attaching bulky groups containing sulfur bridges on the 
lysine residues on the inside of the channel, they blocked the channel and therefore 
the encapsulated calcein molecules were unable to diffuse out of the polymersome. 
However, upon reduction of the sulfur bridges, the remaining bulk on the lysine 
residues was sufficiently small to let the encapsulated calcein pass through the 
channel.
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Triblock copolymer composed polymersome nanoreactors have also been 
investigated by Montemagno et al. They used poly(2-ethyl-2-oxazoline)-fc- 
poly(dimethylsiloxane)-fc-poly(2-ethyl-2-oxazoline) (PEtOz-PMDS-PEtOz) and 
incorporated the energy-transducing protein bacteriorhodopsin (BR) into the shell 
and showed that it retained its photoactivity as a light-driven pump that creates a 
proton gradient across the cell membrane.!88 This proton gradient can be used for 
the synthesis of ATP from ADP as depicted in Figure 16.[89] For this purpose both 
BR and ATP synthase were reconstituted simultaneously into the membrane of the 
polymersome. The coupled activity of BR and F0F1-ATP synthase allowed the 
generation of ATP by photoinduced phosphorylation.
Figure 16. Schematic representation of proteopolymersomes with BR and F0F1-ATP 
synthase, where BR creates a proton gradient which is used in the ATP synthesis from 
ADP.!89!
A different solution to the problem of permeability can be obtained by constructing 
intrinsically porous systems based on polyelectrolytes. Kataoka et al. demonstrated 
the successful compartmentalization of proteins in the earlier described 
PICsomes.t18] To demonstrate the porosity of the system myoglobin (Mb) was 
encapsulated in the lumen of the PICsomes. To assess the oxygen binding 
capability of Mb, metmyoglobin was reduced to deoxymyoglobin. By bubbling 
oxygen through the solution oxymyoglobin was formed, as demonstrated by UV- 
Vis spectroscopy. When argon was purged through deoxymyoglobin was formed
O
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again. Furthermore, they also showed that these capsules withstand harsh 
conditions when trypsin was added to the solution as depicted in Figure 17.
PEG-P(Asp) PEG-P(Asp-AP)
Mb-loaded PICsome
Figure 17. Reversible Mb oxygenation inside the PICsome.!18!
Since polyelectrolytes are also used in the Layer-by-Layer technique these capsules 
are intrinsically porous as well and can therefore be used as nanoreactorsJ90-92] 
Recently Kreft et al. have increased the level of complexity by showing that 
enzymes can be encapsulated using Layer-by-Layer capsules in a shell-in-shell 
conformation.!93] They encapsulated glucose oxidase (GOD) in the first shell using 
the standard techniques for this type of capsule with alternating layers of 
poly(styrene sulfonate) and poly(allylamine hydrochloride). Around this particle a 
second scaffold material containing peroxidase (POD) was created, which was 
subsequently decorated via the LBL technique with the second shell. When all the 
layers of the second shell were deposited, both scaffolds were dissolved resulting 
in microcapsules with two enzymes in different compartments. These enzymes 
were tested on activity as depicted in Figure 18.
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Figure 18. Layer-by-layer nanoreactor. A. Reaction scheme. B. Localization of Glucose 
Oxidase (GOD) and peroxidase (POD) within shell-in-shell capsules. C. In situ imaging of 
resorufin formation.!93!
Also microcapsules synthesized via interfacial polymerization have been applied 
as nanoreactor. Poe et al. encapsulated a nickel complex in a polyurea capsule by 
partially cross-linking poly(ethylene imine) (PEI) with a diisocyanate. By using 
such a capsule it was possible to provide site isolation of two otherwise 
incompatible catalysts. In this system the non-cross-linked PEI converts both 
aromatic and aliphatic aldehydes to nitroalkenes, which are then converted to the 
Michael adducts by the nickel catalyst.!94]
In some cases also neutral polymersomes prove to be sufficiently porous to be 
employed as nanoreactor systems. The earlier described PS-PIAT polymersomes 
(Fig. 6) could be used to encapsulate a variety of enzymes, such as the lipase 
Candida antarctica lipase B (CALB) in the lumen of the capsule.!52] When a 
profluorescent substrate was added outside of the polymersomes fluorescence 
occurred inside the capsules, indicating that the enzymes were still active and that 
the substrate was capable of crossing the polymersome membrane. These 
nanoreactors could also be used for enzymatic polymerizaton of hydrophobic 
lactones.!95] An extension of the capsule formation methodology also allowed the 
specific encapsulation of enzymes in the polymersome bilayer. This technique was 
combined with the traditional method for encapsulating enzymes in the water 
pool, which enabled the construction of a cascade reaction system of two enzymes: 
glucose oxidase (GOx) and horse radish peroxidase (HRP), which were located in 
the water pool and bilayer of the polymersomes, respectively. By adding a third 
enzyme, CALB, in solution outside of the polymersomes, even a three enzyme 
cascade reaction could be performed (Figure 19).[96]
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Figure 19. Schematic representation of the multistep reaction taking place in the three- 
enzyme-polymersome system.!96]
Van Dongen et al. have used a similar three enzyme cascade system to perform this 
reaction in which they positioned the enzyme GOx in the lumen of the 
polymersome, CALB in the bilayer and the enzyme HRP on the outside of the 
polymersome via a covalent linker.[97] For this purpose a mixed solution of 90% PS- 
PIAT and 10 % PS-PEG which was functionalized with an acetylene end group was 
gently injected in an aqueous environment to form clickable polymersomes, which 
could react with azide-functional HRP.[98] This work was extended by attaching a 
cell-penetrating peptide (CPP) to the PS-PEG polymer.!99] They encapsulated HRP 
in a polymersome of PS-PIAT and CPP functionalized PS-PEG and showed that by 
using this CPP on the outside of the polymersome, the polymersome was taken up 
in the cell. The enzyme was still catalytically active, which makes this system the 
first artificial organelle.
As an extension of the work on PS-PIAT polymersomes, Kuiper et al. encapsulated 
GOx and HRP in separate PS-PIAT polymersomes, which retained their activity.!100] 
This showed the concept of communication between the different enzymes without 
the addition of artificial transport mediators in the membrane or any other external 
stimuli.
2.6 Conclusions and outlook
Through evolution Nature has developed compartmentalization as a method to 
perform different multistep reactions within a cell without the problems of 
undesired interactions. This phenomenon has inspired chemists to mimic this 
compartmentalization strategy and perform reactions in a closed environment. 
Polymeric capsules such as polymersomes, layer-by-layer capsules and 
microcapsules have recently proven to be very useful in encapsulating enzymes
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and protecting these from the harsh environmental conditions that are sometimes 
used. By taking advantage of the intrinsic but limited porosity of polyelectrolyte 
capsules, specific types of polymersomes and microcapsules, enzymes and other 
macromolecular catalysts could be caged inside the capsules, whereas substrate 
and product still could diffuse in and out of the nanoreactors. In cases where 
porosity was not an intrinsic feature, the addition of membrane proteins led to 
induced permeability. At the moment researchers are increasing the complexity of 
their reactor systems, moving toward cascade reactions and higher levels of 
positional assembly. Although, when compared to Nature, the ability to program 
molecules to assemble in specific encapsulating architectures has only made its 
first steps, the first results are highly promising and can lead to the development of 
nanoreactors in which the conditions are ideal for multistep reactions which are 
protected from interfering with each other in an undesired fashion.
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Phase separation behavior of block copolymers in 
normal and reversed phase aggregates
Summary-
Biodegradable polymersomes were prepared in both aqueous and apolar 
environments, using amphiphilic block copolymers of poly(ethylene glycol)- 
poly(L-lactic acid) (PEG-PLLA), poly(ethylene glycol)-polycaprolactone (PEG-PCL) 
and poly(ethylene glycol)-poly(lactic-co-glycolic acid) (PEG-PLGA). Polymersomes 
were only formed in an aqueous environment by the kinetic injection method  
when the block copolymer poly(ethylene glycol)-polystyrene (PEG-PS) was added. 
This polymer served as a template for the formation of polymersomes from the 
biodegradable block copolymers. It was observed that for decreasing lengths of the 
polyester blocks increasing amounts of the templating polymer were needed.
In order to encapsulate hydrophobic compounds with a higher level of efficiency, 
reversed polymersomes were prepared by injecting a solution of the above 
mentioned block copolymers into an apolar medium. Again PEG-PS had to be 
added as template to obtain stable aggregates. This resulted in the formation of 
different types of aggregates with a specific morphology, having either dents or 
holes on their exterior. The amount of dents or holes was dependent on the amount 
of template, which indicated a phase separation of the block copolymers in the 
aggregate. The resulting structure of the aggregates was investigated by hydrolysis 
either enzymatically or by a basic buffer. This made it possible to determine the 
position of the biodegradable block copolymer in the aggregates and to conclude 
that distinct domains of each block copolymer were formed within the aggregates.
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3.1 Introduction
Lipids are the most common amphiphilic building blocks in nature. In aqueous 
environments they can self-assemble into micelles, liposomes, bilayer films or 
bigger structures, due to their hydrophilic headgroup and hydrophobic tail. A 
model for the formation of these different morphologies from low  molecular 
weight amphiphiles was developed by Israelachvili, in which a packing parameter, 
describing the geometry of the surfactant, predicts the expected assembly.!1-2] 
Lipids with approximate cylindrical geometry tend to form closed bilayer 
assemblies also known as liposomes, as described in more detail in chapter 2. The 
first phospholipid-based artificial liposome was prepared by Bangham et al.P] and 
was used to create a protecting environment for enzymes.M
Liposomes have attracted extensive attention during the past 30 years as 
pharmaceutical carriers with great potential due to their well-suited properties 
including biocompatibility, biodegradability, low  toxicity and immunogenicity.[5-6] 
The growing number of liposomal formulations in the market or currently under 
clinical evaluation provides proof of their enormous potentials7-8 However, since 
lipid vesicles are composed of low  molecular weight phospholipids or surfactants 
they exhibit less superior physical and chemical stability when compared to 
polymer vesicles.t9-10] These more stable polymeric capsules are also called 
polymersomes, based on their analogy with liposomes. The polymeric building 
blocks are similar to the phospholipids, in that they are comprised of a hydrophilic 
and a hydrophobic domain. Their large size induces improved mechanical stability 
and reduced permeability in the final assemblies. Discher adopted the theory of 
Israelachvili for block copolymers,[10] by introducing a hydrophilic fraction (f) that 
dictates the aggregate formation (Chapter 2). The methods for the formation of 
these polymersomes and their applications have been reviewed extensively in the 
last decade.[11-20]
Biodegradable polymersomes were only reported for the first time several years 
ago.[21-22] They were prepared from amphiphilic block copolymers having a 
hydrophilic block of poly(ethylene glycol) (PEG) and a hydrophobic block of 
poly(lactic acid) (PLA), polycaprolactone (PCL) or poly(methylene carbonate) 
(PMC). In some cases polymersomes were composed of biodegradable block 
copolymers mixed with an inert block copolymer to extend the degradation and 
release time. Ahmed et al. showed that when preparing polymersomes of PEG-
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PLA with PEG-poly(butadiene) (PEG-PBD) the membranes of these polymersomes 
were a homogenous mix of the two polymers.[23] The release rates of encapsulated 
molecules increased linearly with the mole ratio of PEG-PLAJ21]
The polymersomes described above are ideal for encapsulating hydrophilic 
compounds. However, incorporating hydrophobic molecules in these 
polymersomes is much harder, and the number of examples is rather limited. 
Ahmed et al. reported the encapsulation of a hydrophobic drug within the 
membrane as well as a hydrophilic drug in the lumen of a polymersome.[24] They 
showed that the release of hydrophilic and hydrophobic drugs from 
polymersomes led to a significantly improved apoptotic activity of tumor cells 
when compared to treatment with unencapsulated drugs. Ghoroghchian et al. 
incorporated large hydrophobic multi-porphyrin-based fluorophores non- 
covalently[25] within PEO-PBD polymersomes without compromising polymersome 
colloidal or mechanical stability, as was assessed by cryo-TEM and micropipette 
aspiration techniques.[26] Also nanoparticles have been incorporated in the bilayer 
of polymersomes.[27-36] All these systems have the disadvantage that the loading of 
the hydrophobic compound is limited to the volume of the vesicle wall.
Increasing the loading of hydrophobic compounds in vesicles can be achieved by 
creating a hydrophobic interior in the vesicle. Such vesicles are referred to as 
"reversed" vesicles and are prepared in organic, non-polar solvents instead of in 
aqueous solutions. The vesicle has a bilayer where the hydrophobic block of the 
polymer is pointing outside to the non-polar medium and the hydrophilic block is 
positioned inside forming the core of the membrane. Several stable reversed 
vesicles have been prepared by using amphiphilic molecules. Kunieda et al. were 
the first to publish reversed vesicles,[37] which they prepared by first dissolving 
tetraethylene glycol dodecyl ether in dodecane resulting in an isotropic solution. 
By the addition of a small amount of water, these isotropic solutions transformed 
into a lamellar liquid crystalline phase, yielding a multilayered vesicle with a 
hydrophobic core. Few attempts to form reversed aggregates have since then been 
reported.[38-48] To our knowledge only Vriezema et al. described the formation of 
reversed polymersomes when dissolving their amphiphilic block copolymers in 
chloroformJ49] The expectation is that these reversed vesicles would be more stable 
than the reversed liposomes described above for the same reasons as that 
polymersomes are more stable than liposomes when prepared in water.
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In this chapter we first describe our attempts to form biodegradable polymersomes 
in water, which were composed either purely out of biodegradable 
macromolecules or out of a mixture of biodegradable polymers with inert, 
templating amphiphilic block copolymers. Secondly, a study towards the 
formation of reversed aggregates using amphiphilic block copolymers was 
performed. This resulted in unexpected aggregate formation using different 
templating and biodegradable block copolymers. Also degradation studies were 
performed on these reversed aggregates in order to determine the location of the 
biodegradable block copolymers.
3.2 Results and discussion
3.2.1 Polymer synthesis
The biodegradable polymers that were studied were prepared via a ring opening 
polymerization (ROP) as depicted in Scheme 1, where methoxy poly(ethylene 
glycol) (PEG) was used as an initiator in order to construct block copolymers.
Stannous (II) octanoate 
Toluene, 120 ° C
Scheme 1. Synthesis of methoxy-poly(ethylene glycol)-poly(e-caprolactone).
Via the above mechanism biodegradable block copolymers with different lengths 
were synthesized. The hydrophilic PEG segment (Mn = 2000 g/mol) was kept 
constant while the lengths of the different hydrophobic parts (PLLA, PLGA and 
PCL) were varied. An overview of the synthesized polymers is given in Table 1.
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Table 1. Synthesized block copolymers.
Compound Polymer
Mn
(kg/mol)
Polydispersity
(PDI)
Hydrophilic 
fraction (f)
1 PEG45-PLGA75 7.0 1.09 0.30
2 PEG45-PLGA124 10 1.12 0.19
3 PEG45-PLGA246 17 1.09 0.11
4 PEG45-PLGA380 27 1.53 0.070
5 PEG45-PLGA753 51 1.38 0.040
6 PEG45-PCL15 3.7 n.d. 0.54
7 PEG45-PCL40 6.6 1.40 0.30
8 PEG45-PCL85 11 1.37 0.17
9 PEG45-PCL188 22 2.30 0.085
10 PEG45-PCL240 29 1.72 0.070
11 PEG45-PCL356 43 1.47 0.050
12 PEG45-PLLA45 5.3 1.43 0.38
13 PEG45-PLLA83 8.0 1.60 0.26
14 PEG45-PLLA215 17 1.73 0.11
15 PEG45-PLLA398 31 1.84 0.070
3.2.2 Aggregate formation in aqueous solutions
3.2.2.1 Polymersome preparation
In order to prepare aggregates the injection method was used. With this technique 
the dissolved block copolymer was injected into a poor solvent instantaneously.!50] 
In this particular case a polymer solution in tetrahydrofuran (THF) was injected 
into a stirred solution of milli Q. After 15 minutes, a sample was taken and 
analyzed with transmission electron microscopy (TEM) or scanning electron 
microscopy (SEM). An overview of the observed aggregation behavior is given in 
Table 2.
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Table 2. Results of polymersome preparation via the injection method.
Compound Polymer Formation of polymersomes
1 PEG45-PLGA75 no
2 PEG45-PLGA124 no
3 PEG45-PLGA267 no
4 PEG45-PLGA388 no
5 PEG45-PLGA745 tendency to form polymersomes
6 PEG45-PCL15 not tested
7 PEG45-PCL40 no
8 PEG45-PCL85 tendency to form polymersomes
9 PEG45-PCL188 not tested
10 PEG45-PCL240 tendency to form polymersomes
11 PEG45-PCL356 no
12 PEG45-PLLA45 no
13 PEG45-PLLA83 no
14 PEG45-PLLA215 no
15 PEG45-PLLA398 no
None of the synthesized compounds formed well-defined polymersomes. Some of 
the block copolymers had a tendency to form spherical aggregates as depicted in 
Figure 1, while most other block copolymers formed polymer films.
Figure 1. SEM image of aggregates prepared from PEG45-PCL85 with the injection method. 
3.2.2.2 Templating
Discher et al. showed that by mixing a biodegradable polymer (PEG-PLA) with a 
biocompatible polymer poly(ethylene glycol)-fc-polybutadiene (PEG-PBD) 
polymersomes can be obtained. The rationale was that the biodegradable polymer, 
in this case poly(lactic acid), was forced to participate in the polymersome 
formation of the other more hydrophobic polymer, which acts as a template. In our
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experiments PEG-PS was used as a template in the preparation of polymersomes 
from biodegradable block copolymers. PEG45-PS388 with a molecular weight of 42.3 
kg/mole had the right hydrophilic fraction to form well-defined polymersomes as 
can be seen in Figure 2. This polymer was therefore admixed in different amounts 
with polymers from Table 1.
Figure 2. TEM image of aggregates prepared from PEG45-PS388 with the injection method.
For the templating experiments PEG-PS and one of the biodegradable polymers 
from Table 1 were dissolved in THF and were then injected into a stirred solution 
of milli Q. After 15 minutes, a sample was taken and analyzed with TEM or SEM. 
An overview of the results is shown in Table 3. Also in Table 3 are the calculated 
mole fractions of the mixed templating polymer in the aggregates.
Table 3. Results of the templating method using PS-PEG. Capacity of polymersome 
formation and mole fraction of PS-PEG in the aggregates are given.
wt.% PEG-PS
25% 50% 75% 25% 50% 75%
Polymersome Mole fraction of
Compound Polymer formation PEG45-PS388 (%)
1 PEG45-PLGA75 No Yes Yes 5 14 33
4 PEG45-PLGA388 No No No 18 40 67
7 PEG45-PCL40 No Yes Yes 5 14 32
10 PEG45-PCL240 No No No 19 41 68
13 PEG45-PLA83 No Yes Yes 6 16 36
15 PEG45-PLA398 No No No 20 43 69
Polymers with a short hydrophobic block formed well-defined polymersomes 
when mixed with PEG-PS in ratios of 40-50 wt.% (14 mol% or higher), as is 
visualized in Figure 3.
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Figure 3. SEM images of PEG45-PCL40 templated with different ratios of PEG45-PS388. A. 25 
wt.% PEG45-PS388. B. 50 wt.% PEG45-PS388. C. 75 wt.% PEG45-PS388. Similar images were 
obtained when PEG45-PLGA75 and PEG45-PLA83 were templated with different ratios of 
PEG45-PS388.
At 25 wt.% PEG-PS (Figure 3A) only a few polymersomes were obtained, while 
still a lot of polymer film was formed. Successful templating using 50 wt.% or 75 
wt.% PEG-PS (Figure 3, B and C) resulted in the formation of polymersomes only, 
ranging from 100 to 500 nm in diameter. No film formation was observed in these 
samples.
Although it was expected that, based on Discher's theory, the biodegradable block 
copolymers with a larger hydrophobic block would have a stronger tendency to 
form polymersomes, this was not observed in these experiments. From Figure 4 it 
is clear that for all evaluated ratios, mainly polymer film is formed, although there 
is some tendency to form spherical aggregates.
Figure 4. SEM images of PEG45-PCL240 with different ratios of PEG45-PS388 added. A. 25 wt.% 
PEG45-PS388. B. 50 wt.% PEG45-PS388. C. 75 wt.% PEG45-PS388. Similar images were obtained 
when PEG45-PLGA388 and PEG45-PLA398 were templated with different ratios of PEG45-PS388.
In our hands it was not possible to prepare polymersomes from biodegradable 
polymers in an aqueous environment without using a templating polymer. An 
explanation for this could be the preparation method. The method of inducing 
aggregate formation determines if an aggregate is prepared under thermodynamic 
or kinetic control. Over the years many procedures have been developed like the
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already mentioned injection method.[51] This technique, however, results in 
aggregates that are formed under kinetic control. Other methods are, amongst 
others, the rehydration method, in which a film of aggregates is dried on a surface 
and submersed into water, sonication, electroformation and slow addition of a 
poor solvent to the amphiphile in a good solvent.!52] The latter method results in 
continuous aggregate formation under thermodynamic control, therefore allowing 
the amphiphiles to adopt the most favorable morphologyJ53-55]
The preparations of biodegradable polymersomes as reported in literature have all 
been carried out using a method with thermodynamic control. Discher et al. used  
the rehydration method, while Meng et al. used an injection method in which the 
polymer was dissolved in a water miscible and a non-misdble solvent. This allows 
for the membrane to be fluidic; the solvent was removed afterwards using 
dialysis.[22-23]
Biodegradable polymersomes could not be prepared when using kinetic control, 
which is probably due to the weak amphiphilic behavior of these block copolymers 
which does not allow for the instantaneous formation of a membrane. However, 
when adding a templating polymer, polymersome formation was observed, which 
was due to the strong amphiphilic behavior of PEG-PS. This block copolymer 
immediately precipitates, thereby forming vesicles. This precipitation forces the 
biodegradable block copolymers to co-precipitate, thereby yielding vesicles when  
small hydrophobic blocks of the biodegradable block copolymer were used. A 
possible explanation for the successful templating with PEG-PS for the shorter 
degradable polymers might be that in the membrane there is a better match 
between the shorter polymers and PEG-PS, which facilitates the packing of the two 
different block copolymers in the membrane. This behavior was not observed 
when biodegradable polymers having longer hydrophobic blocks were templated 
with PEG-PS. Even when high amounts of PEG-PS were used no polymersomes 
could be formed.
3.2.3 Aggregates in reversed phase
3.2.3.1 Reverse aggregate formation
In order to encapsulate hydrophobic compounds, reversed aggregates might be 
prepared by using the injection method in apolar medium to induce phase 
separation in the block copolymers. Therefore, a solution of biodegradable
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polymer in THF, mixed with or without PEG45-PS388 as a templating polymer, was 
injected into a stirred solution of hexane. After 30 minutes, a sample was taken and 
analyzed with TEM or SEM.
From the polymers listed in Table 1, only PEG45-PLLA83 formed aggregates in 
hexane without blending with a templating polymer as depicted in Figure 5A. An 
interesting observation was that these assemblies had small indentations or 
possibly holes on the outer surface. When aggregates of this polymer were 
prepared by blending with the templating polymer PEG45-PS388, more and bigger 
indentations on the exterior of the aggregates became visible and also the 
aggregates were much larger compared to the non-templated ones as shown in 
Figure 5B.
Figure 5. SEM images of aggregates of PEG45-PLLA83. A. Prepared via the injection method 
in hexane. B. Blended with PEG-PS (50 wt.%) and injected into hexane.
As mentioned before, for the other polymers with different PLLA hydrophobic 
block lengths no aggregates were formed when injected in hexane. When using a 
templating polymer a similar aggregation behavior as in Figure 5B was observed 
for the low molecular weight PLLA block (12), as depicted in Figure 6. For 
polymers having a longer PLLA block, only undefined aggregates were observed.
Figure 6. SEM images of aggregates of PEG-PLLA templated with PEG45-PS388 (50 wt.%) 
polymers. A. PEG45-PLLA45. B. PEG45-PLLA215. C. PEG45-PLLA398.
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When reversed aggregates were prepared using a less crystalline block copolymer, 
PEG-PCL, undefined aggregates were formed as can be seen in Figure 7A. 
However, when a small amount of templating polymer was used (25 wt.%), 
spherical aggregates were formed with holes in the surface of the shell. These 
aggregates also appeared to be smaller in diameter compared to the aggregates 
formed by PEG45-PLLA83. By increasing the amount of templating polymer, the 
holes in the surface of the aggregates became smaller and less abundant, as 
depicted in Figure 7 B-E. The occurrence and the size of the holes therefore 
appeared to be correlated to the amount of PEG-PS present.
Figure 7. SEM images of the aggregates of PEG45-PCL40 templated with different ratios of 
PEG45-PS388. A. 0 wt.% PEG45-PS388. B. 25 wt.% PEG45-PS388. C. 50 wt.% PEG45-PS388. D. 75 
wt.% PEG45-PS388. E. 100 wt.% PEG45-PS388.
In order to investigate this templated aggregation behavior further, PEG-PCL 
polymers listed in Table 1 with different lengths of the hydrophobic block were 
tested. However, since no more templating polymer of PEG45-PS388 was available, 
two PEG-PS polymers with different hydrophobic blocks were used, namely 
PEG45-PS320 and PEG45-PS149.
Since the length of the hydrophobic block of PEG45-PS320 had a difference of 60 
styrene units with the previously used PEG-PS, it was first tested whether this 
polymer could be used for templating PEG-PCL when injected into hexane. PEG45- 
PCL40 and PEG45-PS320 were weighed in different ratios and dissolved in THF. This 
solution was injected into hexane and the solution was shaken by hand to obtain
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reversed microspheres. After 30 minutes samples were taken and analyzed by 
electron microscopy. An overview of the aggregates is depicted in Figure 8.
Figure S. SEM images of the aggregates of PEG45-PCL40 templated with different ratios of 
PEG45-PS320. A. 0 wt.% PEG45-PS320. B. 15 wt.% PEG45-PS320. C. 25 wt.% PEG45-PS320. D. 50 
wt.% PEG45-PS320. E. 75 wt.% PEG45-PS320.
From Figure 8 it can be observed that the blended polymers have a similar 
aggregation behavior when compared with the previous experiments. When only 
15 wt.% of PEG45-PS320 was blended with PEG45-PCL40, aggregates were already 
formed, but well-defined assemblies were only observed upon raising the amount 
of PEG-PS to 25 wt.%. Again, the holes or indentations were decreasing in size and 
number when more PEG-PS was used for the aggregate formation.
Next PEG-PCL with different hydrophobic block lengths (compound 6-11 in Table 
1) were blended with PEG45-PS320. All these polymers were tested on aggregation 
behavior using the injection method. The minimal amount of templating polymer 
necessary to form stable aggregates was evaluated with SEM. The results are 
depicted in Figure 9. It was clearly observed that longer hydrophobic PCL blocks 
needed more templating polymer to yield aggregates.
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Figure 9. Minimal amounts of templating polymer necessary to obtain aggregates. SEM 
images of different molecular weights of PEG45-PCL templated with PEG45-PS320. A. 15 wt.% 
PEG-PS vs PEG45-PCL15. B. 15 wt.% PEG-PS vs PEG45-PCL40. C. 25 wt.% PEG-PS vs PEG45- 
PCL85. D. 50 wt.% PEG-PS vs PEG45-PCL188. E. 60 wt.% PEG-PS vs PEG45-PCL240. F. 75 wt.% 
PEG-PS vs PEG45-PCL356.
When more than these initial values of templating polymer were used, the 
aggregates behaved similarly to the systems described above and which are 
illustrated in Figure 8. However, it was interesting to observe that the length of the 
PCL block was of influence on the minimal percentage of PEG-PS necessary to 
obtain stable structures. Table 4 shows these minimal amounts of blended PEG-PS 
in weight and mole percent.
Table 4. Amount of PEG45-PS320 blended with biodegradable polymer.
Biodegradable polymer
Weight percent 
PEG45-PS320
Mole percent
PEG45-PS320
PEG45-PCL15 15 1.9
PEG45-PCL40 15 3.3
PEG45-PCL85 25 10
PEG45-PCL188 50 39
PEG45-PCL240 60 56
PEG45-PCL356 75 79
A clear trend can be derived from these data (Figure 10); a higher mole percentage 
of PEG-PS was needed to form well-defined aggregates when the PCL blocks 
became longer.
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Figure 10. Plot of the minimal amount of PEG45-PS320 needed to form aggregates vs. the 
length of the PCL block.
3.2.3.2 Degradation experiments
In order to gain more insight in the composition of the polymer aggregates and to 
investigate whether domain formation had occurred on the aggregate surface, it 
was attempted to remove one of the block copolymers selectively. For this purpose 
hydrolysis experiments on the degradable PCL block were performed. In order to 
conduct this experiment, aggregates of PEG45-PCL40 and PEG45-PS320 (50 wt.%) were 
formed in hexane and after 15 minutes freeze dried. These freeze dried products 
were redispersed in water in order to be able to carry out the planned hydrolysis. 
Since the redispersion in water could lead to a change of morphology of the 
aggregates, first SEM was performed on the redispersed samples. Figure 11 shows 
the comparison of these aggregates in hexane and after redispersion in water.
Figure 11. A. SEM images of aggregates of PEG45-PCL40 and PEG45-PS320 in hexane. B. 
Aggregates after redispersion and freeze drying in water.
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From these pictures it can be concluded that no morphological change had 
occurred and that the aggregates that were formed in hexane were stable in water. 
The degradation experiments could therefore be conducted using these aggregates. 
In first instance, an enzyme, Candida antarctica lipase B (CalB), was used, which is 
known to hydrolyze ester bonds. The degradation was followed for several days 
and changes in the morphology of the aggregates were analyzed by SEM as 
depicted in Figure 12.
Figure 12. SEM images during the enzymatic degradation experiments with CalB of PEG45- 
PCL40 and PEG45-PS320 aggregates at different time intervals. A. Aggregates at the start of the 
experiment. B. After one hour. C. After two days. D. After five days. E. After eight days. F. 
After two weeks.
From Figure 12 it can be observed that no significant morphological changes had 
occurred during degradation. It should also be noted that after five days the 
concentration of CalB was tripled to speed up the hydrolysis of the PCL block. 
However, this also had little effect on the morphology of the aggregates. It was 
therefore assumed that CalB was unable to reach the PCL blocks, which might be 
buried between the PS blocks. Also the fact that the aggregates were placed in 
water and not in a buffered solution might have had an influence on the activity of 
CalB. A different approach to hydrolyze the ester bonds was to expose these 
aggregates to a buffer solution of basic pH. This would hydrolyze the ester bonds 
without being dependent on the activity of an enzyme. This degradation 
experiment was performed in a Tris buffer of pH 8.5 and the aggregates were 
analyzed by electron microscopy as depicted in Figure 13. Also the length of the
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chosen PCL block was longer, in order to make the PCL chain more accessible, 
which would facilitate the hydrolysis.
Figure 13. SEM images of degradation experiments of aggregates of PEG45-PCL85 and PEG45- 
PS320 using a Tris HCl buffer. A. After 3 days. B. After 4 days. C. After 7 days. D. After 14 
days.
When comparing the SEM images, it was striking to see that even after 14 days, no 
changes had occurred in the morphology of the aggregates. This meant that the 
PEG-PCL had to be selectively positioned at the interior of the aggregates or that 
the presence of polystyrene had a protective effect on the PCL block.
In order to establish whether PS was protecting the PCL blocks from degradation, 
a smaller PS block was chosen. Aggregates were prepared from PEG45-PS149 (50 
wt.%) with PEG45-PCL85 as described above. When preparing the aggregates in a 
similar fashion as described above, a new type of aggregate was formed as 
depicted in Figure 14A.
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Figure 14. SEM images of aggregates of PEG45-PCL85 templated with PEG45-PS149 (50 wt.%). 
A. Aggregates were freeze dried 30 minutes after preparation. B. Aggregates were 
immediately freeze dried after preparation. The arrow indicates an aggregate having an 
acorn shape.
First it was thought that this acorn shape was induced by leaving the aggregates in 
hexane, therefore the procedure was repeated and the aggregates were 
immediately freeze dried. When the aggregates were redispersed in water and 
analyzed by SEM, the same morphology could be detected however, as can be seen 
in Figure 14B.
Although this morphology was different from the previous aggregates, hydrolysis 
experiments were still thought to be useful, as they could give insight in the phase 
separation of this specific polymer assembly. The degradation of the PCL blocks 
was performed with the enzyme CalB in water and analyzed by SEM at different 
time intervals as shown in Figure 15.
Figure 15. SEM images of aggregates of PEG45-PCL85 templated with PEG45-PS149 (50 wt.%) at 
different time intervals during enzymatic degradation using CalB. A. Aggregates before 
degradation had occurred. B. Aggregates after 9 days with CalB.
From these figures it could be clearly seen that the PCL-containing block 
copolymer was located on one side of the aggregate. It can therefore be concluded 
that the two block copolymers form two domains in the aggregate. The PCL-
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containing block copolymer, located in one of these domains, is completely 
hydrolyzed by the enzyme, resulting in a hole in the aggregate as shown in Figure 
15B. This behavior might come from a strong phase separating behavior of the two 
block polymers, indicating that a smaller PS block will not blend with PCL.
Also a degradation experiment was performed by using a basic Tris buffer. Here a 
similar approach was taken as described earlier. The aggregates were placed in a 
buffered solution of pH 8.5 and analyzed over time by electron microscopy. When 
analyzing the aggregates after 7 days, an identical result was obtained as when  
degradation was performed using an enzyme, as can be seen in Figure 16.
Figure 16. SEM images of degradation experiments with aggregates of PEG45-PCL85 
templated with PEG45-PS149 (50 wt.%) in Tris HCl buffer (pH 8.5). A. Aggregates dispersed in 
buffer at the start of the experiment. B. Aggregates after 7 days in buffer.
These experiments also showed that the aggregates, when prepared by templating 
with a short PS block, were not hollow. This phase separation behavior was in 
contrast with the systems in which the longer PS block was used, in which case the 
aggregates did not show any visual degradation. The intriguing part of the latter 
aggregates is that holes occurred on the surface of the aggregates, which could be 
controlled in size and number by changing the blending ratio. This shows that 
there might be some domain formation on the outside of these self-assembled 
aggregates. The phenomenon of phase separation in aggregates was recently 
published by Massignani et al., where they demonstrated that functional domains 
could be created on polymersome surfaces. This was achieved by mixing different 
polymersome-forming copolymers in order to induce polymersome-confined 
polymer-polymer phase separation. A  different surface topology was identified as 
a function of the poly(2-methacryloxy ethyl phosphoryl choline)-poly(2- 
(diisopropyl amino) ethyl methacrylate) / poly(ethylene glycol)-poly(2- 
(diisopropyl amino) ethyl methacrylate) ratio.!56 Furthermore, studies on
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polymersome phase separation have also been recently carried out by Discher and 
colleagues on poly(acrylic acid)-polybutadiene/poly(ethylene glycol)- 
polybutadiene copolymer combinations.!57! Here the ability of phase separation 
was combined with the responsive nature of poly(acrylic acid), showing ion and 
pH-induced transitions from patchy polymersomes to patchy micelles.
Based on the Flory Huggins theory, it is not unusual that phase separation occurs 
when these two polymers are mixed, since polymers with long blocks are quickly 
immiscible.!58] It is, however, striking that a shorter block of PS leads to a full phase 
separation, whereas a longer PS block does not show this behavior. Phase 
separation of a system is dependent on the length of the polymer chain and should 
therefore be more pronounced in the aggregates where the long PS blocks are 
present. A  possible explanation might be found in the preparation method of the 
aggregates. By using the injection method, the aggregates are kinetically trapped. It 
is possible that the aggregates having the longer PS blocks freeze in their 
conformations faster and thereby only allowing for small domains to be formed. 
When a shorter PS block is used there might be a higher mobility for the PS blocks 
to fully separate themselves from the PCL blocks.
3.3 Conclusions
A series of biodegradable amphiphilic block copolymers, PEG-PLGA, PEG-PLA 
and PEG-PCL, were used to prepare biodegradable polymersomes with the 
injection method. With electron microscopy it was observed that none of the 
synthesized block copolymers formed well-defined polymersomes in water, 
although some polymers displayed a tendency to form polymersomes.
By applying a templating method, where the polymersome forming block 
copolymer PEG-PS was mixed with the biodegradable block copolymers, it was 
possible to form polymersomes. However, the high molecular weight 
biodegradable block copolymers did not form polymersomes even with 75 wt.% 
PEG-PS present, while the shorter polymers did give well-defined polymersomes 
at a ratio of 50 wt.% PEG-PS.
Changing to an apolar medium for the preparation of reversed polymersomes had 
a great influence on the aggregation behavior. Aggregates could only be formed 
with PEG45-PLA83, while all other block copolymers did not give any defined
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aggregates. When templating with PEG-PS, spherical particles were formed for 
block copolymers comprised of PEG-PCL and for block copolymers with short 
PLLA blocks. Interestingly, little nicks or holes on the surface of the aggregates 
were observed, which could be tuned by the amount of templating polymer that 
was used.
In order to locate the biodegradable block copolymers, degradation studies were 
performed using the enzyme CalB, or a basic Tris HCl buffer. However, no visual 
changes could be found when analyzing the aggregates using an electron 
microscope. When a shorter PS block was used as a template for aggregate 
formation, a change in morphology of the aggregates was observed. An acorn-like 
shape was adopted and no nicks or holes were found on the exterior of the 
aggregates. Enzymatic degradation and basic buffer degradation studies revealed 
the location of the biodegradable polymer and showed that both polymers phase 
separated and formed two domains within the aggregates. The different 
morphologies of the aggregates might be explained by the preparation method. 
However, more studies are needed to investigate whether this behavior will occur 
for polymers having different lengths of PCL. Also interesting would be to use 
other biodegradable block copolymers having a PEG block and observe whether 
these types of aggregates or different ones are formed.
3.4 Experimental
General
3,6-Dimethyl-1,4-dioxane-2,5-dione (DL-lactide), (3-cis)-3,6-dimethyl-1,4-dioxane-2,5-dione 
(L-lactide) (98%), methoxy poly(ethylene glycol) (PEG), tin(II) bis(2-ethylhexanoate) 
(stannous octanoate, SnOct2) (>95%) and Tris(hydroxymethyl)aminomethane hydrochloride 
(Tris HCl) were purchased from Sigma-Aldrich. 1,4-Dioxane-2,5-dione (Glycolide, 97%) was 
purchased from Maybridge. PEG45-PS388, PEG45-PS320 and PEG45-PS149 were kindly provided 
by Encapson. Candida antarctica lipase B was purchased from Fluka. Hexane and diethyl 
ether were purchased from Baker. CH2Q 2 was distilled over CaH2, THF and toluene were 
distilled over Na/benzophenone. All other chemicals were used as received unless stated 
otherwise.
Analysis and Characterization
Proton nuclear magnetic resonance (:H  NMR) spectra were recorded at room temperature 
on a Bruker DPX300 spectrometer or a Bruker DPX200 spectrometer. Chemical shifts are
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expressed in parts per million (5 scale) relative to the internal standard tetramethylsilane (5 
= 0.00 ppm) for CDCk.
Molecular weights of the polymers were measured using size exclusion chromatography 
(SEC) on a Shimadzu system equipped with a guard column and a PL gel 5 |om mixed D 
column (Polymer Laboratories) with differential refractive index detector, using THF as an 
eluent at 1 mL/min and T = 35°C. Polystyrene (PS) standards in the range of 580 to 377,400 
g/mol (Polymer Laboratories) were used to calibrate the SEC.
Samples used for lyophilization were rapidly frozen in liquid nitrogen. Lyophilization was 
performed with an Ilshin FD 8515 at a condenser temperature of -92°C and 5 mTorr for at 
least 24 hours.
Transmission electron micrographs were taken on a JEOL JEM-100CX II microscope. The 
samples for TEM were prepared by drying a drop of a dispersion on a carbon-coated copper 
grid in air.
Scanning electron microscopy studies were performed on a JEOL JSM-6330F electron 
microscope. The samples for SEM were prepared by drying a drop of a dispersion on a clean 
glass substrate in air. The samples were sputtered with a layer of Pd/Au using a Cressington 
208 sputter coater.
Synthesis
General polymerization procedure fo r PEG45-PLGA.
Methoxy poly(ethylene glycol), DL-lactide and glycolide were placed in a Schlenk tube and 
dissolved in toluene. To this mixture stannous octanoate in dry toluene (400 |jl, 0.10 M) was 
added and the mixture was refluxed for 19 h under argon. The reaction mixture was 
allowed to cool to room temperature and poured into a mixture of hexane and diethyl ether 
(4:1 v/v) to precipitate the polymer. The mixture was centrifuged and the resulting white 
pellet was redissolved in dichloromethane and evaporated to dryness.
JH  NMR (300 MHz, CDCls) 5 (ppm): 1.56 (m, CffiCHO), 3.64 (s, OCH2CH2O), 4.91 (m, 
OCOCH2O), 5.12 (m, COCH(CHs)O).
Synthesis o f PEG45-PLGA75 (1).
Polymerization was performed as described above using PEG (100 mg, 50 |omol), DL-lactide 
(132.5 mg, 0.92 mmol) and glycolide (72 mg, 0.6 mmol). This yielded a white polymer in 83 
% (0.26 g, 37 |omol).
Molecular weight determination:
NMR: Mn = 6980 g/mol.
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GPC: Mn = 3351 g/mol, Mw = 3658 g/mol, PDI = 1.09.
Synthesis o f PEG45-PLGA124 (2).
Polymerization was performed as described above using PEG (100 mg, 50 |omol), DL-lactide 
(265 mg, 1.84 mmol) and glycolide (144 mg, 1.24 mmol). This yielded a white polymer in 83 
% (0.42 g, 41 |omol).
Molecular weight determination:
NMR: Mn = 10326 g/mol.
GPC: Mn = 3500 g/mol, Mw = 3784 g/mol, PDI = 1.12.
Synthesis o f PEG45-PLGA267 (S).
Polymerization was performed as described above using PEG (100 mg, 50 |omol), DL-lactide 
(397 mg, 2.76 mmol) and glycolide (211 mg, 1.82 |omol). This yielded a white polymer in 86 
% (0.60 g, 35 |omol).
Molecular weight determination:
NMR: Mn = 17300 g/mol.
GPC: Mn = 15457 g/mol, Mw = 16385 g/mol, PDI = 1.09.
Synthesis o f PEG45-PLGA388 (4).
Polymerization was performed as described above using PEG (100 mg, 50 |omol), DL-lactide 
(530 mg, 3.68 mmol) and glycolide (281 mg ,2.42 mmol). This yielded a white polymer in 83 
% (0.75 g, 27 |omol).
Molecular weight determination:
NMR: Mn = 27400 g/mol.
GPC: Mn= 20147 g/mol, Mw = 30824 g/mol, PDI = 1.53.
Synthesis o f PEG45-PLGA745 (B).
Polymerization was performed as described above using PEG (25 mg, 13 |omol), DL-lactide 
(300 mg, 2.09 mmol) and glycolide (200 mg, 1.73 mmol). This yielded a white polymer in 87 
% (0.46 g, 8.9 |omol).
Molecular weight determination:
NMR: Mn = 51006 g/mol.
GPC: Mn= 33002 g/mol, Mw = 45542 g/mol, PDI = 1.38.
General polymerization procedure fo r PEG45-PCL.
Methoxy poly(ethylene glycol) and e-caprolactone were placed in a Schlenk tube and 
dissolved in toluene. To this mixture stannous octanoate in dry toluene (400 |jl, 0.10 M) was 
added and the mixture was refluxed for 19 h under argon. The reaction mixture was
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allowed to cool to room temperature and poured into a mixture of hexane and diethyl ether 
(4:1 v/v) to precipitate the polymer. The mixture was centrifuged and the resulting white 
pellet was redissolved in dichloromethane and evaporated to dryness.
1H  NMR (300 MHz, CDCls) & (ppm): 1.38 and 1.60 (m, COCraCsfleCaO), 2.23(t, 
COCH2C3H 6CH2O , J = 7.2 Hz), 3.58 (s, OCH2CH2O), 3.98(t, COCH2C3H 6CH2O, J = 7.2 Hz).
Synthesis o f PEG45-PCL15 (6).
Polymerization was performed as described above using PEG (0.18 g, 91 |omol) and £- 
caprolactone (0.21 g, 1.8 mmol). This yielded a white polymer in 85 % (0.29 g, 77 |omol).
Molecular weight determination:
NMR: Mn = 3710 g/mol.
GPC: not determined.
Synthesis o f PEG45-PCL40 (7).
Polymerization was performed as described above using PEG (100 mg, 50 |omol) and £- 
caprolactone (250 mg, 2.2 mmol). This yielded a white polymer in 92 % (0.32 g, 49 |omol).
Molecular weight determination:
NMR: Mn = 6560 g/mol.
GPC: Mn= 8370 g/mol, Mw=11681 g/mol, PDI = 1.40.
Synthesis o f PEG45-PCL85 (8).
Polymerization was performed as described above using PEG (200 mg, 0.10 mmol) and £- 
caprolactone (0.97 g, 8.5 mmol). This yielded a white polymer in 83 % (0.97 g, 83 |omol).
Molecular weight determination:
NMR: Mn = 11690 g/mol.
GPC: Mn= 12526 g/mol, Mw = 17162 g/mol, PDI = 1.37.
Synthesis o f PEG45-PCL188 (9).
Polymerization was performed as described above using PEG (200 mg, 0.10 mmol) and £- 
caprolactone (1.9 g, 17 mmol). This yielded a white polymer in 90 % (0.54 g, 46 |omol).
Molecular weight determination:
NMR: Mn = 21620 g/mol.
GPC: Mn= 21334 g/mol, Mw = 48047 g/mol, PDI = 2.3.
Synthesis o f PEG45-PCL240 (10).
Polymerization was performed as described above using PEG (100 mg, 50 |omol) and £- 
caprolactone (1.20 g, 10.5 mmol). This yielded a white polymer in 85 % (1.10 g, 37 |omol).
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Molecular weight determination:
NMR: Mn = 29360 g/mol.
GPC: Mn= 28777 g/mol, Mw = 49497 g/mol, PDI = 1.72.
Synthesis o f PEG45-PCL356 (11).
Polymerization was performed as described above using PEG (50 mg, 25 |omol) and e- 
caprolactone (1.20 g, 10.5 mmol). This yielded a white polymer in 91 % (1.13 g, 27 |omol).
Molecular weight determination:
NMR: Mn = 42584 g/mol.
GPC: Mn= 32697 g/mol, Mw = 47738 g/mol, PDI = 1.47.
General polymerization procedure fo r PEG45-PLLA.
Methoxy poly(ethylene glycol) and L-lactide were placed in a Schlenk tube and dissolved in 
toluene. To this mixture stannous octanoate in dry toluene (400 |jl, 0.10 M) was added and 
the mixture was refluxed for 19 h under argon. The reaction mixture was allowed to cool to 
room temperature and poured into a mixture of hexane and diethyl ether (4:1 v/v) to 
precipitate the polymer. The mixture was centrifuged and the resulting white pellet was 
redissolved in dichloromethane and evaporated to dryness.
NMR (300 MHz, CDCls) 5 (ppm): 1.56 (m, CH3CHO), 3.64 (s, OCH2CH2O), 5.12 (m, 
COCH(CH3)O).
Synthesis o f PEG45-PLLA45 (12).
Polymerization was performed as described above using PEG (50 mg, 25 |omol) and L- 
lactide(85 mg, 0.590 mmol). This yielded a white polymer in 85% (0.12 g, 23 |omol).
Molecular weight determination:
NMR: Mn = 5312 g/mol.
GPC: Mn= 5428 g/mol, Mw = 7762 g/mol, PDI = 1.43.
Synthesis o f PEG45-PLLA83 (13).
Polymerization was performed as described above using PEG (50 mg, 25 |omol) and L- 
lactide(150 mg, 87 |omol). This yielded a white polymer in 83% (0.17 g, 21 |omol).
Molecular weight determination:
NMR: Mn = 7976 g/mol.
GPC: Mn = 13392 g/mol, Mw = 21394 g/mol, PDI = 1.60.
Synthesis o f PEG45-PLLA215 (14).
Polymerization was performed as described above using PEG (50 mg, 25 |omol) and L- 
lactide(400 mg, 2.7 mmol). This yielded a white polymer in 88% (0.39 g, 22 |jmol).
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Molecular weight determination:
NMR: Mn = 17487 g/mol.
GPC: Mn= 16775 g/mol, Mw = 29021 g/mol, PDI = 1.73.
Synthesis o f PEG45-PLLA398 (15).
Polymerization was performed as described above using PEG (50 mg, 25 |omol) and L- 
lactide(500 mg, 3.47 mmol). This yielded a white polymer in 88% (0.49 g, 16 |omol).
Molecular weight determination:
NMR: Mn = 30656 g/mol.
GPC: Mn= 30888 g/mol, Mw = 30888 g/mol, PDI = 1.84.
Aggregation studies
Preparation o f aggregates in the aqueous phase
A biodegradable block copolymer (10 mg) was dissolved in freshly distilled THF (1 ml) and 
was then injected into a stirred solution of Milli Q (5 ml, R = 18.2 MQ). The solution was 
stirred for an additional 15 minutes.
Preparation o f aggregates using the templating method
A mixture of a biodegradable block copolymer and PEG-PS, with a total mass of 10 mg, 
were dissolved in freshly distilled THF (1 ml) and injected into a stirred solution of Milli Q. 
The solution was stirred for an additional 15 minutes.
Preparation o f aggregates in an apolar phase
The preparation of aggregates was executed following the procedures described above, only 
Milli Q was replaced for hexane.
Degradation studies
Degradation using a buffered solution
Lyophilized aggregates (1 mg), which were formed as described above in the reversed 
phase, were added to a Tris HCl buffered solution (100 mM, pH 8.5, 1 mL). At certain time 
intervals, samples were collected and analyzed by electron microscopy.
Enzymatic degradation
Lyophilized aggregates (1 mg), which were formed as described above in the reversed 
phase, were added to Milli Q (1 mL) containing CalB (1 mg). The obtained dispersion was 
shaken mechanically and samples were taken at certain time intervals and analyzed by 
electron microscopy.
55
Chapter 3
3.4 References
[1] J. N. Israelachvili, S. Marcelja, R. G. Horn, Quarterly Reviews of Biophysics 1980, 
13, 121.
[2] J. N. Israelachvili, D. J. Mitchell, B. W. Ninham, Journal of the Chemical Society- 
Faraday Transactions Ii 1976, 72, 1525.
[3] A. D. Bangham, R. W. Horne, Journal of Molecular Biology 1964, 8, 660.
[4] A. D. Bangham, M. M. Standish, Weissman.G, Journal of Molecular Biology 1965, 
13, 253.
[5] A. L. Klibanov, K. Maruyama, V. P. Torchilin, L. Huang, Febs Letters 1990, 268, 235.
[6] R. R. Sawant, V. P. Torchilin, Soft Matter 2010, 6, 4026.
[7] M. L. Immordino, F. Dosio, L. Cattel, International Journal of Nanomedicine 2006,
1, 297.
[8] V. P. Torchilin, Nature Reviews Drug Discovery 2005, 4, 145.
[9] B. M. Discher, Y. Y. Won, D. S. Ege, J. C. M. Lee, F. S. Bates, D. E. Discher, D. A. 
Hammer, Science 1999, 284, 1143.
[10] D. E. Discher, F. Ahmed, Annual Review of Biomedical Engineering 2006, 8, 323.
[11] D. E. Discher, A. Eisenberg, Science 2002, 297, 967.
[12] K. Kita-Tokarczyk, J. Grumelard, T. Haefele, W. Meier, Polymer 2005, 46, 3540.
[13] D. Lensen, D. M. Vriezema, J. C. M. van Hest, Macromolecular Bioscience 2008, 8, 
991.
[14] J. A. Opsteen, J. Cornelissen, J. C. M. van Hest, Pure and Applied Chemistry 2004, 
76, 1309.
[15] S. F. M. van Dongen, H. P. M. de Hoog, R. Peters, M. Nallani, R. J. M. Nolte, J. C. M. 
van Hest, Chemical Reviews 2009, 109, 6212.
[16] D. M. Vriezema, M. C. Aragones, J. Elemans, J. Cornelissen, A. E. Rowan, R. J. M. 
Nolte, Chemical Reviews 2005, 105, 1445.
[17] H. N. Yow, A. F. Routh, Soft Matter 2006, 2, 940.
[18] K. T. Kim, S. A. Meeuwissen, R. J. M. Nolte, J. C. M. van Hest, Nanoscale 2010, 2, 
844.
[19] C. LoPresti, H. Lomas, M. Massignani, T. Smart, G. Battaglia, Journal of Materials 
Chemistry 2009, 19, 3576.
[20] M. Massignani, H. Lomas, G. Battaglia, in Modern Techniques fo r  Nano- and 
Microreactors/-Reactions, Vol. 229, 2010, 115.
[21] F. Ahmed, D. E. Discher, Journal of Controlled Release 2004, 96, 37.
[22] F. H. Meng, C. Hiemstra, G. H. M. Engbers, J. Feijen, Macromolecules 2003, 36, 
3004.
[23] F. Ahmed, A. Hategan, D. E. Discher, B. M. Discher, Langmuir 2003, 19, 6505.
[24] F. Ahmed, R. I. Pakunlu, A. Brannan, F. Bates, T. Minko, D. E. Discher, Journal of 
Controlled Release 2006, 116, 150.
[25] P. P. Ghoroghchian, P. R. Frail, K. Susumu, D. Blessington, A. K. Brannan, F. S. 
Bates, B. Chance, D. A. Hammer, M. J. Therien, Proceedings of the National 
Academy of Sciences of the United States of America 2005, 102, 2922.
[26] P. P. Ghoroghchian, J. J. Lin, A. K. Brannan, P. R. Frail, F. S. Bates, M. J. Therien, D. 
A. Hammer, Soft Matter 2006, 2, 973.
56
Phase separation behavior of block copolymers in normal and reversed phase aggregates.
[27] W. H. Binder, R. Sachsenhofer, Macromolecular Rapid Communications 2008, 29, 
1097.
[28] W. H. Binder, R. Sachsenhofer, D. Farnik, D. Blaas, Physical Chemistry Chemical 
Physics 2007, 9, 6435.
[29] J. Z. Du, S. P. Armes, Journal of the American Chemical Society 2005, 127, 12800.
[30] J. Z. Du, Y. P. Tang, A. L. Lewis, S. P. Armes, Journal of the American Chemical 
Society 2005, 127, 17982.
[31] M. Krack, H. Hohenberg, A. Kornowski, P. Lindner, H. Weller, S. Forster, Journal 
of the American Chemical Society 2008, 130, 7315.
[32] S. Lecommandoux, O. Sandre, F. Checot, J. Rodriguez-Hernandez, R. Perzynski, 
Journal of Magnetism and Magnetic Materials 2006, 300, 71.
[33] S. B. Lecommandoux, O. Sandre, F. Checot, J. Rodriguez-Hernandez, R. Perzynski, 
Advanced Materials 2005, 17, 712.
[34] Y. T. Li, A. E. Smith, B. S. Lokitz, C. L. McCormick, Macromolecules 2007, 40, 8524.
[35] Y. Mai, A. Eisenberg, Journal of the American Chemical Society 2010, 132, 10078.
[36] W. Mueller, K. Koynov, K. Fischer, S. Hartmann, S. Pierrat, T. Basche, M. Maskos, 
Macromolecules 2009, 42, 357.
[37] H. Kunieda, K. Nakamura, D. F. Evans, Journal of the American Chemical Society 
1991, 113, 1051.
[38] J. F. Ding, G. J. Liu, Macromolecules 1997, 30, 655.
[39] J. F. Ding, G. J. Liu, Chemistry of Materials 1998, 10, 537.
[40] D. Dominguez-Gutierrez, M. Surtchev, E. Eiser, C. J. Elsevier, Nano Letters 2006, 6, 
145.
[41] W. P. Gao, Y. Bai, E. Q. Chen, Z. C. Li, B. Y. Han, W. T. Yang, Q. F. Zhou, 
Macromolecules 2006, 39, 4894.
[42] H. Kunieda, K. Nakamura, M. R. Infante, C. Solans, Advanced Materials 1992, 4, 
291.
[43] H. G. Li, X. Xin, T. Kalwarczyk, E. Kalwarczyk, P. Niton, R. Holyst, J. C. Hao, 
Langmuir 2010, 26, 15210.
[44] S. Rangelov, M. Almgren, K. Edwards, C. Tsvetanov, Journal of Physical Chemistry 
B 2004, 108, 7542.
[45] S. H. Tung, H. Y. Lee, S. R. Raghavan, Journal of the American Chemical Society
2008, 130, 8813.
[46] K. Vijayakrishna, D. Mecerreyes, Y. Gnanou, D. Taton, Macromolecules 2009, 42, 
5167.
[47] X. N. Xu, L. Wang, Z. T. Li, Chemical Communications 2009, 6634.
[48] J. Zhang, Y. F. Song, L. Cronin, T. B. Liu, Chemistry-a European Journal 2010, 16, 
11320.
[49] D. M. Vriezema, J. Hoogboom, K. Velonia, K. Takazawa, P. C. M. Christianen, J. C. 
Maan, A. E. Rowan, R. J. M. Nolte, Angewandte Chemie-International Edition 2003, 
42, 772.
[50] A. S. Domazou, P. L. Luisi, Journal of Liposome Research 2002, 12, 205.
[51] Letchford K, B. H, European Journal of Pharmaceutics and Biopharmaceutics 2007, 
65.
[52] J. Z. Du, R. K. O'Reilly, Soft Matter 2009, 5, 3544.
[53] Z. C. Li, Y. Z. Liang, F. M. Li, New Journal of Chemistry 2002, 26, 1805.
57
Chapter 3
[54] L. B. Luo, A. Eisenberg, Journal of the American Chemical Society 2001, 123, 1012.
[55] L. F. Zhang, A. Eisenberg, Macromolecules 1999, 32, 2239.
[56] M. Massignani, C. LoPresti, A. Blanazs, J. Madsen, S. P. Armes, A. L. Lewis, G. 
Battaglia, Small 2009, 5, 2424.
[57] D. A. Christian, A. W. Tian, W. G. Ellenbroek, I. Levental, K. Rajagopal, P. A. 
Janmey, A. J. Liu, T. Baumgart, D. E. Discher, Nature Materials 2009, 8, 843.
[58] L. M. Robeson, Polymer blends: A comprehensive review, Hanser Verlag, Munich 2007.
58
An optimized preparation of core-shell 
microcapsules using double emulsions
Chapter 4
Summary-
Many parameters have an influence on the morphology and encapsulation 
efficiency of biodegradable microcapsules, which are formed out of a water-in-oil- 
in-water (w/o/w) emulsion. Here, several of these parameters were investigated by 
combining two different mathematical approaches to streamline the number of 
experiments that needed to be done to yield the optimal microcapsules with 
respect to encapsulation efficiency and microcapsule size. First a fractional factorial 
design was used to screen for the most dominant factors. These factors were 
optimized further by applying a D-optimal design. This resulted in microcapsules 
having a single core with a diameter below 10 microns and an encapsulation 
efficiency of 78%.
Chapter 4
4.1 Introduction
The use of biodegradable capsules for controlled delivery of proteins, hydrophilic 
drugs, antibodies and other water soluble compounds has grown immensely over 
the last couple of decades.[1-5] These capsules can be prepared by several methods 
like double emulsifications, organic phase separation, supercritical fluid and spray 
drying techniques using biodegradable polymers, such as poly(lactic acid) (PLA), 
poly(lactic-co-glycolic acid) (PLGA) or derivatives thereof.[6] Each technique has its 
own advantages and disadvantages, however, the double emulsification method is 
most commonly used to prepare PLGA microcapsules having a water soluble 
compound in their aqueous core.
Usually double emulsions are prepared in a two-step emulsification process using 
two surfactants: a hydrophobic one designed to stabilize the interface of the water- 
in-oil (w/o) internal emulsion and a hydrophilic one for the external interface of the 
oil globules (for water-in-oil-in-water (w/o/w) emulsions). The primary w/o  
emulsion is prepared under high-shear conditions to obtain small droplets of water 
in a non-miscible volatile solvent containing a polymer. The second step is an 
emulsification of the first emulsion with an external aqueous phase. The emulsion 
is prepared with less shear to avoid rupture of the internal droplets. Upon 
evaporation of the volatile solvent, the polymer precipitates and forms a shell 
around the internal aqueous phase as depicted in Figure 1.[1]
Figure 1. Schematic overview of the preparation of a double emulsion.
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Efficient preparation of w /o/w  microparticles is a complicated procedure in which 
many parameters can affect the morphology as well as the encapsulation efficiency 
of a compound. In this study, w e present a full optimization of the most relevant 
parameters in a model w /o/w  double emulsification system in order to optimize 
the encapsulation efficiency and the size of the capsules. Besides the fact that a 
high loading is aimed for, the targeted capsules should also contain one core and 
have a size between 1-10 ^m, which makes these capsules suitable for drug 
delivery purposes, e.g. by activating these capsules using ultrasound as described 
in Chapter 5.
Performing a full optimization with a high level of resolution of all of the 
parameters that might affect the preparation of w /o/w  microcapsules would of 
course give maximum information about which parameters are most influential. 
However, this would mean that a number of nAk experiments would need to be 
performed, k being the number of parameters, and n the number of levels for each 
parameter. For n=4 and k=15, for example, the number of experiments is 
>1,000,000,000, which is by far not feasible. A more effective approach is to first 
perform a full factorial design experiment with a low  number of n=2.[7] In this 
traditional full factorial design the number of experiments are related to the 
number of parameters (k) by 2Ak, meaning that even then the number of 
experiments can quickly become very large.
The solution to this problem is that only a part of all the possibilities is varied 
using fractional factorial design.[7] A major application of fractional factorials is in 
evaluating the parameters' direct influence and combined influence on 
experimental runs in which many factors are considered with the purpose of 
identifying those factors that have large effects. This statistical approach assumes 
that certain interactions involving more than two parameters are negligible and it 
therefore gives information about the most dominant parameters and the 
interactions between two parameters. After this fractional factorial approach, the 
most influential parameters are screened in more detail, mapping these parameters 
in several dimensions. This gives the best insight in optimal conditions, while only 
performing a fraction of the number of experiments. An optimal set of parameters 
can be extracted from a mathematical model fitted on this detailed dataset.
There are several examples in literature which describe an optimization study for 
the entrapment of a hydrophilic compound in PLGA microcapsules. Celebi et al.
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used a 23 full factorial design for the preparation and evaluation of salbutamol 
sulphate containing PLGA microspheres. They tested three variables on the effect 
of particle size and entrapment ratio.[8] They evaluated their results using analysis 
of variance and response surface graphs and concluded that drug concentration 
had a major influence on the encapsulation efficiency.
Hachicha et al. have optimized the preparation of microparticles using a fractional 
factorial design in which they encapsulated vancomycin by using a double 
emulsion.[9] Here they adapted a literature procedure and varied the speed and 
time of mixing when preparing the second emulsion. After performing 15 
experiments large PLGA particles were obtained that had encapsulated almost all 
vancomycin. They compared the encapsulation efficiency, size, zeta potential and 
release from the particles with the predicted model and showed that they had a 
significant correlation with the particle sizes and encapsulation efficiency, and a 
low  correlation for the release profile and zeta potential.
Rawat et al. used a 32 full factorial design to study the effects of the external 
aqueous phase volume and surfactant concentration on the entrapment and size of 
Eudragit microspheres. They showed the formulation optimization represented an 
economical approach to successfully preparing microspheres involving fewest 
numbers of experiments.™
It must be noted that all these capsules had multiple cavities in the microsphere 
itself and that some parameters, such as choice of polymer, and polymer 
concentration were adopted from previous studies. A vast amount of formulations 
for double emulsions is known in the literature where variations in type and 
concentration of polymer, organic solvent, added surfactant, temperature, 
concentration of drugs, and many more are described.[11-16] Since many parameters 
can be varied, optimization is mostly performed empirically, while keeping 
important parameters constant.
When the main effects are known, a better optimization study can be performed, 
like D-optimal design.[17] This computer model can be used to extract the most 
information from the preparation parameters based on the input of the number of 
parameter levels that have to be screened, the amount of experiments that have to 
be performed and the polynomial function that is going to describe the coherence 
between the data points. Based on this input, a design is provided, which allows 
for a maximal data extraction.
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In this chapter, an optimization study was performed for the preparation of core­
shell microcapsules using the double emulsion technique with a single core. The 
parameters to be optimized were particle size (1-10 ^m) and encapsulation 
efficiency (EE). First, the general parametric behavior was established using a 
quick univariate study, varying only one parameter at a time. This was needed to 
establish the fractional levels of most unknown parameters. These parameters were 
then used in a fractional factorial design which was performed on 9 independent 
factors for the preparation of single core-shell particles containing a model drug 
(fluorescein). From these factors, the most influential ones were selected and PLGA 
capsules were further optimized using a D-optimal design. These capsules were 
evaluated on their size and encapsulation efficiency (EE). The results showed that 
there was a very good correlation between the experimental data and the predicted 
model of the D-optimal design. Using the w /o/w  emulsification technique single 
core-shell capsules were prepared with high encapsulation efficiencies.
4.2 Results and discussion
Many factors can influence the preparation of double emulsion capsules, amongst 
others stirring speeds in the first and second emulsion, volumes of the first and 
second water phase, volume of the organic phase, concentration of the 
encapsulated model drug, type of polymer, its composition, molecular weight and 
concentration in the organic phase, temperature, amount and type of surfactant in 
the first and second emulsion and method of solvent removal of the organic phase. 
These are too many factors to test, therefore a preliminary study was performed in 
order to create a starting position. In a preliminary study of 4 prescreening 
experiments, the type of polymer, the stirring speed of the first and second 
emulsification, method of solvent removal, the addition of a surfactant in the first 
emulsion and the type of surfactant in the second emulsion were screened.
4.2.1 Synthesis of the used polymers
Two types of polymers were chosen to prepare microcapsules from: PLA and 
PLGA. These polymers were prepared via a ring opening polymerization (ROP) of 
the respective cyclic diesters of lactic acid and glycolic acid. Two initiators were 
used: 1-octanol and water. The first initiator produces an end-capped polymer 
whereas water initiation leads to a free carboxylic acid end group. In order to
63
Chapter 4
obtain polymers of different chain lengths, end groups and ratios, different 
conditions were applied to the synthesis, which are summarized in Table 1.
Table 1. Summary of the polymers synthesized for this study with their properties.
theoretical Mn, NMR Prepared Initiator
Nr Polymer type (kDa/mol) (kDa/mol)a PDI in Octanol Water
1 PDLLA 29.5 20.0 1.96 Toluene 1 -
2 PLGA 90:10 18.2 16.5 1.92 Toluene - 1
3 PLGA 90:10 7.8 8.0 2.08 Toluene - 1
4 PLGA 90:10 14.1 13.3 2.34 Melt - 1
5 PLGA 80:20 13.9 9.1 2.16 Melt - 1
6 PLGA 70:30 9.0 7.5 2.50 Dioxane - 1
7 PLGA 70:30 17.9 14.6 2.06 Melt - 1
8 PLGA 70:30 13.6 10.4 2.16 Melt - 1
9 PLGA 50:50* - 11.9 - -
a Calculated from the signal ratio between the monomer and the end group in the :H  NMR 
spectrum in deuterated chloroform.
* Purchased from Purac
With polymer 1 from Table 1, microcapsules were prepared using a water-in-oil-in- 
water emulsion technique, where the oil phase consisted of a solution of the 
polymer in a volatile solvent. First, an emulsion of water-in-oil was prepared using 
an ultraturrax, this emulsion was then rapidly added to a stirred secondary 
aqueous solution containing a surfactant, usually poly(vinyl alcohol) (PVA), 
thereby creating a double emulsion. All capsules were prepared with fluorescein in 
the aqueous phase of the first emulsion to investigate the encapsulation efficiency. 
The volatile solvent was removed by an extraction/evaporation method to yield the 
microcapsules.
4.2.2 Prescreening experiments
The prescreening experiments were performed by changing one parameter at a 
time, while keeping the other parameters constant. In this prescreening two 
quantitative parameters were tested: stirring speeds of the first and second 
emulsion, and three qualitative parameters: method of solvent removal, surfactant 
type in the oil phase and surfactant type in the external aqueous phase. A full 
overview of the parameters that were used during the prescreening as well as the 
parameters that were screened with their ranges are listed in Table 2. The optimal
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conditions found per prescreening experiment (shown in table columns) were used 
in the consecutive prescreening.
Table 2. Prescreening of several parameters for the preparation of w/o/w emulsions. Ranges 
or variables of the prescreened parameters are indicated per prescreening in bold.
Prescreening
Parameter 1 2 3 4
Vol. internal aq. phase (w1) (mL) 2 2 2 2
Fluorescein conc. in w 1 (mg/mL) 10 10 10 10
Vol. organic phase (oil) (mL) 4 4 4 4
Polymer conc. in oil (mg/mL) 150 150 150 150
Vol.external aq. phase (w2) (mL) 10 10 10 10
Type of polymer PDLLA PLGA PLGA PLGA
Ratio polymer comp. 
(Lactide:Glycolide, L-G))
100:0 50:50 50:50 50:50
Mol. weight polymer (kDa/mol) 20.0 11.9 11.9 11.9
Stirring speed 1st emulsion (krpm) 15-20 20 20 20
Stirring speed 2nd emulsion (krpm) 5-10 10
Reduced
10 10
Method of solvent removal Evaporation
pressure
Heating
Evaporation
Evaporation Evaporation
Type of surfactant in oil Span 80
PVA
Tween-80
Type of surfactant in w 2 PVA PVA PVA F-108
SCH
AO T
Conc. surfactant in oil (wt.%) - - 0.25
1
0.01
Conc. surfactant in w 2 (wt.%) 1 1 1 5
1.5
0.5
4.2.2.1 Prescreening 1: Stirring speeds
In order to evaluate the influence of the stirring speed on the size of the 
microspheres in the first prescreening, different stirring speeds for the 1st and 2nd 
emulsification step were applied. Here PDLLA (entry 1 from Table 1) was used as 
the capsule forming polymer. The optical microscopy and SEM images of the 
resultant microcapsules are shown in Figure 2.
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Figure 2. Optical microscopy (1) and SEM pictures (2) of microspheres prepared with 
PDLLA using a speed of 20,000 rpm (A, B) or 15,000 rpm (C, D) for the first emulsification, 
and a speed of 10,000 rpm (A, C) or 5,000 rpm (B, D) for the second emulsification.
From this figure it can be observed that when the stirring speed for the first 
emulsification step was lowered from 20,000 to 15,000 rpm (A respectively C or B 
respectively D in Figure 2), while keeping the other parameters constant, the size 
distribution of the formed capsules was reduced. When for the second 
emulsification step the stirring speed was reduced from 10,000 to 5,000 rpm (A and 
B or C and D in Figure 2), larger capsules were formed with multiple cavities 
instead of single cavities as observed by optical microscopy. The explanation for 
this is that a lower stirring speed will give larger oil droplets in the second 
emulsification step. These oil droplets can contain multiple water droplets, that 
were formed in the first emulsification step. If, however, the emulsification speed 
of the second emulsion is sufficiently high, one oil droplet will contain only one 
water droplet as depicted in Figure 3.
1“ emulsification step 2nd emulsification step
water-in-oil emulsion water-in-oil-in-water emulsion
(w l/o emulsion) (wl/o/w2 emulsion)
Figure 3. Schematic representation of the influence of the second emulsification speed on the 
formation of capsules.[18]
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These first experiments gave a good indication for the stirring speeds that have to 
be used for the design of experiment strategy. Three qualitative factors (method of 
solvent removal, the addition of a surfactant in w1 and the type of surfactant in 
w2) were subsequently prescreened to simplify the experimental design and 
concentrate on optimization of the quantitative factors. These experiments were 
performed with PLGA (lactide:glycolide 50:50) (entry 9 from Table 1), since it is 
known from literature that the more hydrophilic polymer results in even higher 
encapsulation efficiencies.[1920]
4.2.22 Prescreening 2: Method of solvent removal
It is generally assumed that fast polymer precipitation on the surface of the droplet 
can prevent drug loss into the external aqueous phase and when precipitation of 
the polymer in the oil phase is delayed, the EE becomes lower as shown in Figure 
4.[14]
▲ >-- d™8
Figure 4. Schematic representation of the mechanism influencing encapsulation efficiency.
The method and rate of solvent removal is a critical parameter for the solidification 
rate of the dispersed phase. The volatile solvent can be removed by (i) using a 
rotary evaporator under reduced pressure or (ii) pouring the double emulsion into 
a 40°C aqueous solution or (iii) extraction and evaporation with a 5% isopropanol 
(IPA) solution in water. These three techniques were compared with respect to 
their effect on particle size and EE and the results are shown in Table 3. The EE 
was calculated using the formula described in the experimental section.
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Table 3. Comparison of three methods of solvent removal on the encapsulation efficiency 
and particle size.
Method Mean particle size* (|am) EE (%)
Reduced pressure 0.92
Heating 0.66
Evaporation 0.70
* Measured by dynamic light scattering (DLS)
In Table 3 it can be seen that the encapsulation efficiency was the highest when the 
volatile solvent was extracted and evaporated using a 5% aqueous IPA solution. 
Therefore this method was selected for further investigations.
4.22.3 Prescreening 3: Surfactants in the first emulsification step
To form stable capsules, the oil phase needs to be stabilized in the external aqueous 
phase. Different surfactants can be used to form a protective barrier around the 
dispersed oil droplets, thereby preventing coalescence of these droplets as depicted 
in Figure 5.[21]
cT*o  ' 9Coalescence
Figure 5. Coalescence mechanism of two droplets.
In addition to their function as protective barrier, surfactants stabilize the emulsion 
by acting as a 'bridge' between the oil droplets and the water, thereby reducing the 
surface energy of the interface.[22] Some emulsifiers enhance the stability of the 
droplets by imparting a charge on their surface, thus reducing the physical contact 
between the droplets and thereby decreasing the chance of coalescence.
Emulsifiers can be classified in terms of the hydrophilic-lipophilic balance (HLB), 
which is useful for surfactant selection.[23] The HLB takes into account the relative 
composition of the surfactant molecule, i.e. the ratio of the hydrophilic and 
hydrophobic fragments.
11
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It is generally considered that surfactants with a low  HLB (2-8) are oil soluble and 
are preferably used for w/o emulsions, whereas surfactants with a high HLB (>12) 
are water soluble and find applications in o/w  emulsions. Capsules are formed 
when the stabilizing agent concentration is above the critical micelle concentration 
(CMC), the concentration at which micelle formation begins. It is therefore 
important to know the CMC value of the surfactants studied.[22]
In the double emulsion-solvent evaporation method, stability of the primary (w1/o) 
emulsion can be a critical factor for efficient encapsulation of hydrophilic 
compounds.!14] When the first emulsion is unstable, the encapsulation efficiency is 
low, because the internal aqueous phase (w1) tends to merge with the neighboring 
external aqueous phase (w2). Stability of the primary emulsion can be enhanced by 
including emulsifying agents with a low  HLB, which dissolve in the oil. Span-80 
(HLB = 4.3) was tested to see if the encapsulation efficiency was increased, 
however the EE dropped from 30% to 26% when Span-80 was added, therefore no 
surfactant was used in the first emulsification step.
42 .2 .4  Prescreening 4: Surfactants in the second emulsification step
As mentioned above, the presence of stabilizing agent in w2 reduces surface 
tension between water and oil and facilitates the solid particle formation. Several 
types of water soluble stabilizers with high HLB values were selected in order to 
compare their ability to aid in the encapsulation of products as listed in Table 4.
Table 4. Comparison of five surfactants on their effect of encapsulation efficiency.
Surfactant Type HLB CMC
(wt.%)
Conc.
(wt.%)
EE (%)
PVA Non-ionic polymer I 8 P4] n.a. 1 30
Tween-80 Non-ionic surfactant 15[25] 0.002 0.01 6
PEG-Poly(propylene 
glycol)-PEG (F-108)
Block copolymer >24[26] 4.5 5 0
Sodium cholate 
hydrate (SCH)
Anionic surfactant 1 8 P7] 1.1 1.5 15
Sodium bis(2-ethylhexyl) 
sulfosuccinate (AOT)
Anionic surfactant >10[28] 0.1 0.5 17
According to the results shown in Table 4, PVA gave the highest EE, therefore PVA 
was selected as the model surfactant for further investigations.
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4.2.3 Screening design: fractional factorial design
This preliminary screening described above was a necessary first step in order to 
assess the parameters that should be taken into account. As a second step, in order 
to determine which parameters are dominant in the preparation of double 
emulsion capsules, a fractional factorial design (FFD) experiment was executed. 
This will allow to determine the influence of the other parameters, which were not 
screened during the prescreening, on EE and size when preparing double emulsion 
capsules. These parameters were tested in the range indicated in Table 5.
Table 5. FFD of several parameters for the preparation of w/o/w emulsions. Ranges or 
variables of the screened parameters are indicated in bold.
Parameter FFD
Vol. internal aqueous phase (w1) (mL) 1-2
Fluorescein concentration in w1 (mg/mL) 5-10
Vol. organic phase (oil) (mL) 4
Polymer concentration in oil (mg/mL) 100-200
Vol.external aqueous phase (w2) (mL) 5-10
Type of polymer PLGA
Ratio of polymer composition (Lactide:Glycolide) 70:30 -  90:10
Molecular weight of polymer (kDa/mol) 8.0-15.0
Stirring speed 1st emulsion (krpm) 15-20
Stirring speed 2nd emulsion (krpm) 10-15
Method of solvent removal Evaporation
Type of surfactant in oil -
Type of surfactant in w2 PVA
Conc. surfactant in oil (wt.%) -
Conc. surfactant in w2 (wt.%) 0.5-1
The following parameters were screened using fractional factorial screening 
design: the effect of polymer composition, molecular weight and concentration, 
fluorescein concentration, the volumes of the internal aqueous phase (w1) and 
external aqueous phase (w2), PVA concentration in w2 and emulsification speed of 
the two emulsions on the encapsulation efficiency. It must be noted that the 
volume of the organic phase was kept constant at 4 mL for these experiments. 
Table 6 shows the 9 factors, which were studied at two levels, coded upper and 
lower limits (Xi = +1; Xi = -1).
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Table 6. Factor levels for 29-5 fractional factorial design.
Factor Factor studied Abbreviation Factor levels (Xi)
-1 +1
U1 Volume of internal aqueous phase (mL) w1 1 2
U2 Fluorescein concentration in w1 (mg/mL) Fluo 5 10
U3 Polymer concentration (mg/mL) PLGA conc. 100 200
U4 Volume of external aqueous phase (mL) w2 5 10
U5 PVA concentration (wt.%) PVA 0,50 1
U6 Ratio of polymer composition (L-G) PLGA ratio 70-30 90-10
U7 Molecular weight of polymer (kDa/mol) PLGA Mw 8.0 15.0
U8 Speed 1st emulsification (rpm) w/o speed 15,000 20,000
U9 Speed 2nd emulsification (rpm) w/o/w speed 10,000 15,000
First, the effects of the process factors U1-U9 on the considered responses (EE and 
size) were studied, using a 29-5 fractional factorial screening design (2k-r). These 
experiments allow insight in these nine effects and in some two-factor interactions, 
while only performing 16 experiments. An overview of the performed experiments 
and their results for EE and size are listed in Table 7.
Table 7. Factorial design of the parameter screening step (29-5 fractional factorial design) and 
observed responses.
Exp Factors Responses
PLGA PLGA PLGA w/o w/o/w EE Size
w1 Fluo conc. w2 PVA ratio Mw speed speed (%) (|°m)
1 1 5 100 5 0.5 70-30 8.0 15,000 15,000 0 0.89
2 2 5 100 5 1 70-30 15.0 20,000 10,000 62 0.69
3 1 10 100 5 1 90-10 8.0 20,000 10,000 50 1.06
4 2 10 100 5 0.5 90-10 15.0 15,000 15,000 0 0.90
5 1 5 200 5 1 90-10 15.0 15,000 10,000 60 1.41
6 2 5 200 5 0.5 90-10 8.0 20,000 15,000 18 1.20
7 1 10 200 5 0.5 70-30 15.0 20,000 15,000 26 1.26
8 2 10 200 5 1 70-30 8.0 15,000 10,000 79 0.78
9 1 5 100 10 0.5 90-10 15.0 20,000 10,000 5 1.15
10 2 5 100 10 1 90-10 8.0 15,000 15,000 47 0.54
11 1 10 100 10 1 70-30 15.0 15,000 15,000 57 0.55
12 2 10 100 10 0.5 70-30 8.0 20,000 10,000 0 0.63
13 1 5 200 10 1 70-30 8.0 20,000 15,000 72 0.65
14 2 5 200 10 0.5 70-30 15.0 15,000 10,000 36 1.20
15 1 10 200 10 0.5 90-10 8.0 15,000 10,000 19 0.96
16 2 10 200 10 1 90-10 15.0 20,000 15,000 51 0.65
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These results were plotted in a Pareto chart to observe the effect of each of the 
parameters as depicted in Figure 6 and 7. All effects were normalized when  
plotted, however their values are denoted in the figures.
Figure 6. Pareto chart of the 29-5 fractional factorial design of the capsule size. Negative and 
positive effects are indicative for the factor levels.
From Figure 6 it can be seen that the first emulsification speed was of no influence 
on the microcapsule size. The concentration of PVA (-0.21) and the volume of the 
second water phase (-0.21), followed by the polymer concentration (+0.17) seemed 
to be dominant factors, while the other factors were of secondary importance.
Concerning the effect on the EE as shown in Figure 7, it was clear that the PVA 
concentration was the most influencing factor (+0.83), followed by the 
concentration of PLGA in the oil phase (+0.12). The PLGA ratio, as well as the 
second emulsification speed had a minor influence on the encapsulation efficiency.
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Figure 7. Pareto chart of the 29-5 fractional factorial design of the encapsulation efficiency.
The influence of the PVA concentration was also confirmed by electron microscopy 
studies of the capsules as depicted in figure 8. When a concentration of 0.5% (w/w) 
PVA was used, many incomplete or ill-formed capsules could be seen. When more 
PVA was used (1%), perfectly spherical capsules were formed. This difference in 
morphology of the capsules also explains the low EE obtained when using a lower 
concentration of PVA.
Figure 8. A. SEM image of capsules prepared with 0.5% PVA. B. SEM image of capsules 
prepared with 1% PVA.
To achieve optimal encapsulation conditions, the four major influences on the 
encapsulation efficiency and capsule size as mentioned above were studied in 
further detail by performing a D-optimal design. In order to determine the 
conditions for obtaining the highest EE, the five other parameters studied with the 
fractional factorial design were kept constant and the level was chosen taking in 
consideration the sign of the estimated effect. When a factor had a negative effect,
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its low  level was chosen and when a factor had a positive effect, the response was 
higher when it was at its higher level. One exception was made: for the molecular 
weight of PLGA, the lowest level was chosen. This exception was permitted since 
this factor had only a very low  effect (0.040). A comparison with FFD and an 
overview of the parameters with their ranges, which were further optimized using 
D-optimal design are listed in Table 8.
Table 8. Overview of the parameters for the preparation of w/o/w emulsion. Ranges or 
variables of the screened parameters are indicated in bold.
Parameter FFD D-optimal design
Vol. internal aqueous phase (w1) (mL) 1-2 2
Fluorescein concentration in w1 (mg/mL) 5-10 5
Vol. organic phase (oil) (mL) 4 4
Polymer concentration in oil (mg/mL) 100-200 175-325
Vol.external aqueous phase (w2) (mL) 5-10 5
Type of polymer PLGA PLGA
Ratio of polymer composition (L:G) 70:30 -  90:10 70:30 -  90:10
Molecular weight of polymer (kDa/mol) 8.0-15.0 8.0
Stirring speed emulsion 1 (krpm) 15-20 15
Stirring speed emulsion 2 (krpm) 10-15 6-14
Method of solvent removal Evaporation Evaporation
Type of surfactant in oil - -
Type of surfactant in w2 PVA PVA
Conc. surfactant in oil (wt.%) - -
Conc. surfactant in w2 (wt.%) 0.5-1 1-3
4.2.4 Optimization design: a D-optimal design
The D-optimal design methodology was used in order to investigate in more detail 
the effect of the remaining factors (concentration of PVA, speed of the second 
emulsification, polymer composition and polymer concentration) at three levels. 
The levels of the chosen factor candidates are given in Table 9.
Table 9. Factor levels applied to D-optimal Experimental Design.
Factor Factors studied Abbreviation -1
Factor levels 
0 1
U3 Polymer conc. in oil (mg/mL) PLGA conc. 175 250 325
U5 PVA concentration (wt.%) PVA 1 2 3
U6 Ratio polymer composition (L:G) PLGA ratio (L:G) 70:30 80:20 90:10
U9 speed 2nd emulsion (rpm) w/o/w speed 6,000 10,000 14,000
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The 25 experiments that were performed are listed in Table 10 together with the 
responses on size and encapsulation efficiency.
Table 10. D-optimal Experimental Plan and observed responses.
Exp. Factors Responses
PLGA PLGA w/o/w EE Size
conc. PVA ratio speed (%) (Mm)
1 325 3 90:10 6,000 27
lo4
2 175 1 90:10 14,000 50 0.9; 4.0b
3 325 3 90:10 14,000 14 5.0a
4 325 3 70:30 10,000 62 5.0b
5 325 1 70:30 6,000 78 0.9; 5.0b
6 175 1 70:30 6,000 62 1.0; 4.6b
7 325 2 90:10 10,000 7.0 9.0a
8 325 1 90:10 14,000 60 1.1; 4.6b
9 325 3 70:30 14,000 46 0.5, 5.3b
10 175 1 80:20 6,000 56 0.6; 3.6b
11 175 1 70:30 14,000 65 0.7b
12 325 1 70:30 14,000 78 0.8; 5.1b
13 175 3 70:30 14,000 27 0.7b
14 325 3 80:20 6,000 34 22a
15 325 1 90:10 6,000 63 37a
16 175 3 80:20 10,000 19 4.9b
17 250 3 70:30 6,000 51 7.0a
18 250 2 80:20 14,000 10 4.0a
19 250 1 70:30 10,000 68 1.0, 4.9a
20 175 2 90:10 6,000 1.0 19a
21 175 3 90:10 14,000 10 0.6, 5.6a
22 325 2 70:30 6,000 45 1 0 a
23 175 3 90:10 6,000 14 1 0 a
24 175 3 70:30 6,000 35 6.0a
25 250 1 90:10 6,000 55 13a
aMeasured by SEM, two values are given when two distributions were observed. 
bMeasured by Dynamic Light Scattering (DLS), two values are given when two distributions 
were observed.
From these experiments, the following equation (1) was constructed and used to 
demonstrate the relationship between the factors and the response EE. It must be 
noted that this equation was logit transformed, since the EE can only be a value 
between 0-100%.
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EE= 78 (1)(i +e-factorEE) 
where factorEE =
0.0326 * concPLGA- 0.00031 * concPLGA* ratioPLGA - 10.1 * concPVA+ 2.24 * (concpVA)2
- 0.083 * ratioPLGA
When the number of independent variables in a model increases, it becomes more 
difficult to visualize their impact in a plot. Therefore several 2D surface curves 
were plotted (Figure 9 and 10). Here only two predictors are plotted, while the 
other two parameters are fixed on the optimum. The contour lines in both plots are 
the EE's and the sizes respectively of the different systems.
Figure 9. 2D surface plot for the effect of selected variables on the encapsulation efficiency of 
the microspheres listed in Table 10. The contour lines represent the EE's of the different 
systems.
76
An optimized preparation of core-shell capsules using double emulsions
Figure 10. 2D surface plot for the effect of selected variables on the size of the microspheres 
listed in Table 10. The contour lines represent the sizes of the microspheres of the different 
systems.
The 2D surface plots were used to determine the optimal conditions to achieve the 
maximum encapsulation efficiency. These optimal conditions are at the 
intersection of the lines which are depicted in the 2D surface plots (Figure 9 and 
10). As shown in the 2D surface plots the optimal experimental conditions were: a 
PVA concentration of 1%, a PLGA ratio of 70:30 and a PLGA concentration of 325 
mg/mL. These optimal experimental conditions gave capsules, with sizes between 
5 and 10 |am.
In order to establish how well the model succeeded in explaining the initial 
dataset, the model quality was determined. A model evaluation for the EE and the 
size are depicted in Figure 11 as true vs. predicted plots.
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Figure 11. A. Plot of true vs. predicted EE. B. Plot of true vs. predicted size.
If all points are on the diagonal line, the model fits perfectly with the experimental 
data and then has a mathematical model skill of 1. This measure was calculated by 
comparing the model prediction with the measured value using the mean of the 
response variable. The experiments which gave the largest deviation from the 
predicted values were numbered. In this study a model skill of 0.921 was found for 
EE, which fits very well with the model. On the other hand, in the case of the size, 
the model skill (0.645) revealed that the model was only moderately adequate, 
possibly due to the fact that the size of the microspheres was more difficult to 
quantify. Two different techniques (DLS and SEM) were used to determine the size 
of the capsules and the distribution was often large or two distributions were 
observed. Although the model prediction gave a low  model skill for the size 
results, the results could also be analyzed with a scatter plot of the size dispersity 
vs. the speed of the second emulsion as depicted in Figure 12. This plot confirmed 
what was already observed in Figure 11B.
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Figure 12. Scatter plot of the size versus the second emulsion speed.
At a stirring speed of 6,000 rpm, the dispersity of the capsule size was very large, 
however large capsules were only obtained when preparing the microcapsules 
with PLGA having a ratio of 90:10 or 80:20. When using PLGA with a ratio 70:30, 
capsules were observed having a size between 1-10 |am. When stirring at speed 
higher than 14000 rpm, only small capsules were observed.
These conditions of polymer concentration and PLGA composition, however, are 
at the edge of the chosen experimental domain. To verify whether these conditions 
are optimal, two additional experiments were conducted. Since the concentration 
of PVA was considered to have an optimum at 1%, only two parameters were 
studied: a higher PLGA concentration (425 mg/mL) with a PLGA ratio of 70:30, 
which was the optimal polymer composition and a lower PLGA ratio of 50:50 at a 
concentration of 325 mg/mL, since this was the optimal concentration in the 
previous design. An overview of the parameters is listed in Table 11. The speed of 
the second emulsification was chosen on the basis of the highest EE, which was 
6,000 rpm.
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Table 11. Results of the additional experiments which were performed and their observed 
response.
Exp.a Factors Response
PLGA conc PVA PLGA ratio w/o/w speed EE (%)
26 325 1 50-50 6,000 64
27 425 1 70-30 6,000 56
aExperiments were performed with an internal aqueous phase of 2 mL, a fluorescein 
concentration of 5 mg/mL, an external aqueous phase of 5 mL, a volume of the organic 
phase of 4 mL, a molecular weight of the polymer of 8 kDa/mol and a stirring speed for the 
first emulsification of 15,000 rpm.
A new model was built for the encapsulation efficiency plot as shown in Figure 13.
Figure 13. 2D surface curves for the effect of the PLGA ratio and PLGA concentration on the 
encapsulation efficiencies of the resulting microspheres.
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From this figure it was concluded that the optimum for the PLGA concentration 
was slightly shifted towards a lower concentration of 287 mg/mL. Also the optimal 
ratio of polymer composition was adjusted towards a polymer with a ratio of 
lactide to glycolide of 66:34, together with a stirring speed of 7,600 rpm. However, 
these new  optima do not significantly differ from the old optima that were found 
previously, which shows the robustness of the preparation method.
The shift in PLGA ratio can be explained by the high concentration that was used  
for the preparation of PLGA microcapsules having a lactide:glycolide ratio of 
70:30. This high concentration led to a high viscosity of the polymer solution, 
which made it more difficult to prepare a uniform first emulsion. This emulsion 
resulted in a lower encapsulation efficiency when preparing the double emulsion 
microcapsules. Also changing the lactide to glycolide ratio of PLGA resulted in a 
lower EE, which was probably due to better solubility of PLGA with a ratio of 
70:30 in dichloromethane, compared to PLGA with a 50:50 ratio. The latter polymer 
becomes more soluble in water due to the higher glycolide content and upon  
evaporation of the volatile solvent could give capsules which are not fully formed 
due to the more hydrophilic character of the polymer.
4.3 Conclusions
In this study a systematic optimization of the preparation of biodegradable 
microspheres with high encapsulation efficiencies has been performed using the 
double emulsion technique. To our knowledge such a detailed analysis of variables 
in the encapsulation of hydrophilic material inside microcapsules using w /o/w  
emulsions has never been performed before. The design of experiment approach 
allowed us to improve the encapsulation efficiency of a water soluble fluorophore 
in a systematic level and with a minimal set of experiments. The results of the 
mathematical analysis showed that of all variables studied the concentration of 
stabilizing agent in the second water phase (PVA), the volume of the second 
aqueous phase and the polymer concentrations determined the size of the particles 
and the EE the most. With the optimized set of parameters, microcapsules with an 
encapsulation efficiency of 78%, a size below 10 ^m and having only one lumen 
were successfully created.
Design of experiment has clearly shown its value in this optimization process and 
this research serves as groundwork for the further understanding of w /o/w
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microsphere formation. These systems are promising for the development of drug 
carrier systems for controlled delivery. To that purpose, further studies have to be 
performed after the release profiles of the optimized microspheres.
4.4 Experimental
Materials
3,6-Dimethyl-1,4-dioxane-2,5-dione (DL-lactide), (3-cis)-3,6-dimethyl-1,4-dioxane-2,5-dione 
(L-lactide) (98%), fluorescein, poly(ethylene glycol)-fo-poly(propylene glycol)-fo- 
poly(ethylene glycol) (PEG-PPG-PEG, Pluronic® F-108, Mn=14,600), poly(vinyl alcohol) 80% 
hydrolyzed (PVA, Mn=9,000-10,000 Da), tin(II) bis(2-ethylhexanoate) (stannous octanoate, 
SnOct2, >95%) and sodium cholate hydrate (SCH) were purchased from Sigma-Aldrich. 1,4- 
Dioxane-2,5-dione (Glycolide, 97%) was purchased from Maybridge. Sodium bis(2- 
ethylhexyl) sulfosuccinate (AOT) was purchased from Fluka. Span-80 was purchased from 
Merck. Dioxane and methanol were purchased from Baker. Dichloromethane was distilled 
over Na/benzophenone. All other chemicals were used as received.
Instrumentation
Proton nuclear magnetic resonance (:H  NMR) spectra were recorded at room temperature 
on a Bruker DPX300 spectrometer or Bruker DPX200 spectrometer. Chemical shifts are 
expressed in parts per million (5 scale) relative to the internal standard tetramethylsilane (5 
= 0.00 ppm) for CDCk.
Molecular weight distributions were obtained using Gel Permeation Chromatography 
(GPC) on a Shimadzu GPC equipped with a guard column and a PL gel 5 pm mixed D 
column (Polymer laboratories) with differential refractive index and UV detection (254 nm), 
using THF as eluent at 1 mL/min and T=35 °C. Polystyrene (PS) standards in the range of 
580 to 377,400 g/mol (Polymer Laboratories) were used to calibrate the GPC.
UV-Vis studies were performed on a Varian Cary 50 spectrophotometer using a Hellma QS 
cuvette with a light path of 10 mm.
Scanning Electron micrographs were taken on a JEOL JSM-T300 microscope. SEM samples 
were prepared by drying a drop of the dispersion on microscopy glass. A Pd/Au layer was 
sputtered on the SEM sample before analysis using a Cressington 208 HR sputter coater.
Optical micrographs of the dispersion dried on glass were taken with a Jenaval microscope 
using a 250x magnification.
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Dynamic light scattering measurements were carried out using a Malvern Zetasizer Nano 
series. The capsules were dispersed in water and polystyrene cuvettes were used.
The design of experiment analysis software and model fitting tool was performed on 
commercially available software provided by FutureChemistry.
Preparation of microcapsules
Microspheres were prepared by the double emulsion method. Fluorescein was dissolved in 
water and emulsified with a methylene chloride solution of the polymer to form a w/o 
emulsion. The homogenization step was carried out with an ultraturrax for 5 min. This 
primary emulsion was then rapidly added with a syringe to an aqueous solution containing 
a stabilizer (most of the time PVA). Again the solution was homogenized for 5 min. to form 
the double w1/o/w2 emulsion. The volatile solvent was then removed and the resulting 
microspheres were collected. The microcapsules were washed using deionized water and 
centrifugated during 20 min at 5,000 rpm. This washing procedure was repeated two more 
times.
Polymer preparation
PDLLA (1)
D,L lactide (43 g, 298 mmol) was dissolved in dry toluene (500 mL). Subsequently, 1-octanol 
(190 mg, 1.46 mmol) and stannous octanoate (2 drops) were added and the reaction mixture 
was refluxed for 20h at 130oC under an argon atmosphere. The reaction mixture was 
concentrated by rotary evaporation and the polymer was purified by precipitation in 
MeOH, yielding a white flaky polymer which was dried under vacuum. This yielded a 
white polymer in 62% (27 g).
!H NMR (300 MHz, CDCls) 5 5.26-5.16 (br. m, COCHCH3OH), 1.59-1.54 (br. m, 
COCHCH3O), 1.27 (br. m, CH3(CH2>CH2O, 12H), 0.88 (t, CH3(CH2>O, 3H, J=9 Hz).
Molecular weight determination:
NMR: Mn = 19,960 g/mol.
GPC: Mn = 43,608 g/mol, Mw = 85,660 g/mol, PDI = 1.96.
Typical procedure for the preparation o f PLGA
D,L lactide and glycolide were added to a reaction tube with a screw cap. Subsequently a 
solvent, water (few drops) and stannous octanoate were added and the reaction mixture 
was refluxed for 20h at 130oC under an argon atmosphere. The reaction mixture was 
concentrated by rotary evaporation and the polymer was purified by precipitation in 
methanol, yielding a white flaky polymer which was dried under vacuum.
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1H  NMR (2GG MHz or 3GG MHz, CDCk) & 5.22-5.14 (br. m, OCHCHaC=O), 4.SG-4.7G (br. m, 
OCH2CO), 4.4G (q, OCHCH3COOH, J=7 Hz), 1.59-1.54 (br. m, OCHCH3CO).
PLGA 90-10 (2)
Polymerization was performed as described above for PLGA using D,L lactide (15 g, 1G4 
mmol), glycolide (1.35 g, 11.6 mmol), toluene (3GG mL), water (16 mg, 1.46 mmol) and 
stannous octanoate (1G drops). This yielded a white polymer in 77% (12 g).
Molecular weight determination: NMR:
Mn = 16,512 g/mol.
GPC: Mn = 9,861 g/mol, Mw = 28,823 g/mol, PDI = 1.92.
Lactide to glycolide ratio was determined by 1H  NMR: 92:S.
PLGA 90-10 (3)
Polymerization was performed as described above for PLGA using D,L lactide (15 g, 1G4 
mmol), glycolide (1.21 g, 1G.4 mmol), toluene (3GG mL), water (37 mg, 2.1 mmol) and 
stannous octanoate (1G drops). This yielded a white polymer in 81% (12 g).
Molecular weight determination: NMR:
Mn = 7,98G g/mol.
GPC: Mn = 7,G42 g/mol, Mw = 14,674 g/mol, PDI = 2.G8.
Lactide to glycolide ratio was determined by *H NMR: 92:8.
PLGA 90-10 (4)
Polymerization was performed as described above for PLGA using D,L lactide (2G g, 139 
mmol), glycolide (1.79 g, 15.4 mmol), toluene (4GG mL), water (28 mg, 1.54 mmol) and 
stannous octanoate (1G drops). This yielded a white polymer in 75% (15 g).
Molecular weight determination:
NMR: Mn = 13,3G6 g/mol.
GPC: Mn = 15,671 g/mol, Mw = 36,747 g/mol, PDI = 2.34.
Lactide to glycolide ratio was determined by 1H  NMR: 9G:1G 
PLGA 80-20 (S)
Polymerization was performed as described above for PLGA in the melt using D,L lactide 
(12 g, 83 mmol), glycolide (2.46 g, 2G.8 mmol), water (19 mg, 1.G4 mmol) and stannous 
octanoate (1G drops). This yielded a white polymer in 96% (12 g).
Molecular weight determination:
NMR: Mn = 9,G8G g/mol.
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GPC: Mn = 12,225 g/mol, Mw = 26,483 g/mol, PDI = 2.16.
Lactide to glycolide ratio was determined by 1H  NMR: 8G:2G 
PLGA 70-30 (ó)
Polymerization was performed as described above for PLGA using D,L lactide (12 g, 83 
mmol), glycolide (4.2 g, 36.2 mmol), dioxane (3GG mL), water (33 mg, 1.81 mmol) and 
stannous octanoate (1G drops). This yielded a white polymer in 82% (1G g).
Molecular weight determination:
NMR: Mn = 7,475 g/mol.
GPC: Mn = 3,195 g/mol, Mw = 7,961 g/mol, PDI = 2.5.
Lactide to glycolide ratio was determined by 1H  NMR: 67:33 
PLGA 70-30 (7)
Polymerization was performed as described above for PLGA in the melt using D,L lactide 
(12 g, 83 mmol), glycolide (4.2 g, 36.2 mmol), water (16 mg, G.9 mmol) and stannous 
octanoate (1G drops). This yielded a white polymer in 74% (9 g).
Molecular weight determination:
NMR: Mn = 14,563 g/mol.
GPC: Mn = 8,829 g/mol, Mw = 18,215 g/mol, PDI = 2.G6.
Lactide to glycolide ratio was determined by 1H  NMR: 7G:3G 
PLGA 70-30 (S)
Polymerization was performed as described above for PLGA in the melt using D,L lactide 
(2G g, 139 mmol), glycolide (6.9 g, 15.4 mmol), water (36 mg, 1.98 mmol) and stannous 
octanoate (1G drops). This yielded a white polymer in 62% (16 g).
Molecular weight determination:
NMR: Mn = 1G,393 g/mol.
GPC: Mn = 4,837 g/mol, Mw = 1G,462 g/mol, PDI = 2.16.
Lactide to glycolide ratio was determined by 1H  NMR: 72:28
Determination of Encapsulation efficiency
The encapsulation efficiency (EE), or the percentage of the total amount of fluorescein used 
in the preparation that was actually encapsulated, was determined by quantifying the 
amount of fluorescein found in the supernatants collected during the cycles of nanoparticle 
washes (MFluo-Supernatants) and comparing that to the mass of fluorescein used for 
nanoparticle preparation (MFluo-Preparation), as described in Equation 1.
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(M-Fluo-Preparation M-Fluo-Supematants)EE=------------M----------------- 1---------- x100%
-^ Fluo-Preparation
The molar concentration of fluorescein lost in the supernatant was determined by 
absorption spectroscopy using standard curves (r2>0.99) of known concentrations of 
fluorescein in the surfactant solution used for nanoparticle suspensions. A UV-Vis 
spectrophotometer was used for this purpose. Fluorescein absorption was measured at the 
peak wavelength of 485 nm  (maximum absorption) in an aqueous PVA solution (1 wt.%).
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Biodegradable polymeric microcapsules for 
selective ultrasound-triggered drug release.
Chapter 5
Summary
A series of hollow biodegradable polymeric microcapsules were prepared, of 
which their susceptibility to ultrasound was used for triggered release. High speed 
imaging of the ultrasound experiments showed a strong correlation between the 
acoustic pressure needed to activate these microcapsules and their shell thickness 
to diameter ratio. Based on this information a selective triggering of capsules with 
two different shell thickness to diameter ratios was successfully performed. The 
capsules were mixed in a single system and were activated independently from 
each other by a differentiation in acoustic pressure levels. This application is of 
great interest in the field of drug delivery, since this system allows for localized 
multiple drug releases in a selective fashion.
Part o f  this research was published as: Dennis Lensen, Erik C. Gelderblom, Dennis M. Vriezema, Philippe 
M armottant, Nico Verdonschot, M ichel Versluis, Nico de Jong and Jan C.M. van Hest, Soft Matter, 2011, 7, 
5417-5422.
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5.1 Introduction
Diagnostic ultrasound imaging is nowadays routinely performed with ultrasound 
contrast agents (UCAs). Typically, UCAs are microcapsules with a diameter 
between 1 and 10 ^m, which are comprised of a gas-filled interior. The 
microcapsule shell can be composed of a broad variety of molecules, including 
lipids, proteins, polysaccharides or synthetic polymers.!1-5! UCAs scatter ultrasound 
efficiently and they also respond to low energy ultrasound by emitting harmonic 
frequencies, resulting in contrast enhancement with respect to the surrounding 
tissue. Air-filled microbubbles are not very practical as contrast agents, since the 
air dissolves very rapidly in the blood stream and the bubbles are lost from the 
circulation before the ultrasound examination can be completed. Fluorinated gases 
combined with a stabilizing shell are therefore commonly used to stabilize the 
microbubbles for a sufficiently long time; around 5-10 minutes is possible.13, 61 
Alternatively, air-filled microbubbles with fluorinated polymer shells have also 
been used for this purpose.!7-9!
UCAs are generally classified as soft-shelled or as hard-shelled agents. Soft-shelled 
agents are microbubbles of which the shell is composed of a lipid monolayer with a 
thickness of 2-3 nm. They undergo volume expansions and contractions that 
generate an acoustic signal in the far-field of which the non-linear subharmonic or 
harmonic components give their specific contrast-enhancement for medical 
ultrasound imaging.!10-12! A drawback of these soft-shelled agents is that upon 
expansion and contraction of the flexible lipid membrane at elevated pressures, 
submicron-sized lipid aggregates such as micelles and liposomes are shedded from 
the microbubble, thereby destroying the UCAs.[13]
The current theoretical models for soft-shelled microbubble triggering using 
ultrasound incorporate the response of the shell by exploring small amplitude 
vibration.[12, 14-171 However, for discriminating a contrast agent from the 
surrounding tissue, a non-linear response of the large amplitude vibration regime 
is of importance, caused by either buckling[18] or destruction of the contrast 
agent.[19, 201 In buckling, a monolayer of lipids shows "compression-only" behavior. 
!21, 22! Here, only the compression is significant, while no expansion occurs, since 
these lipid monolayers do not undergo in-plane compression. The bending 
modulus of the monolayer is very small, so it is energetically more favorable to 
bend the membrane than to compress it.
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Hard-shelled microbubbles have a typical shell thickness in the range of 20-100 nm 
and are usually prepared from polymers. They hardly show volume expansions at 
low acoustic pressure due to the increased damping contribution of the polymer 
shell and remain intact until a certain pressure threshold is reached. Above this 
threshold their shell ruptures and the gas core escapes.!23] It is believed that 
ultrasound echoes are most likely generated only after shell disruption and gas 
release. However, some hard-shelled microbubbles do generate acoustic signals 
without losing gasJ8] These bubbles often indent through a buckling instability, 
which is a way to conserve their surface area and allow for a change in the volume. 
By using fluorinated polymers for the microbubble shell, the water intrusion 
through pores in the shell is very much reduced due to the hydrophobic surface 
properties of these polymers.[7, 8, 24]
Recently Marmottant et al. have developed a new theory describing the behavior 
of hard-shelled microbubbles when undergoing buckling or rupturing using 
ultrasonic pressureJ25] Such microbubbles can more easily sustain in-plane 
compression in contrast to the soft-shelled microbubbles, thus allowing for 
stabilization against dissolution of the gas inside. This, however, holds for limited 
compressions as these microbubbles also undergo buckling if the compressive 
constraint is large enough. They also compared this theoretical study with the 
experimental results of Bouakaz et al. obtained earlier, in which the contrast agent 
PB127 (Point Biomedical) was used.[19]
Ultrasound-triggered drug release has attracted increasing interest, since the 
release trigger can be applied locally.[1, 5, 26] Bohmer et al. have recently shown that 
polymeric PLLA capsules with different shell thicknesses can be triggered both in- 
vitro and in-vivo, although using different ultrasonic pressures.[26] They 
incorporated a model drug, Evans blue, in liposomes and polymeric capsules with 
different shell thicknesses and triggered them in a gel using high pressures. By 
comparing the destruction zone of the capsules as a function of the ultrasonic 
pressure, they observed that a thicker shell required a higher ultrasonic pressure. 
They varied the ultrasonic pressure in rather big steps of 1 MPa. At higher 
pressures hard-shelled capsules were destroyed with dramatic changes in the gas 
volume.[8, 19 23] Although this leads to a loss of US properties after breakage, it also 
opens up the possibility of using UCAs as drug delivery vehicles, since the capsule 
content is efficiently released. Furthermore, by applying both low and high US 
pressure, UCA-based drug delivery vehicles can be used for monitoring and
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release, respectively, which substantially improves therapeutic treatment. A next 
step forward would be realized if UCA drug delivery vehicles could be employed 
in selective drug release. This could be achieved if a mixture of microcapsules is 
used which releases its encapsulated drugs at different ultrasound parameters, 
such as pressure, pulse repetition frequency or pulse length.
In this chapter we describe in detail the ultrasonic pressure needed to trigger a 
series of biodegradable polymeric microcapsules with adjustable sensitivity 
toward ultrasound. Tuning of the shell thickness of a capsule made it possible to 
selectively trigger capsules using diagnostic ultrasound at a mechanical index of 
1.2, which was well below the maximum mechanical index[27] of 1.9 as regulated by 
the FDA.[28] Also a strong correlation was found between the activation pressure of 
the ultrasound, the pressure at which a capsule shell buckles or ruptures, and the 
shell thickness of similar sized capsules. These results were in perfect agreement 
with the theoretical model of Marmottant et al. for hard-shelled microcapsules. 
Furthermore, selective triggering of microcapsules in a single system having 
different shell thicknesses was proven, which is a promising step toward more 
controlled drug delivery applications.
5.2 Results and discussion
For the preparation of ultrasound responsive microcapsules with different shell 
thicknesses, an emulsion-evaporation technique was employed.[29] Here, an oil-in- 
water emulsion was used, in which the oil phase consisted of a mixture of the 
shell-forming polymer, in this case perfluoroctanol-poly(lactic acid) (PFO- 
PLLA),[24] a volatile solvent, dichloromethane, and a non-volatile non-solvent, 
decane. As the dichloromethane started to evaporate small polymer-rich droplets 
were formed by phase separation within the emulsion droplets. These polymer- 
rich droplets migrated to the interface and engulfed under the right conditions the 
original droplet. Further removal of the volatile solvent resulted in more polymer 
precipitate which migrated to the shell, thus forming core-shell microcapsules. By 
using different initial concentrations of polymer in the organic phase and by 
maintaining the same mechanical energy for droplet formation, four different 
capsules were prepared with increasing shell thickness, see Table 1.
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Table 1. Overview of the properties of PFO-PLLA microcapsules prepared using an 
emulsion-evaporation technique with different polymer concentrations.
Capsule Polymer
mass
[mg]a
Calculated 
shell thickness 
[nm]b
Measured 
shell thickness 
[nm]c
Measured 
capsule 
diameter [|am]c
Ratio shell 
thickness and 
diameter [10-3]
1 100 43 65 3.54 18
2 200 97 121 4.16 29
3 300 144 196 4.29 46
4 500 137 158 2.67 59
a All polymers were dissolved in 1.5 mL dichloromethane and 1.0 mL decane. The emulsion 
was prepared by stirring at 10,000 rpm using an ultraturrax. 
b See experimental for the calculation.
c Average sizes from ten measurements obtained from cryo SEM studies.
In order to obtain hollow biodegradable microcapsules, decane was removed from 
the core using lyophilization. No deformations of the capsules were observed 
before and after lyophilization as was presented in a previous study.[30] The 
removal of decane from the core of these capsules was confirmed by DSC 
measurements (Figure 1), since after freeze drying no melting peak for decane at - 
28°C was found.
-40 -20  0
Temperature [°C]
Figure 1. DSC graph (endo up) of the four different PFO-PLLA capsules after lyophilisation.
By using cryo-SEM it was possible to determine the capsule diameters and their 
shell thicknesses (Table 1) as depicted in Figure 2.
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Figure 2. A. Scanning electron micrographs of PFO-PLLA microcapsules 1-4 from Table 1 
with different shell thicknesses. Scale bars represent 1 |jm. B. Plot of the polymer mass 
versus the ratio of the shell thickness and diameter.
From Figure 2B it is observed that the ratio between the shell thickness and the 
diameter shows a gradual increase upon increasing the polymer mass, which 
demonstrates that there is good control over the desired shell thickness. However, 
there is a slight deviation of the ratio shell thickness to diameter, since the 
thickness of the shell is not completely homegeneous. Furthermore, as expected, 
larger capsules have thicker shells as a result of a larger initial droplet size, since 
more decane in the core will result in more polymer ending up in the shell.
Listed in Table 1 are the calculated shell thicknesses for these capsules by applying 
equation 1 (denoted in the experimental). The calculated shell thicknesses were 
slightly lower than the measured values, which can be partly explained by the fact 
that the exact capsule radius was difficult to estimate from cryo-SEM, since the 
capsules were not fully exposed from the ice. Moreover, the calculation assumes 
ideal mixing conditions of the decane and the polymer solution and that all 
polymer material ends up in a microcapsule. This, however, may not have been 
achieved during microcapsule preparation and may have therefore led to an 
overestimation of the shell thickness.
In order to investigate the effect of the ratio of the shell thickness to the capsule 
size on the response to ultrasound pressure, the capsule dynamics was studied 
optically using the Brandaris 128 ultra high-speed camera during insonification of 
the capsules.t31] The pressure pulse that was applied to the microcapsules during 
ultrasound treatment is depicted in Figure 3A. The Brandaris camera was operated 
at a frame rate of 5 million frames per second (Mfps), thus allowing for a highly
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detailed insight in the behavior of the microcapsules during the applied pressure 
wave.
At low acoustic pressures (50-250 kPa) no capsules were disrupted. However, the 
capsules with the thinnest shell (entry 1 in Table 1) showed buckling behavior at an 
acoustic pressure of 250 kPa as shown in Figure 3B.
Figure 3. A. Schematic representation of the sine wave of the applied ultrasound pressure. B. 
Buckling behavior of a thin-shelled polymer capsule (entry 1 in Table 1) at 250 kPa. 
Numbers 1-6 correspond to the applied pressure as depicted in Figure 3A.
Here, the capsule's expansion and contraction correspond to the pressure at 
different times as indicated in Figure 3A.
By increasing the acoustic pressure by 40 percent to 350 kPa, capsule 1 continued to 
buckle as depicted in Figure 3B. However, above a certain acoustic pressure 
threshold, the shell yielded, resulting in rupture of the shell at its thinnest point 
and release of the gas content as depicted in Figure 4 (1a-1e). The capsules with a 
higher shell thickness/diameter ratio did not show buckling behavior, apparently 
due to a shell thickness of these capsules that was too high to allow indentation. 
All capsules (1-4 from Table 1) responded by rupturing when the acoustic pressure 
was sufficiently high.
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Figure 4. Rupture of the capsules 1-4 using ultrasound at high acoustic pressure. a. Capsule 
just before rupture. b. Shell of the capsule ruptures (arrow). c. Gas escapes from the core of 
the capsule. d. Contraction of the capsule, when a positive pressure is applied. e. Second 
expansion of the gas and full rupture of the capsule, when maximal pressure is applied. 
Images are snapshots of movies recorded by the Brandaris camera.
From Figure 4 it can be observed that the release of the gas was more violent when 
the capsules had a thicker shell/diameter ratio. The capsules with higher ratios 
could withstand the expansion of the gas when insonified. When even higher 
acoustic pressures were used to trigger the capsules, the gas in the capsules 
expanded further, giving rise to a stronger, more impulsive gas release. The ratio 
of the calculated shell thickness and diameter of the capsules was plotted against 
the acoustic pressure of the ultrasound needed to rupture the capsules in Figure 
5A.
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Figure 5. Plot of the ratio of capsule shell to capsule diameter against the acoustic pressure, 
together with the theoretical prediction for the onset of buckling and rupturing. The 
following parameters were used: a Young's modulus of E=225 MPa, and a critical elongation 
for rupture of emax=1.8%.[25l Symbols in the graph represent the measured data points. The 
errors for the ratio shell thickness / diameter were calculated from the diameter of the 
capsules in the high speed recordings and are respectively 12±1, 23±2, 33±3 and 51±4.5.
It shows that the ratio of shell thickness to diameter of the capsules correlates 
strongly with the ultrasound pressure needed to disrupt the capsules. A buckling 
behavior was only observed for capsules with low shell/diameter ratios and at low 
ultrasound pressure. However, for the capsules with the larger shell 
thickness/diameter ratio this behavior was no longer observed and the capsules 
only responded by instant rupturing when the ultrasound pressure was above the 
release threshold.
This behavior depicted in Figure 5 corresponds nicely with the recent theory of 
Marmottant et al.[25] where they predicted the rupture and buckling threshold for 
varying bubble radii. When the shell thickness to bubble diameter ratio is varied, 
the pressure for buckling onset is predicted to vary as Pbuckling=E (d/R)2, with E the 
elastic Young's modulus, d the shell thickness and R the bubble radius. The 
rupture is achieved when the shell material is elongated more than a critical 
elongation emax, and occurs at a pressure Pbuckling=3E (d/R) emax. They also stated that 
above a certain shell thickness/diameter ratio, no buckling will be observed and the 
bubbles will only rupture while releasing their gas content, which is in perfect 
agreement with our observations.
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The good control over the ratio of shell thickness to diameter of these capsules, as 
well as their predictable behavior toward ultrasound pressure, makes these 
capsules ideal as sequential drug delivery vehicles. In order to demonstrate the 
proof of concept, two different capsules were mixed with markedly different ratios 
(Capsules 1 and 4 in Table 1). In order to visualize these capsules, the thin-shelled 
capsules were loaded with the dye Nile Red, which was visualized using 
fluorescence microscopy. An overlay image of the fluorescence microscope image 
and the bright-field microscope image marks the location of the different capsules 
as can be seen in Figure 6A.
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Figure 6. Overlay microscope images of mixed microcapsules having different ratios of shell 
thickness to diameter, triggered by ultrasound. A. Image of the microcapsules when no 
pressure was applied. B. Image of the microcapsules when 400 kPa of pressure was applied. 
C. Image of the microcapsules when 1.2 MPa was applied.
By applying first a low pressure (400 kPa), the thin shelled capsules were activated 
as depicted in Figure 6B. The wall of these capsules was disrupted allowing water 
to penetrate into the capsules. As a consequence the microcapsules sank and 
moved out of focus of the microscope. Moreover, the larger capsule showed a more 
violent disruption and displacement than the smaller ones, which is due to the 
bigger volume of gas present in this capsule. From this image it was observed that 
all the thinner shelled capsules with the same ratio of shell thickness/diameter 
were triggered. When applying a second pressure pulse of 1.2 MPa, also the thicker 
shelled microcapsules were disrupted (Figure 6C). It can be clearly seen that the 
gas, which was entrapped in these capsules had escaped, while the shells of the 
capsules remained. This demonstrates that capsules with different shell thicknesses 
can be triggered independently from each other using different ultrasonic 
pressures, thereby releasing their contents.
In addition, thin shelled PFO-PLLA microcapsules were fixated in an agarose gel 
to prove the concept of triggering the capsules in a matrix. Therefore 
microcapsules were positioned between two agarose layers as depicted in Figure 7.
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Figure 7. Thin-shelled microcapsules fixated in agarose gel.
The fixated microcapsules were insonified using a commercially available 
ultrasound system. Figure 8A depicts the capsules in the agarose gel when 
insonified with a pressure of 2.4 MPa. The white area shows the microcapsules 
when insonified. These microcaspules are very well visible due to their gas core, 
which reflects the ultrasonic wave very well.
Figure 8. Thin-shelled capsules triggered in agarose gel using ultrasound. A. Image of 
microcapsules during insonification at a pressure of 2.4 MPa (Mechanical Index = 1.5) using 
a convex array transducer. The bright white area is the region where the microcapsules are 
located. B. Image of the microcapsules in the agarose gel turned over 90° after 2.4 MPa of 
pressure was applied using a linear transducer. The dark region is where the ruptured 
microcapsules are located.
After insonification, no microcaspules could be observed as depicted in Figure 8B. 
It must be noted that microcapsules were insonified using a 2-6  MHz convex array 
transducer operated at 2.5 MHz (Mechanical Index = 1.5). For the analysis, the 
sample was rotated 90° and analysed using a 5-13 MHz linear array transducer 
operated at 10 MHz (Mechanical Index = 0.5), which is normally used for ultrasonic 
imaging. The dark region showed where the gas filled capsules were located.
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However, no scattering was observed, meaning that all the capsules were ruptured 
and that the entrapped gas escaped when pressure was applied. Additionally, this 
showed that these thin-shelled microcapsules could be triggered when fixated in 
an agarose gel over a length of 34 mm. It will be of great interest to determine the 
scope of external activation of these microcapsules, for instance in tougher matrices 
and over larger length scales.
5.3 Conclusions
In this chapter we have shown the preparation of a series of microcapsules with an 
adjustable shell thickness to diameter ratio. By controlling the ultrasound 
parameters we have demonstrated with high speed imaging that different acoustic 
pressures were needed to disrupt the capsules with varying shell thickness to 
diameter ratios. Also, the ultrasound behavior of these capsules was proven to be 
in excellent agreement with the recently developed theory of Marmottant et al. 
Additionally, we have also shown that capsules with different shell thickness to 
diameter ratios can be triggered independently from each other in a single system, 
giving the possibility to release drugs in a stepwise or selective manner. Since the 
US pressures applied were well below the maximum Mechanical Index allowed for 
diagnostic imaging, this implies that these capsules can be used to deliver drugs 
without safety hazards. Additionally, thin-shelled capsules could be triggered 
when fixated in an agarose gel using a commercially available ultrasound system. 
This is an indication that it might be possible to obtain in vivo activation with these 
microspheres.
5.4 Experimental
Materials
L-lactide, poly(vinyl alcohol) (PVA, Mw 9-10 kDa, 80% hydrolyzed), Methoxy-poly(ethylene 
glycol) (PEG, Mw=3350), tetrahydrofuran (THF) and stannous(II) octanoate (Sn(Oct)2) were 
purchased from Sigma-Aldrich (Schnelldorf, Germany). Decane was purchased from Fluka 
(Schnelldorf, Germany). 2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-pentadecafluoro-1-octanol (PFO) was 
purchased from ABCR (Karlsruhe, Germany). Methanol was purchased from Baker 
(Griesheim, Germany). Dichloromethane was distilled over CaCl2 and toluene was distilled 
over Na/benzophenone. All other chemicals were used as received.
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Equipment
Proton nuclear magnetic resonance (1H  NMR) spectra were recorded at room temperature 
on a Varian 400 MHz spectrometer. Chemical shifts are expressed in parts per million (5 
scale) relative to the internal standard tetramethylsilane (5 = 0.00 ppm) for CDCk.
Molecular weights of the polymers were measured using size exclusion chromatography 
(SEC) on a Shimadzu system equipped with a guard column and a PL gel 5 |jm mixed D 
column (Polymer Laboratories) with a differential refractive index detector, using THF as an 
eluent at 1 mL/min and T=35°C. Polystyrene standards in the range of 580 to 377,400 g/mol 
(Polymer Laboratories) were used to calibrate the SEC.
Differential Scanning Calorimetry (DSC) measurements were performed on a Perkin Elmer 
Pyris Diamond DSC, equipped with a Perkin Elmer Intracooler 2P. Samples were prepared 
in an aluminum cup with less than 1 mg of sample. Empty aluminum cups were used as a 
reference. All samples were measured with heating rates of 5 °C/minute.
Cryo-SEM was performed on a JEOL JSM-6330F electron microscope. Lyophilized PFO- 
PLLA capsules were dispersed in double distilled water (dd water, R = 18.2 MQ) and 
manually shaken in an eppendorf tube. The dispersion was centrifuged at 3,000 rpm (605 g) 
and the supernatant was taken out using a syringe fitted with a needle. The capsules were 
redispersed in dd water and the procedure was performed two more times. Finally the 
capsules were dispersed in dd water and rapidly frozen in liquid nitrogen The samples were 
cut using a scalpel and allowed to condensate for 5 minutes in the SEM. Hereafter the 
samples were sputtered with a layer of Pd/Au.
Samples used for lyophilization were rapidly frozen in liquid nitrogen. Lyophilization was 
performed with an Ilshin FD 8515 at a condenser temperature of -92°C at 5 mTorr for at least 
24 hours.
Synthesis of PFO-PLLA
Poly(L-lactic acid) terminated by PFO was synthesized according to Lee et al.[24] PFO (1.02 g, 
2.55 mmol) and L-lactide (6.61 g, 0.46 mol) were suspended in toluene (50 mL) under an 
argon atmosphere, while stirring. After 5 minutes Sn(Oct)2 (10 mg, 26 |omol), dissolved in 
toluene (1 mL), was added to the suspension and the mixture was heated to 130°C for 18 
hours. The mixture was allowed to cool to room temperature and evaporated to dryness. 
The resulting white polymer was dissolved in a minimal amount of dichloromethane and 
precipitated in methanol. The precipitate was filtered off and was purified once more by the 
procedure described above. The precipitate was dried under high vacuum for 24 hours to
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yield a white solid (6.30 g, yield: 73%). The :H NMR spectrum of the resulting polymer was 
similar as the polymer described in the literature.!7!
Molecular weight determination: NMR: Mn = 3395 g/mol, GPC: Mn = 6233 g/mol, Mw = 8583 
g/mol, DPI = 1.38.
General procedure for preparing PFO-PLLA microcapsules
PFO-PLLA was weighed and dissolved in dichloromethane (2.0 g) and to this decane (0.76 
g) was added. This solution was added slowly to a solution of PVA in water (1 wt.%, 15 mL) 
which was stirred at 10,000 rpm using an ultraturrax. The formed emulsion was stirred for 
an additional 5 minutes and then transferred to a beaker containing PVA in water (1 wt.%, 
40 mL) and stirred for 24 hours using a magnetic stirring bar to allow the dichloromethane 
to evaporate. The dispersion was centrifuged at 3,000 rpm (605 g) for 10 minutes, followed 
by isolation of the top layer of floating capsules. The capsules were redispersed in a PEG 
solution (5 wt.%) and centrifuged twice more at 3,000 rpm (605 g), each time redispersing 
the floating capsules. Finally the floating capsules were isolated, redispersed in a minimal 
amount of PEG solution and lyophilized to remove the decane from the lumen.
Fluorescent PFO-PLLA capsules were prepared identically to the procedure described above, 
only Nile Red (1 mg) was added to the polymer solution.
Ultrasound measurements
Microcapsules were dispersed in dd water and injected in an Opticell. This cell was placed 
under water and the microcapsules were measured by a setup described by Overvelde et 
al.l32l The capsules were insonified using a 1.0 MHz single element transducer (Precision 
Acoustics Ltd) transmitting 16-cycle-sine wave bursts, with pressures between 50-1200 kPa 
(MI = 0.05-1.2), as verified with a calibrated 0.2 mm PVDF needle hydrophone (Precision 
Acoustics Ltd). Images of insonified microcapsules were recorded using a 60* water- 
immersed objective and 2* magnifier, and recorded in six sequences of 128 image frames at 
a frame rate near 5 million frames per second using the Brandaris 128 ultrahigh-speed 
camera system.!31! Images were processed using custom-designed software written in 
MATLAB (Mathworks).
For the sequential ultrasound measurement an identical ultrasound setup was used as 
described above. The capsules were insonified using a 1.0 MHz single element transducer 
(C302; Panametrics-NDT; Olympus-NDT) transmitting 16-cycle-sine wave bursts, with 
pressures between 50-1200 kPa (MI = 0.05-1.2), as verified with a calibrated 1.0 mm PVDF 
needle hydrophone (Precision Acoustics Ltd). The PFO-PLLA capsules with Nile Red were 
visualized using a excitation wave length of 550 nm and emission snaphots were recorded at
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580 nm. Overlay images of bright-field and fluorescent snapshots of insonified 
microcapsules were recorded using a 40* water-immersed objective and 2* magnifier using 
custom-designed software written in MATLAB (Mathworks).
For the measurement with fixated microcapsules in agarose, a Siemens Antares ultrasonic 
scanner was used. Microcapsules were insonified using a 2-6 MHz convex array transducer 
operated at 2.5 MHz (MI = 1.5). For the analysis, the sample was rotated 90° and analysed 
using a 5-13 MHz linear array transducer operated at 10 MHz (MI = 0.5).
Calculation for the shell thickness
Calculating the shell thickness of a capsule (h) with a variable radius of the capsule (R):
Vcapsule Vcore+Vshell
4 3 4 , ^ 3 
-w R = 3 n (R ) +
  mpolymer
Ppolymer
mpolymer
4 r>3 4 (t»\ 3 Ppolymer-  TCR3= -  n (R ) + - ^ -----Vcore
3 3  V decane
Assuming that all the polymer ends up in the shell, this results in:
4 ( 3Vdecane=Vcore= 3  n vR )
mpolymer
R = 3- =  , where f=Vl+f ' Vd,ecane
h=R-R'
with mpolymer = weighed amount of polymer [g], ppolymer = density of the polymer [g/cm3]/7! 
Vdecane = amount of decane [mL], R = measured diameter of the capsule/2 [|am] and h = 
thickness of the shell [|am]
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Chapter 6
Self-healing bone cement
Summary
Bone cement mechanical failure is a common cause for implant malfunctioning. 
The presence of microcracks in bone cement accelerates this process. One method 
to circumvent this problem is the development of self-healing bone cement as 
described in this thesis. Standard bone cement was filled with a variety of 
microcapsules, which contained monomer and initiator. We hypothesized that 
when a crack propagated through the bone cement and ruptured a capsule, it 
would release the encapsulated monomer which would fill up the crack and heal 
the bone cement by polymerization via the co-encapsulated initiator. The concept 
was demonstrated by first manually applying the monomer ethylene glycol 
dimethacrylate (EGDMA) with initiator on a fractured bone cement sample, which 
partly restored the mechanical properties of the specimen. When poly(urea 
formaldehyde) (PUF) microcapsules were used which contained either methyl 
methacrylate (MMA) or ethylene glycol dimethacrylate (EGDMA) and an initiator 
no self-healing properties were found, since these microcapsules were too fragile to 
survive the bone cement preparation method. Therefore poly(melamine 
formaldehyde) (PMF) microcapsules were prepared, which proved to be more 
stable in the bone cement MMA solution. When new specimens, containing PMF 
capsules with EGDMA and initiator, were prepared and tested for tensile strength, 
it became apparent that also these capsules did not give a self-healing capacity to 
the matrix. Furthermore, the mechanical properties of the bone cement decreased 
when more capsules were mixed through the bone cement, although a higher 
loading of microcapsules did lead to a crack stopping effect in the cement.
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6.1 Introduction
Self-healing polymers are a newly developed class of smart materials that have the 
capability to repair themselves when they are damaged without the need for any 
external intervention.
White et al. were one of the pioneers in this field by discovering that a ring- 
opening metathesis polymerization (ROMP) could be used as an effective chemical 
reaction to repair crack damage in an epoxy matrix using a Grubbs' catalyst.[1] They 
encapsulated the monomer dicyclopentadiene (DCPD) in poly(urea formaldehyde) 
(PUF) capsules and mixed these capsules in an epoxy matrix together with the 
catalyst. The microcapsules ruptured in response to mechanical damage in the 
form of a propagating crack through the epoxy composite (Figure 1).
Figure 1. The autonomic healing concept is healing without intervention. A 
microencapsulated healing agent is embedded in a structural composite matrix containing a 
catalyst capable of polymerizing the healing agent. A. Cracks form in the matrix wherever 
damage occurs. B. The crack ruptures the microcapsules, releasing the healing agent into the 
crack plane through capillary action. C. The healing agent comes in contact with the catalyst, 
triggering polymerization that closes the crack. Figure adapted from reference 1.
Upon rupture, the liquid contents of the microcapsules leaked out into the crack 
plane of the epoxy through capillary action. When the DCPD and the embedded 
catalyst came into contact, the ROMP reaction occurred, resulting in polymer
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formation in the crack plane. The fracture toughness of the epoxy composite was 
restored to up to 75-90% of the initial value.
Ever since this report of White et al.,[1] the field of self-healing materials has started 
to grow to include new self-healing chemistries based on e.g. poly(dimethyl 
siloxane) (PDMS)[2-4] and solvent-induced chemical reactions.[5, 6] Also new self­
healing concepts using micro-vascular,[7-12] hollow fiber delivery methods[13 14] and 
related nonautonomic technologies such as re-mendable polymers[15-20] have 
emerged.
The biggest impact for self-healing functionality will likely be in applications such 
as brittle thermosets and composites where damage, formed deep within the 
structure cannot be easily detected and repaired.[21] These damages need to be 
repaired in an early stage in order to prevent failure, higher maintenance costs or 
loss of productivity. The repair solutions designed for these applications need to be 
autonomic, repairing the damage at an early stage to prevent further propagation.
These same arguments also hold for certain biomedical applications, in particular 
the field of implant technology, since failure or malfunctioning in implants often 
requires revision surgery. One of the main reasons for the failure of cemented 
arthroplasties is a condition known as aseptic loosening, in which debris particles, 
formed as a result of bone cement fatigue failure, induce inflammatory tissue 
responses that lead to bone destruction and loosening of the prosthesis.[22, 23] The 
microcapsule based self-healing concept has proven its success in epoxy and 
epoxy-based structural composites[1, 2, 21, 24] and this presents a compelling 
opportunity to use this concept in bone cement.
In this chapter the possibility of constructing self-healing PMMA bone cement was 
studied in analogy to the White system. Capsules containing monomer were mixed 
in with bone cement, in order to repair microcracks and prevent mechanical 
failure. The self-healing capacity of these systems was tested with different types of 
capsules, monomers and matrix materials present in the bone cement in order to 
find the optimal conditions for this self-healing capability.
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6.2 Results and Discussion
For extending the life-time of a hip or knee replacement, self-healing poly(methyl 
methacrylate) (PMMA) bone cement could serve as a solution. One of the options 
is to prepare a capsules-based self-healing system. By taking this approach, 
microcapsules need to be prepared, which are compatible with the bone cement, 
and filled with a healing agent. Furthermore, they should be sturdy enough to 
survive the bone cement preparation procedure and sufficiently brittle to be 
activated when microcracks appear. This requires a subtle balance in mechanical 
properties.
6.2.1 Preparation of monomer-containing poly(urea formaldehyde) 
microcapsules
The procedure for the preparation of poly(urea formaldehyde) microcapsules was 
adopted from White et al. in which they synthesized microcapsules containing 
dicyclopentadiene (DCPD) surrounded by a poly(urea formaldehyde) (PUF) 
shell.[1] Since the bone cement matrix consists of PMMA, the most logical monomer 
to select was methyl methacrylate (MMA). The first step was to establish if the 
monomer could be encapsulated. Therefore, an in situ polymerization reaction of 
urea and formaldehyde taking place in an oil-in-water emulsion containing MMA 
was performed, as schematically depicted in Figure 2.
Figure 2. Schematic illustration of the formation of PUF capsules via an oil-in-water 
emulsion polymerization process.
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Here, the reaction of urea and formaldehyde occurs in the aqueous phase as 
depicted in Scheme 1. During the polymerization of urea and formaldehyde, 
initially a so-called prepolymer is formed which consists of a mixture of four 
distinct urea groups containing one, two or three methylol groups. Under acidic 
conditions and at elevated temperatures, this prepolymer mixture forms a three­
dimensional network with both methylene and methylol connections. However, as 
the reaction proceeds the formed polymer precipitates at the oil-water interface 
thereby forming a shell around the MMA droplets.
Scheme 1. Mechanism of the poly(urea formaldehyde) network formation via methylene 
and methylol bridges.
The resulting microcapsules, prepared in the presence of MMA, were visualized by 
scanning electron microscopy (SEM) as depicted in Figure 3. A majority of the 
capsules was broken, whereas the intact capsules did not yield a nice spherical 
shape.
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Figure 3. Scanning electron micrograph of PUF microcapsules filled with MMA.
This rupture and deformation of the capsules could be attributed to the solubility 
of MMA in water (~ 1.6 g/100 mL). This presumably caused migration of MMA 
from the oil droplets to the aqueous phase, thereby rupturing the initially formed 
PUF shell of the capsule.
It was chosen to substitute the MMA monomer for ethylene glycol dimethacrylate 
(EGDMA), which is nearly insoluble in water. The emulsion polymerization 
reaction of urea and formaldehyde was repeated with EGDMA as the oil phase. In 
this case, much fewer capsules were broken and, moreover, the capsules were 
spherically shaped, as established with SEM (Figure 4). The average size of the 
capsules was 55 pm. However, the size of the capsules could be altered between 1 
to 500 micron by varying the stirring speed of the emulsion between 200 and 10,000 
rpm.
Figure 4. Scanning electron micrograph of PUF capsules prepared with EGDMA as the oil 
phase.
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To prepare self-healing PMMA, not only a monomer is needed, also an initiator 
needs to be present in the matrix. The idea was to incorporate it along with the 
monomer EGDMA in the capsules. The initiator should have a high activation 
temperature or be activated using a second molecule, an activator. This activator 
can be incorporated in the matrix, since rupturing of the capsules leads to leaking 
of the initiator and EGDMA from the capsules. The initiator which will come into 
contact with the activator, will start the polymerization of EGDMA.
A commonly used initiator, with a high activation temperature is benzoyl peroxide 
(BPO). This initiator can also be activated a room temperature by amines. The most 
commonly used class of activators for BPO are tertiary aromatic amines.[25] The 
decomposition of BPO is based on a redox reaction with the amine moiety, 
resulting in the formation of a radical species, which initiates the polymerization 
reaction. In commercial bone cement, N,N-dimethyl-4-toluidine (DMT) is 
incorporated in the matrix, which can serve as an activator for the decomposition 
of BPO at ambient temperatures as depicted in Scheme 2.
Scheme 2. Representation of the activation mechanism of benzoyl peroxide by a tertiary 
aromatic amine.!25!
Capsules were prepared containing EGDMA in which 1% (w/w) of the initiator 
benzoyl peroxide (BPO) was dissolved (Figure 5). The addition of BPO in the 
reaction mixture did not interfere with the capsule preparation procedure and 
well-defined PUF capsules were obtained. To prevent premature initiation of the 
polymerization reaction owing to thermal decomposition of BPO, 30 ppm of the 
inhibitor hydroquinone (HQ) was dissolved in the oil phase as well.
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Figure 5. Scanning electron micrograph of a PUF capsule loaded with both monomer 
(EGDMA) and initiator (BPO). A small amount of hydroquinone was mixed in to suppress 
polymerization inside the capsules.
When analyzing the capsules, it was also observed that upon the application of 
pressure liquid came out of the capsules, indicating that no polymerization 
reaction occurred during the capsule formation. To demonstrate this 
quantitatively, the capsule content was analyzed by 1H NMR spectroscopy. For this 
purpose, the capsules were crushed and their contents were extracted with 
deuterated chloroform (CDQ 3). Analysis of the contents of the capsules showed no 
formation of polymer. These capsules were tested over a period of three months 
and during this period the contents of the capsules remained in a liquid state, 
clearly proving the stability of the system.
The polymerization reaction, by crushing microcapsules in a NMR tube and 
adding a droplet of DMT, was monitored using 1H NMR spectroscopy and showed 
no monomer peaks of EGDMA at 5.5 and 6.2 ppm after 2 days. As can be seen in 
Figure 6, after two days a gel was formed, which indicates that rupture of the 
capsules in the presence of an activator certainly leads to the formation of polymer. 
This is a clear demonstration that the capsules can aid in the self-healing of a 
PMMA matrix.
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Figure 6. Images taken of a dispersion of crushed capsules filled with monomer and 
initiator. A. Before the addition of the activator DMT. B. Two days after the addition of the 
activator DMT. Turning the NMR tube upside down clearly demonstrated the formation of 
a gel.
6.2.2 Mechanical testing
PMMA bone cement (CEMEX RX, Code 1200/A, Tecres) specimens were prepared 
according to standard procedures, where a solid part, comprising PMMA, barium 
sulphate and benzoylperoxide was mixed with a liquid monomer solution 
comprised of MMA and N,N- dimethyl-p-toluidine to obtain a plastic dough. This 
dough was transferred to a Teflon mold and allowed to harden for 24 hours. 
Hereafter the specimens were cut to specific dimensions as depicted in Figure 7. 
The V-shaped cut ensures that the breaking of the specimen always starts from this 
point. Underneath this V-shaped cut, a small piece of silicon tube was glued in 
order to function as a lever for when the specimen was broken. This ensured that 
the two specimen halves could be rejoined at the same place.
3.3 mm
1.5 mm H I 4
110 mm
Front view Side view
Figure 7. Dimensions of the specimens.
78 mm
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The specimens were tested by performing a break test using a tensile testing 
apparatus as depicted in Figure 8. One side of the specimen was clamped, while 
the other end underwent a downward displacement using a piston. This 
displacement was controlled and translated to the force that was applied on the 
specimen upon breaking.
Figure 8. Setup used for mechanical testing of the bone cement specimens.
The specimens were tested by first determining the displacement and force needed 
to break the specimen. The piston was then placed back in the initial starting 
position and the specimen was allowed to heal for a certain time interval. A second 
cycle was then conducted in order to establish whether self-healing had occurred.
For the testing of the self-healing capacity of the capsules, 6 types of specimens 
were prepared having different amounts of microcapsules in the cement as listed 
in Table 1. Specimens 2 and 3 contained capsules with only monomer, while 
specimens 4-6 contained capsules that encapsulated monomer and initiator. Also 
listed in the table are the average displacements and forces that were needed to 
break the bone cement specimens.
Table 1. Different specimens of bone cement and properties of breaking and healing.
Specimen Amount
(wt.%)
Core material Displacement
(mm)a
Force
(N)a
Healing
1 0 6.1 37.3 No
2 5 EGDMA 5.6 31.6 No
3 10 EGDMA 5.4 30.2 No
4 5 EGDMA + BPO 6.0 28.2 No
5 10 EGDMA + BPO 5.0 24.3 No
6 15 EGDMA + BPO 4.6 22.4 No
aAveraged over a minimum of 5 tests.
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The mechanical tests performed on both monomer-filled and monomer and 
initiator containing capsules did not reveal any self-healing behavior (Figure 9 A 
and B).
Time [s] Time [s]
Figure 9. Plot of the displacement of the piston and the force needed to break the bone 
cement. A. No capsules in the bone cement. B. Different amounts of capsules in the bone 
cement.
Furthermore, the PMMA specimens containing capsules broke at lower force in 
comparison with the bare PMMA specimens, as can be seen in Table 1. A plausible 
explanation is that the incoming crack propagated at the matrix-capsule interface 
as there hardly was any binding force between these two different types of 
material. This implies that the capsules did not rupture and, correspondingly, 
remained intact in the matrix or fell out of the cement leaving an imprint behind as 
depicted in Figure 10. The only effect of the capsules therefore was to introduce 
cavities into the PMMA matrix, which weakens the material and therefore results 
in a breakage of the specimens at a lower loading.
Figure 10. Scanning electron micrograph of the crack plane containing free lying PUF 
capsules.
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When preparing the specimens for testing, it furthermore became evident that not 
all microcapsules did survive the mixing. Because the bone cement mixture 
became a viscous paste the brittle shells of the microcapsules collapsed. 
Furthermore, when these PUF capsules were added to MMA, they started to leak 
immediately, as observed by release of the encapsulated dye. Due to the leaking, 
the encapsulated monomer was released during mixing, thereby explaining why 
no healing behavior was observed. A  solution to this problem could lie in the 
preparation of capsules which have a tougher shell and thus do not leak when 
coming into contact with MMA, and thereby surviving the mixing process. 
Therefore a different type of capsule was chosen, namely based on poly(melamine 
formaldehyde) (PMF) capsules. PMF capsules are known for their encapsulation of 
fragrances and their thicker shell compared to PUF capsules.[26] This thicker shell 
might withstand the MMA monomer upon mixing with the matrix, since MMA 
will need more time to diffuse through the shell. When the capsules are mixed 
through the matrix, the MMA will start to polymerize and thereby form oligomers, 
which might not display this plasticizing effect of MMA upon the capsules. Also, 
due to their thicker shell the capsules will have more resistance to the forces 
working on them during the mixing procedure.
6.2.3 Preparation of PMF capsules
For the preparation of PMF capsules, a procedure of Yuan et al. was adopted, 
where an in situ polymerization is used in an emulsion.!27! First a prepolymer of 
melamine and formaldehyde had to be synthesized as depicted in Scheme 7. This 
prepolymer was added to an emulsion of EGDMA and water containing a 
surfactant. The capsules were prepared by addition of a second surfactant, 
decreasing the pH and increasing the temperature. This made the prepolymer 
polymerize further and precipitate on the EGDMA-water interface, thereby 
forming a shell around the EGDMA droplet.
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Scheme 7. Mechanism of the melamine formaldehyde polymer formation via 
hexamethylolmelamine and trimethylolmelamine.
Several conditions were tested in order to optimize the shell thickness and the 
diameter of the capsules using different concentrations of the second surfactant 
and pH as listed in Table 2.
Table 2. Preparation of PMF capsules using different conditions.
Nr PVA (wt.%) pH Reaction time (min) Diameter (|am) Shell thickness (|am)
1 0 4.0 180 No capsules
2 0.25 4.0 120a 100 2
3 0.50 4.0 180 60 0.5
4 0.50 3.5 180 60 1
5 0.50 3.0 180 No capsules
a reaction was stopped earlier due to clustering of the capsules.
From this table it can be noted that the addition of the second surfactant 
(poly(vinyl alcohol), PVA) is vital for the stability of the capsules. When no or little 
amount of surfactant (entry 1 and 2 from table 3) was used, no capsules or capsules 
which were much bigger and had irregular shells were formed. Also a significant 
amount of clustering was observed together with a large number of broken 
capsules when only a small amount of surfactant was used.
Adjusting the pH had a significant influence on the shell thickness. By adjusting 
the pH to 4.0, capsules could be produced with a shell of 0.5 |am and an average 
diameter of 60 |am as depicted in Figure 11. Preparing capsules using a slightly
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lower pH (pH=3.5) produced capsules with a thicker shell, however they were very 
deformed as depicted in Figure 11C. When an even lower pH was used, no 
capsules were formed, and precipitation of the polymer was observed after 3 
hours.
Figure 11. Scanning electron micrographs of A. PMF capsules. B. Broken PMF capsules from 
which their shell thickness could be assessed. C. Deformed PMF capsules when pH 3.5 was 
used.
When testing the stability of these capsules in MMA, it was observed that the 
capsules showed no leaking of dye for several minutes. Although the capsules 
became leaky after some time, they were more stable than PUF capsules and could 
therefore be used in the bone cement.
6.2.4 Optimizing the bone cement composition and mechanical testing
As mentioned before, when preparing the bone cement, a dough was obtained, 
through which the capsules were mixed. From this, specimens were prepared for 
testing, by pressing the dough in a mold. The force needed to get the dough in the 
mold led to breaking of the capsules and thereby no healing effect could be 
determined during the breaking tests. In order for the capsules to survive the 
molding procedure, a new composition of the bone cement was used. By using 
twice the amount of monomer, which is a liquid, a viscous liquid could be obtained 
instead of a highly viscous dough. Capsules could easily be distributed through 
the liquid and be poured into the mold without using force.
When breaking a specimen formed by this new procedure, it was observed that the 
capsules now formed an integral part of the bone cement matrix, as displayed in 
Figure 12.
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Figure 12. Scanning electron micrograph of the crack plane of bone cement A. Overview of 
PMF capsules in bone cement. B. Detail of shell in the bone cement.
In order to test the self-healing capacity of the bone cement, specimens were 
prepared having 10 wt.% of capsules, compared to the solid component and were 
left to harden for 24 hours. The setup for testing was similar as described above 
and the specimens were tested at several time intervals. Figure 13 shows a 
displacement/force graph in time after the bone cement was allowed to heal for 15 
minutes.
Figure 13. Displacement of the piston and the force needed to break the bone cement 
containing 10 wt.% PMF capsules filled with EGDMA.
From this figure it could be observed that the bone cement was broken in the first 
cycle and that after 15 minutes no healing could be detected in the second cycle. 
Similar curves were obtained when the bone cement was left to heal for 1 hour and 
1 day. One possible explanation for the absence of healing could be found in the 
set-up of the experiment. After breaking of the bone cement the broken ends need 
to be rejoined exactly on the same spot, ensuring a perfect fit for healing to take
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place. This could be quite difficult to achieve and it is therefore unlikely that 
healing will be observed. In addition, if some bone cement chipped away while 
breaking, the fit would never be perfect and the space between the two rejoined 
ends could be too big for the healing capacity of the capsules.
Since the capsules could be fully integrated in the matrix, a different set of self­
healing experiments was conducted. For the mechanical testing of the bone 
cement, specimens were prepared with different ratios of PMF capsules embedded 
in PMMA bone cement as listed in Table 3.
Table 3. Overview of prepared specimens with different amounts of microcapsules in the 
PMMA bone cement.
Specimen Amount of capsules (wt.%)
7 0
8 1
9 5
10 10
11 15
12 20
To assess the crack-healing capacity of these composite materials, fracture tests 
were performed using a double cantilever beam (DCB) specimen Therefore the 
specimens that were prepared were cut according to the drawing in Figure 14 A.
Figure 14. Double cantilever beam specimen. A. Shape and dimensions of the specimen. B. 
Direction of the force applied on the specimen during the DCB experiment.
Load was applied on the specimens listed in Table 3 in a direction perpendicular to 
the notch with pin-loading grips as shown in Figure 14B. The virgin fracture
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toughness was determined from the critical load to propagate the crack and with 
failure of the specimen as end result. Immediately after crack propagation, the 
loading was removed in order to prevent complete breaking of the specimen and 
the crack was allowed to heal at room temperature with no manual intervention. 
As a control, specimen 7 was treated by applying a droplet of EGDMA together 
with BPO onto the specimen. After 5 minutes the remainder of the droplet was 
removed. This would allow for the healing solution to fill up the virgin fracture 
and induce the healing of the specimen. Fracture tests were repeated after 24 hours 
to quantify the amount of healing. The results of the force needed to fail the 
specimen and the ability to heal are listed in Table 4.
Table 4. Different specimens of bone cement and their properties of breaking and healing.
Specimen Amount of 
capsules (wt.%)
Failure 
force (N)a
Healing Failure 
force (N)b
7 0 62 Yes 18
8 1 62 No -
9 5 66 No -
10 10 59 No -
11 15 52 No -
12 20 48 No -
a Average force from at least 8 measurements needed to form a crack in the specimen 
b Average force from 5 measurements
From Table 4 it can be observed that the percentage of capsules in the bone cement 
was of influence on the critical load of the specimens. When specimens contained 
up to 5 wt.% capsules the critical loading was similar compared to the normal bone 
cement (specimen 7 from Table 4). When more capsules were mixed through the 
bone cement, the specimens were weaker, resulting in a lower critical loading of 
the specimen.
None of the specimens containing microcapsules showed any healing capacity. 
Specimen 7, however, did show healing capacity as depicted in Figures 15 A and B.
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A  B
Time [sec.] Time [sec.]
Figure 15. Representative graphs of self-healing behavior. A. Initial crack test and self­
healing of specimen 7. B. Initial crack test and self-healing of specimens 8-12.
From Figure 15A it can be observed that during the initial break test the load 
applied on the specimen was stopped at around 35 N, which was at the end of the 
curve. When a second fracture test was conducted, in first instance the slope of the 
healing test curve was similar to the slope of the breaking test, until the polymer 
which healed the matrix started to fail. After failing, the curve continued in a 
straight line to the force level at which it was stopped in the breaking test. If no 
healing would have been observed, the slope of the healing test would be similar 
to the dotted line in Figure 15B. Here no additional force was needed to crack the 
healed polymer, therefore the force curve showed a linear transition towards the 
force where it was stopped in the first breaking test. This indicated that self-healing 
had occurred with specimen 7, which proved that in principle the presence of 
EGDMA and an initiator in bone cement could induce self-healing properties. 
Unfortunately, no self-healing behavior was observed with the specimens which 
contained microcapsules, filled with EGDMA and initiator. A possible explanation 
for this might be that, although the capsules were more resistant towards leaking, 
the polymerization time of MMA was still too long. This would cause the MMA to 
plasticize the PMF wall of the microcapsules, thereby partially releasing the 
EGDMA from the core during the preparation of the specimen. This would allow 
MMA radical species to also activate the EGDMA and thereby polymerize the 
interior of the microcapsules. This could also explain the partially filled capsules, 
as seen in Figure 15. The PMF wall was well incorporated into the matrix, although 
a void could be seen between the capsule wall and the EGDMA, which had 
polymerized. Another possible explanation could be that the capsules still break 
during preparation of the bone cement or during curing of bone cement. From the 
preparation of the bone cement, it is known that the matrix shrinks upon
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hardening. This might rupture the capsules, since they were well incorporated in 
the matrix, which will cause leaking of EGDMA into the matrix where it will be 
polymerized.
An interesting observation was that specimen 12, although not showing self­
healing behavior, did have remarkable properties when the specimen cracked 
completely as depicted in Figure 16.
0  10 20  30  40  50  60  70  80  90  100 
Time [sec.]
Figure 16. Complete breaking of a specimen containing 20 wt.% of microcapsules (Specimen 
12 from Table 4).
From this figure it could be concluded that the specimen fails several times, 
although it does not fail completely. After each failure the propagation of the crack 
stopped and extra force had to be applied before the specimen would fail again. A 
possible explanation could be that the capsules incorporated in the matrix act as a 
crack stopper. When a specimen fails, a crack runs through the specimen and will 
continue to rupture the specimen when it doesn't encounter anything along the 
cracking path. However, when a capsule is in its path, the force is distributed over 
the capsule's surface. This allows the force to build up until either the shell of the 
capsule ruptures or a crack path is created around the capsule as depicted in 
Figure 17.
5 0 - break  test
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Figure 17. The cracking path of a specimen in which a capsule acts as a crack stopper. The 
cracking continues after either the shell of the capsule ruptures (1) or a pathway is created 
around the capsule (2).
6.3 Conclusions
In an attempt to create self-healing bone cement, microcapsules filled with 
monomer were mixed in with standard bone cement formulation. Microcapsules 
were successfully prepared, which contained the monomer ethylene glycol 
dimethacrylate (EGDMA), a suitable initiator (BPO) and a stabilizer 
(hydroquinone) In first instance microcapsules composed of poly(urea 
formaldehyde) (PUF) were tested. Tensile breaking tests showed that when these 
microcapsules were mixed in with bone cement they were unable to induce 
healing. A possible explanation is that the shell of these particles was too fragile to 
survive the bone cement preparation procedure. Therefore poly(melamine 
formaldehyde) (PMF) microcapsules were prepared, which proved to be more 
stable in MMA and were therefore used in the additional testing experiments. 
However tensile strength measurements showed that also these capsules did not 
induce a self-healing capacity to the matrix. Lowering the viscosity of the bone 
cement formulation and changing the mechanical testing set-up to a double 
cantilever beam (DCB) test unfortunately did not improve the self-healing 
properties. Only when the monomer mixture was manually applied on the 
specimen after the first breaking test, mechanical properties were restored to a 
certain extent. This demonstrated that the monomer mixture in principle can 
induce self-healing capacity. In order to prepare self-healing bone cement, capsules 
will have to be prepared which do not leak when they are in contact with MMA or 
upon matrix polymerization, and which are still brittle enough to rupture when a 
crack propagates through the capsule.
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6.4 Experimental
Materials
Sodium dodecylbenzene sulfonate (SDBS), dibenzoyl peroxide (BPO), urea, ammonium 
chloride and resorcinol were purchased from Acros. Formaldehyde (37% in water), 
poly(styrene-alt-maleic anhydride) (EMA), hydroquinone (HQ), poly(vinyl alcohol) (PVA), 
methyl methacrylate (MMA), glycidyl methacrylate (GMA), ethylene glycol dimethacrylate 
(EGDMA), 1-octanol, sodium hydroxide (NaOH) and sodium carbonate (Na2CO3) were 
purchased from Sigma Aldrich. Melamine was purchased from Fluka. Cerex RX (Code 
1200/A) was a kind gift from Tecres. All materials were used as received unless stated 
otherwise.
Instrumentation
Proton nuclear magnetic resonance (1H NMR) spectra were recorded on a Bruker DPX300 
spectrometer in CDCk. Chemical shifts are expressed in parts per million (5 scale) relative to 
the internal standard tetramethylsilane (5 = 0.00 ppm).
Infrared (IR) spectra were obtained using an ATI Matson Genesis Series FTIR 
spectrophotometer fitted with an ATR cell. Data is presented as the frequency of absorption 
(cm-1).
Tensile strength was measured on an MTS power machine. Specimens were loaded with an 
increasing displacement of 0.5 mm/sec. Measurements were made with a sampling rate of 10 
Hz. The displacement was increased from zero millimeters until the specimen breaks. The 
range of the load was from 0 to 100 N.
Double Cantilever Beam (DCB) measurements were conducted on a Zwick 1445 Universal 
Testing System. Specimens were loaded with an increasing displacement of 1.0 mm/min. 
Measurements were performed using custom- written software in Labview with a sampling 
rate of 50 Hz. The range of the load cell was from 0 to 100 N. The temperature at which the 
specimens were measured was 23°C for the breaking test and 24°C for the healing test.
Synthesis
Methyl methacrylate-filled PUF microcapsules
Microcapsules were prepared via an in situ polymerization process in an oil-in-water 
emulsion. At room temperature, 200 mL of deionized water and 50 mL of aqueous solution 
of EMA (2.5 wt.%) were mixed in a 1000 mL beaker. The beaker was suspended in a 
temperature-controlled water bath. The solution was agitated using a three-bladed propeller
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placed just above the bottom of the beaker. Under agitation, urea (5.00 g, 83.3 mmol), 
ammonium chloride (0.50 g, 9.35 mmol) and resorcinol (0.50 g, 4.54 mmol) were dissolved in 
the solution. The pH was raised from 2.60 to 3.75 by dropwise addition of NaOH solution 
(1M) and subsequently lowered to pH = 3.50 using HCl solution (1M). One to two drops of 
1 -octanol were added to eliminate surface bubbles. A slow stream of 60 ml of MMA, 
containing a minute amount of the red dye Oil-Red-O, was added to form an emulsion and 
allowed to stabilize for 10 minutes. After stabilization, formaldehyde (12.67 g, 156.1 mmol) 
was added to obtain a 1.9:1 molar ratio of formaldehyde to urea. The emulsion was covered 
and heated at a rate of 1°C/min to the target temperature of 55°C. After 4 hours of 
continuous agitation the mixer and hot plate were switched off. Once cooled to ambient 
temperature, the suspension of microcapsules was separated under vacuum with a coarse- 
fritted filter. The microcapsules were rinsed with deionized water and air dried. A sieve was 
used to aid in separation of the microcapsules.
Ethylene glycol dimethacrylate filled PUF microcapsules
These capsules were prepared employing a procedure similar to the MMA-containing PUF 
capsules, except for the fact that here 60 mL of EGDMA was added as the oil phase.
Ethylene glycol dimethacrylate and benzoyl peroxide filled PUF microcapsules
The preparation method is similar to the EGDMA filled capsules, only BPO (771 mg, 3.18
mmol) and HQ (1.3 mg, 12 |omol) were dissolved in EGDMA (60 mL, 0.32 mol)
Ethylene glycol dimethacrylate and benzoyl peroxide filled PMF microcapsules 
Preparation of the prepolymer:
Formaldehyde (29.2 mL, 392 mmol) was dissolved in deionized water (40 mL) and placed in 
a 100 mL round bottom flask. To this recrystalized melamine (15.0 g, 119 mmol) was added 
and the pH was adjusted to 8.65 using a saturated Na2CO3 solution. The solution was slowly 
heated to 68°C, while stirring and kept at this temperature for 30 minutes to yield a colorless 
liquid.
Preparation of the capsules:
The prepolymer was added to a 800 mL beaker and to this a 100 mL SDBS solution (0.5 
wt.%) and resorcinol (0.44 g, 4.00 mmol) were added. The solution was mechanically stirred 
at 500 rpm using a three bladed propeller. A solution of EGDMA (20 mL), BPO (256 mg, 1.06 
mmol), HQ (0.39 mg, 3.6 |jmol) and Oil-Red-O (5 mg, 12 |omol) were added to the aqueous 
phase. The emulsion was stirred for 30 minutes to homogenize and 1 drop of 1-octanol was 
added to eliminate surface bubbles. A PVA solution (0.5 wt.%, 20 mL) was added after 30 
minutes. The stirring of the solution was continued and after an additional 20 minutes, the 
pH was adjusted to 4.0 by an HCl solution (1M). The emulsion was heated in a water bath to
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68°C and kept at this temperature for 3 hours. The capsules were washed with water and 
decanted several times before being air dried for 48 hours.
Typical preparation o f the specimens for tensile testing
A desired amount of microcapsules and the powder from the bone cement (CEREX RX) 
were mixed gently in a bowl. The liquid of the bone cement (14 mL) was added and the 
mixture was mixed using a spatula until a dough was obtained. This dough was transferred 
to Teflon mold in which the dough was pressed. The mold was closed using a Teflon cover 
and the bone cement was allowed to harden for 24 hours.
Typical preparation o f specimens for DCB measurements
The powder from the bone cement (40 g, CEREX RX) was gently mixed with the liquid part 
(21.5 mL) in a bowl. When a homogeneous liquid mixture was obtained a desired amount of 
microcapsules was added quickly and the mixture was stirred for 10 seconds. The mixture 
was poured in a square glass mold, where the bone cement started to harden within 5 
minutes. The bone cement was allowed to harden for another 24 hours before the specimens 
were cut to the specifications of ISO 13586.
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Preparation of biodegradable liquid core PLLA 
microcapsules and hollow PLLA microcapsules 
using microfluidics.
Summary
Biodegradable poly L-lactic acid (PLLA) capsules with a narrow size distribution 
were prepared using a microfluidics platform. With this technique, an oil-in-water 
emulsion was produced in which the polymer, a hydrophobic non-volatile non­
solvent and a hydrophobic model drug were dissolved in the organic phase. The 
polymer precipitated at the droplet interface, yielding a drug deliverable 
microcapsule of which the release of this model drug was investigated. These 
capsules with an organic phase in the core were also used to prepare hollow 
particles by conveniently removing the core phase by lyophilization. Optimal 
conditions for the preparation of biodegradable capsules were found with respect 
to the flow rate of the continuous phase and the molecular weight of the PLLA 
polymer. This approach of preparing biodegradable capsules is of potential interest 
for the field of drug delivery.
Part o f  this research was published as: Dennis Lensen, Kevin van Breukelen, Dennis M. Vriezema and Jan C.M. 
van Hest, M acromolecular Bioscience, 2010, 10, 475.
Chapter 7
7.1 Introduction
Microparticles have been a topic of investigation in materials science for already a 
few decades and have found widespread use in the encapsulation of pesticides, 
perfumes, inks and toners.[1] Biodegradable microspheres prepared from poly- 
lactide, poly-lactide-co-glycolide and polycaprolactone have been used as matrices 
for controlled drug delivery.[2] The standard preparation procedure for drug 
delivery particles is based on phase separation using mechanical stirring. In this 
technique an oil-in-water emulsion is employed, in which the oil phase consists of 
a polymer with a volatile solvent and a hydrophobic drug.[3] Polymer particles that 
encapsulate the drug are formed, when the volatile solvent evaporates from the 
droplets, yielding particles with a rather broad size distribution. This technique 
can also be used when preparing liquid filled capsules by either adding an 
additional non-volatile non-solvent to the polymer phase or by preparing a pre­
emulsion of water-in-oil in which the water phase contains the drug. These 
capsules have shown their potential as efficient drug releasing systems, although 
the disadvantage is the minimal control over the size of the capsules.[4]
A method which has drawn much attention for the preparation of monodisperse 
microparticles is based on microfluidics.[5] With this easy-to-use technique 
emulsions are created in which the droplets solidify during the preparation 
process. Since the size of the droplets can be highly controlled, also the particles 
formed have a narrow particle size distribution. There are two broad classes of 
devices for generating emulsions in microfluidic platforms: T-junctions[6-9] and 
Flow-Focusing nozzles.[10-12] Both systems have the possibility to create 
monodisperse particles in a wide range of sizes. For making monodisperse 
polymer particles, both spherical or non-spherical, usually Flow-Focusing devices 
are used for the preparation of solid particles,[5 13-16]liquid filled particles,[1719] 
hollow particles,[20-22] and several other morphologies.[23-27]
By improving the control over the size of the capsules it is possible to have a more 
effective drug release as demonstrated by Xu et al.[14] They showed that when 
comparing drug-loaded poly(lactic acid-co-glycolic acid) (PLGA) solid spheres 
prepared by conventional techniques, as described above, and by microfluidics, the 
monodisperse particles prepared by microfluidics exhibited a significantly reduced 
burst release and a slower overall rate of release compared to the conventionally 
prepared polydisperse particles.
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Hollow capsules, from which the liquid core is removed, are traditionally prepared 
from lipids, proteins or biodegradable polymers and have gas encapsulated in 
their lumen, which makes them very useful as contrast agents, e.g. to image the 
blood circulation.[28] For this application the stiffness of the shell and the size of the 
capsule are closely related to the acoustic response of these capsules.[29-31] Hollow 
capsules can also be used as drug delivery vehicles that are triggered by 
ultrasound which ruptures the shell and releases the hydrophobic drug inside (see 
also chapter 5).[32]
One method to create hollow capsules with improved control over particle size 
was reported by Böhmer et al. who used an inkjet printing approach for making 
uniform monodisperse biodegradable PLLA capsules for diagnostics.[33] Although, 
as already mentioned, hollow capsules have been made before with microfluidics, 
until now, there are however no reports, to our knowledge, about microfluidic 
devices that have been used for the construction of liquid core-shell or hollow 
biodegradable PLLA capsules for the purpose of drug delivery.
Here we describe the efficient formation of PLLA capsules using a Flow-Focusing 
device, which have a liquid core in which a hydrophobic model drug is dissolved. 
By conveniently removing the liquid core by lyophilization, also hollow drug 
loaded PLLA capsules could be prepared. The effects of flow rate and PLLA  
molecular weight were investigated to find the optimal conditions for capsule 
formation. Furthermore, also the release upon capsule degradation of the 
hydrophobic model drug was investigated. With this method biodegradable 
hollow capsules and highly loaded drug delivery capsules can easily be prepared.
7.2 Results and Discussion
For the creation of particles in a microfluidic device, the set-up as depicted in 
Figure 1 was used. Here the symmetric shearing by the continuous phase on the 
dispersed phase caused the front of the dispersed phase to elongate into the main 
channel until the neck of the dispersed phase thinned, which eventually led to 
budding off of a droplet.[34]
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Figure 1. Schematic representation of the microreactor setup with the central channel 
containing the dispersed phase and the two side channels containing the continuous phase.
To investigate the optimal conditions for capsule formation, in first instance the 
effect of flow speed of the continuous phase was investigated. These series of 
experiments were performed with high molecular weight polymer (PLLA65000). 
The flow speed was varied between 10 mL/hour and 65 mL/hour while keeping the 
rate of the dispersed phase constant (3 mL/hour). Droplets of different sizes were 
prepared and the resulting capsules were analysed using electron microscopy.
When capsules were prepared using low flow speeds, a very broad size 
distribution was observed for the capsules, due to satellite formation from the 
original droplet (Figure 2A). The average size of the capsules and also the amount 
of satellites decreased with increasing flow rates. An optimal flow speed was 
found at 35 mL/hour for the continuous phase. This resulted in capsules having an 
average diameter of 50 |am with a size distribution of 8 |am (Figure 2 B and C), 
which is a relatively high distribution when compared to other particles prepared 
by microfluidics, although better than with mechanical stirring.
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Figure 2. Non-lyophilized PLLA capsules filled with dodecane prepared in a microreactor at 
different flow speeds of the continuous phase. A. Flow speed of 25 mL/hour. B. Flow speed 
of 35 mL/hour. C. Size distribution of the capsules (based on 150 capsules counted by hand). 
D. Flow speed of 40 mL/hour; holes are shown on one side of the capsules. Scale bars 
represent 100 |jm.
When higher flow speeds were used, the morphology of the capsules changed. 
Now, capsules were observed with a hole on one side of the shell (Figure 2D). An 
explanation for this phenomenon is given by Tiarks et al.[35]
Small polymer-rich droplets are formed by phase separation within the emulsion 
droplets as the good solvent evaporates. These polymer-rich droplets will migrate 
to the interface and engulf under the right conditions the original droplet. Further 
removal of the solvent results in more polymer precipitate which migrates to the 
shell thus forming core-shell microcapsules. When these conditions are not 
optimal, as is the case when the rate of formation is too high, the dodecane core is 
only partially engulfed, resulting in capsules with a hole in the shell.
Capsule formation using different polymers of PLLA
In order to determine the optimal molecular weight for the formation of these 
capsules, experiments were performed with polymers of PLLA having different 
molecular weights. The conditions that were used were similar to the optimal 
conditions as described above for PLLA65000. When PLLA3000 was used to 
prepare capsules it was observed that only half spheres were formed due to the
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partial engulfment of the droplet by the polymer (Figure 3A). By increasing the 
molecular weight to 10 kg/mol, capsule formation was improved, although still 
capsules with holes were observed. This result is similar to what was found for the 
production of PLLA65000 particles at flow speeds higher than 40 mL/h (Figure 3B).
Figure 3. Capsules prepared with a flow speed of the continuous phase of 35 mL/hour from 
different polymers. A. SEM micrograph of capsules prepared with PLLA3000. B. SEM 
micrograph of capsules prepared with PLLA10000. Scale bars represent 100 |jm.
The correct formation of hollow capsules is therefore dependent on both the speed 
of droplet formation and the molecular weight of the polymer. Since in every 
experiment the same weight percentage of polymer in dichloromethane was used, 
it can be concluded that a higher molecular weight results in an increased viscosity 
of the dispersed phase, and therefore a better ability to stabilize the capsule wall.t36] 
Under the conditions as described above, therefore only with high molecular 
weight PLLA it was possible to prepare core-shell capsules.
Release studies using PLLA capsules prepared under optimal conditions
The capsules prepared at the optimal flow speeds were subjected to release studies. 
Here, the dodecane core with the dye Oil-Red-O can be regarded as a hydrophobic 
model drug. To visualize the release of the inner phase of the capsules, the Oil- 
Red-O absorption was measured using UV-Vis spectroscopy. Before release studies 
were performed first the capsules were washed with dodecane to remove any Oil 
red-O which was adsorbed on the capsule surface.
In order to measure the release of this hydrophobic phase, the capsules were 
placed in a basic solution to speed up the degradation of the polylactic acid chains 
by hydrolysis, thereby destroying the shell of the capsules. Once the shell was 
degraded enough the content of the capsules could diffuse out, which was taken 
up in an additional dodecane phase placed on top of the basic solution. At regular
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time intervals the absorption at a characteristic wavelength for Oil-Red-O in 
dodecane (513 nm) was measured and plotted in Figure 4A.
Figure 4. A. Oil-Red-O release from the degradation of the PLLA capsules measured by UV- 
Vis spectroscopy. B. GPC data of PLLA polymer used to prepare the capsules and the PLLA 
polymer after 1 hour of degradation in a 1 M NaOH solution.
From this figure it can be observed that within the first hour a big release of Oil- 
Red-O was measured. Oil-Red-O dissolves in dichloromethane and could also be 
trapped in the polymer shell of the capsule as well as in the dodecane core of the 
capsule. The measured release of Oil-Red-O as depicted in Figure 4A is therefore 
probably a combination of the induced porosity of the capsule and the release of 
dye from the shell due to hydrolysis. After one hour of capsule exposure to the 
basic solution, GPC analysis (Figure 4B) showed that although there was still PLLA  
present from the shell, considerable hydrolysis had occurred.
Preparing hollow biodegradable PLLA capsules
In order to prepare hollow PLLA capsules, the dodecane filled core-shell particles 
that were prepared under the optimal conditions (PLLA65000, 35 mL/hour) were 
subjected to lyophilization. DSC measurements were performed to prove that 
dodecane was removed from the capsules, since dodecane has a melting 
temperature of -10”C and its presence could therefore easily be detected. Capsules 
measured by DSC before and after lyophilization showed a clear distinction. From 
the resulting graph in Figure 5A it can be observed that only a very small peak was 
observed in the DSC graph of the PLLA capsules after lyophilization compared to 
the capsules containing dodecane in their lumen. From the peak area it was 
calculated that >99 % of the dodecane was removed.
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Figure 5. A. DSC graph (endo up) of PLLA capsules before and after lyophilization. B. SEM 
micrograph of PLLA capsules after lyophilization. C. SEM micrograph of crushed hollow 
PLLA capsules after lyophilization. Scale bars represent 10 |jm.
Additional electron microscopy analysis of the samples showed that the capsules 
were still intact after freezedrying, although minor deformations appeared on the 
surface due to the lyophilization of dodecane (Figure 5B). No proof was found, 
however, of these deformations penetrating through the shell of the capsules. In 
order to demonstrate that the PLLA capsules were hollow, they were crushed and 
analysed by electron microscopy. From Figure 5C it can be seen that the hollow 
capsules have a wall thickness of around 3 |am.
7.3 Conclusions
Dodecane filled biodegradable PLLA capsules were prepared in a microreactor 
setup. By changing the flow rate of the continuous phase and the molecular weight 
of PLLA an optimum was found in which capsules were prepared without defects 
and with a narrow size distribution. When PLLA of lower molecular weight was 
used to prepare capsules using the microreactor, this resulted in incomplete 
capsule formation. This indicates that there is a relationship between the molecular 
weight of the polymer and capsule formation using microfluidics. From the release 
profile of the model drug it can be seen that the core of the capsule was released 
within the first hour, while a considerable fraction of the shell polymer was still 
intact, which was confirmed by GPC.
Hollow PLLA microcapsules were easily obtained by lyophilization of the 
dodecane core. This was confirmed with electron microscopy and DSC 
measurements. These hollow PLLA capsules have potential for application in drug 
delivery of hydrophobic compounds.
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7.4 Experimental
Materials
L-lactide, polyvinylalcohol (PVA, Mw 9-10 kDa, 80% hydrolysed), 1-octanol, Oil Red O, 
sodium hydroxide (NaOH), tetrahydrofuran (THF) and stannous(II) 2-ethylhexanoate 
(Sn(Oct)2) were purchased from Sigma-Aldrich. Dodecane was purchased from Merck. All 
chemicals were used as received. Dichloromethane was distilled over CaCl2 and toluene was 
distilled over Na/benzophenone.
Analysis and Characterization
:H NMR spectra were recorded on a Varian 400 MHz at room temperature and with CDCk 
as solvent.
Molecular weights of the polymers were measured using size exclusion chromatography 
(SEC) on a Shimadzu system equipped with a guard column and a PL gel 5 |om mixed D 
column (Polymer Laboratories) with differential refractive index detector, using THF as an 
eluent at 1 mL/min and T=35°C. Polystyrene (PS) standards in the range of 580 to 377,400 
g/mol (Polymer Laboratories) were used to calibrate the SEC.
Differential Scanning Calorimetry (DSC) measurements were performed on a Perkin Elmer 
Pyris Diamond DSC, equipped with a Perkin Elmer Intracooler 2P. Samples were prepared 
in an aluminum cup with less than 1 mg of sample. Empty aluminum cups were used as a 
reference. All samples were measured with heating rates of 5 ° C/minute.
Samples used for lyophilization were rapidly frozen in liquid nitrogen. Lyophilization was 
performed in an Ilshin FD 8515 with a condenser temperature of -92 °C at 5 mTorr for at least 
24 hours.
UV-Vis studies were performed on a Varian Cary 50 spectrophotometer using a Hellma QS 
cuvette with a light path of 1 mm.
Scanning Electron Microscopy studies were performed with a JEOL JSM-6330F electron 
microscope. The samples for SEM were prepared by drying a drop of a dispersion on a clean 
glass substrate in air. The samples were sputtered with a layer of Pd/Au using a Cressington 
208 sputter coater.
Microreactor setup
A complete setup (FlowStart) was supplied by FutureChemistry, Nijmegen, The 
Netherlands. The syringes mounted on the syringe pumps were connected to FEP tubing 
(1.59 mm OD, 254 |om ID). At the end of each tubing, a special 'flat bottom headless nut' was
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mounted which pressed down onto a flat bottom ferrule to achieve a leak free fluid 
connection to the microreactor. The microreactor was placed in the chip holder with 
threaded holes on the top side in which the nuts were screwed. FEP tubing (same 
dimensions as inlets) was used as outlet.
Microreactor
The actual microreactor was fabricated from borosilicate glass and supplied by 
FutureChemistry, Nijmegen, The Netherlands. Chip dimensions: length 45 mm, width 15 
mm, height 1.8 mm. Channel dimensions: width 110 |om, depth 55 |om, nozzle size 110 |om, 
internal volume 7 |jL ( Figure 1).
Synthesis
Typical polymerization procedure o f poly-L-lactic acid (PLLA)
L-lactide, Sn(oct)2  and 1-octanol were dissolved in toluene and refluxed under an argon 
atmosphere for 17 hours.!37! The solution was allowed to cool to room temperature and 
evaporated to dryness, before being taken up in a minimal amount of dichloromethane and 
precipitated twice in an excess of methanol. The white precipitate was filtered off and dried 
under vacuum.
JH NMR (CDCls): 5= 0.88 (mp, CH3-(CH2>-CH2-CH2-O), 1.21-1.30 (mp, CHs-(CH2)5-CH2-CH2- 
O), 1.47-1.71 (mp, CH3-(CH2)5-CH2-CH2-O-(CO-CH(CH3)-O)n), 4.1-4.2 (mp, CHs-(CH2>-CH2- 
CH2-O), 4.3-4.4 (mp, (CO-CH(CH3)-O)n-CO-CH(CHs)-OH), 5.10-5.25 (mp, (CO-CH(CHs)-O)n- 
CO-CH(CH3)-OH).
All molecular weights that were used were derived from NMR analysis.
Synthesis o f poly-L-lactic acid 3000(PLLA3000)
Polymerization was performed as described above using L-lactide (19.2 g, 0.13 mol), Sn(oct)2 
(0.19 g, 0.48 mmol) and 1-octanol (0.87 g, 6.71 mmol) in toluene (50 mL). This yielded a 
white polymer in 84% (18.2 g, 5.62 mmol).
Molecular weight determination:
NMR: Mn = 3240 g/mol,
GPC: Mn = 5287 g/mol, Mw = 7474 g/mol, DPI = 1.41 
Synthesis o f poly-L-lactic acid 10000(PLLA10000)
Polymerization was performed as described above using L-lactide (10.2 g, 70.8 mmol), 
Sn(oct)2 (43.0 mg, 0.11 mmol) and 1-octanol (92.8 mg, 0.71 mmol) in toluene (50 mL). This 
yielded a white polymer in 91% (7.05 g, 6.48 mmol).
Molecular weight determination:
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NMR: Mn = 10872 g/mol,
GPC: Mn = 5599 g/mol, Mw = 7617 g/mol, DPI = 1.36 
Synthesis o f poly-L-lactic acid 65000(PLLA65000)
Polymerization was performed as described above using L-lactide (20.0 g, 0.14 mol), Sn(oct)2 
(0.18 g, 0.43 mmol) and 1-octanol (34.6 mg, 0.27 mmol) in toluene (50 mL). This yielded a 
white polymer in 92% (15.3 g, 0.25 mmol).
Molecular weight determination:
NMR: Mn = 61992 g/mol,
GPC: Mn = 18398 g/mol, Mw = 42250 g/mol, DPI = 2.29 
Fabrication of biodegradable capsules
The continuous phase, an aqueous solution of polyvinylalcohol (1 wt.%) was introduced 
using a Pharmacia High Precision Pump P-500 into the two side channels of the Flow- 
Focusing device at different speeds (10, 15, 20, 25, 30, 35, 40, 45 and 65 mL/hour).
The dispersed phase was controlled using the flowstart setup from FutureChemistry in the 
central channel, and which consisted of a polymer solution in dichloromethane with 
dodecane (3 vol.%) and a dye, Oil-Red-O as a hydrophobic model drug.
All solvents were passed twice through a Pall Acrodisc 25 mm Glass Fiber Membrane filter 
with 1 |jm pore size prior to use.
Samples were collected in a beaker containing doubly distilled water (dd water, R=18.2 MQ) 
with the exit nozzle submerged, although clear from the bottom. Capsules were left in 
solution, while dichloromethane evaporated slowly until the capsules floated. Using 
lyophilization dodecane was subsequently removed from the core, yielding hollow 
capsules.
Degradation and Release Experiments
An amount of non-lyophilized capsules with dodecane and Oil-Red-O in the core was 
placed in an eppendorf tube in dd water (0.5 mL). First the capsules were washed to remove 
the polyvinylalcohol by shaking the eppendorf tube by hand and leaving the eppendorf 
tube standing until all capsules were floating. The water was removed using a pipette and 
the capsules were redispersed in dd water (0.5 mL). This procedure was repeated twice and 
finally the capsules were redispersed in 0.5 mL of dd water. To these floating capsules in dd 
water, dodecane (250 |jL) was added to remove any Oil-Red-O which was not encapsulated. 
The dodecane solution was removed using a pipette and this procedure was repeated once 
more until no coloration of the dodecane was observed.
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In order to measure the release of the dodecane with the Oil-Red-O from the core of the 
capsule, the water layer was removed and the capsules were placed in a NaOH solution (1 
M, 0.5 mL). Immediately hereafter dodecane (250 |jL) was added. At regular time intervals 
the dodecane fraction was taken off and analyzed by UV-Vis spectroscopy to observe the 
Oil-Red-O concentration. Fresh dodecane (250 |jL) was added immediately to the eppendorf 
tube after each measurement.
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Summary
Compartments of micron and sub-micron dimensions are abundant in Nature in 
the form of for example cells, organelles and viral capsids. Nowadays, small 
compartments can also be prepared synthetically, although not with the same 
complexity as found in natural systems. These synthetic microcapsules can be 
applied in a variety of biomedical applications, such as drug delivery, additives for 
smart bone cement or ultrasound contrast agents. Since these different applications 
have different requirements, not all capsules can be prepared using the same 
procedure or from the same material.
Different polymer-based capsules that have recently emerged as devices for 
encapsulation and delivery are first described in a literature overview in chapter 2. 
Polymeric capsules have, when compared to the traditional lipid-based 
microspheres, as a main advantage that they have a more stable membrane, which 
makes them more robust and gives them better protection against environmental 
influences. These capsules can be prepared by self-assembly, templating, in situ 
polymerization or precipitation and applications have been explored in various 
areas such as drug delivery, diagnostics, sensors and nano-reactors.
In chapter 3 the preparation of biodegradable polymersomes is described via a self­
assembly approach. Polymersomes were prepared in both aqueous and apolar 
environments, using amphiphilic biodegradable block copolymers of poly(ethylene 
glycol)-poly(L-lactic acid) (PEG-PLLA), poly(ethylene glycol)-polycaprolactone 
(PEG-PCL) and poly(ethylene glycol)-poly(lactic-co-glycolic acid) (PEG-PLGA) in 
order to encapsulate hydrophilic or hydrophobic drugs. It was found that 
polymersomes were only formed in an aqueous environment by the kinetic 
injection method when the block copolymer poly(ethylene glycol)-polystyrene 
(PEG-PS) was admixed. This polymer served as a template during polymersome 
formation. It was observed that for decreasing lengths of the polyester blocks 
increasing amounts of the templating polymer were needed.
In order to encapsulate hydrophobic compounds with a higher level of efficiency, 
reversed polymersomes were prepared by injecting a solution of the above 
mentioned block copolymers into an apolar medium. Again PEG-PS had to be 
added as template to obtain stable aggregates. This resulted in the formation of
Summary
aggregates with a specific morphology, having either dents or holes at their 
periphery. The amount of dents or holes was dependent on the amount of 
template, which indicated a phase separation of the block copolymers in the 
aggregate. Domain formation and hence phase separation was confirmed by 
hydrolysis. of the biodegradable block copolymers in the aggregates.
A different type of capsule which can be used for drug delivery is a so called 
double emulsion microsphere. These capsules are formed out of a water-in-oil-in- 
water (w/o/w) emulsion. Many parameters have an influence on the morphology 
and encapsulation efficiency of these microcapsules. In chapter 4 several of these 
parameters were investigated by combining two different mathematical 
approaches to streamline the number of experiments in order to yield the optimal 
biodegradable microcapsules with respect to encapsulation efficiency and 
microcapsule size. First a fractional factorial design was used to screen for the most 
dominant factors. These factors were optimized further by applying a D-optimal 
design. This resulted in microcapsules having a single core with a diameter below 
10 microns and an encapsulation efficiency of 78%.
In the previous two chapters, capsules were described which could release their 
content by (bio)degradation. In chapter 5, a different approach was chosen for the 
delivery of drugs. Here, a series of hollow biodegradable polymeric microcapsules 
were prepared, of which their susceptibility to ultrasound was used for triggered 
release. High speed imaging of the ultrasound experiments showed a strong 
correlation between the acoustic pressure needed to activate these microcapsules 
and their shell thickness to diameter ratio. Based on this information a selective 
triggering of capsules with two different shell thickness to diameter ratios was 
successfully performed. The capsules were mixed in a single system and were 
activated independently from each other by a differentiation in acoustic pressure 
levels. Additionally, thin-shelled capsules could be triggered when fixated in an 
agarose gel using a commercially available ultrasound system. This is an indication 
that it might be possible to obtain in vivo activation with these microspheres.
A common cause for implant malfunctioning is the mechanical failure of bone 
cement. The presence of microcracks in bone cement accelerates this process. One 
method to circumvent this problem is the development of self-healing bone cement 
as described in chapter 6. Standard bone cement was filled with a variety of 
microcapsules, which contained monomer and initiator. We hypothesized that
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when a crack propagated through the bone cement and ruptured a capsule, it 
would release the encapsulated monomer, which would fill up the crack and heal 
the bone cement by polymerization via the co-encapsulated initiator. The concept 
was demonstrated by first manually applying the monomer ethylene glycol 
dimethacrylate (EGDMA) with initiator on a fractured bone cement sample, which 
partly restored the mechanical properties of the specimen. When poly(urea 
formaldehyde) (PUF) microcapsules were used which contained either methyl 
methacrylate (MMA) or ethylene glycol dimethacrylate (EGDMA) and an initiator 
no self-healing properties were found, since these microcapsules were too fragile to 
survive the bone cement preparation method. Therefore poly(melamine 
formaldehyde) (PMF) microcapsules were prepared, which proved to be more 
stable in the bone cement MMA solution. When new specimens, containing PMF 
capsules with EGDMA and initiator, were prepared and tested for tensile strength, 
it became apparent that also these capsules did not give a self-healing capacity to 
the matrix. Furthermore, the mechanical properties of the bone cement decreased 
when more capsules were mixed in, although a higher loading of microcapsules 
did lead to a crack stopping effect in the cement.
In the final chapter of this thesis biodegradable poly L-lactic acid (PLLA) capsules 
with a narrow size distribution were prepared using a microfluidics platform. With 
this technique, an oil-in-water emulsion was produced in which the polymer, a 
hydrophobic non-volatile non-solvent and a hydrophobic model drug were 
dissolved in the organic phase. The polymer precipitated at the droplet interface, 
yielding a microcapsule loaded with hydrophobic compounds of which the release 
of this model drug was investigated. These capsules with an organic phase in the 
core were also used to prepare hollow particles by conveniently removing the core 
phase by lyophilization. Optimal conditions for the preparation of biodegradable 
capsules were found with respect to the flow rate of the continuous phase and the 
molecular weight of the PLLA polymer. This approach of preparing biodegradable 
capsules is of potential interest for the field of drug delivery.
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Samenvatting
Compartimenten met micron of sub-micron afmetingen zijn er veelvuldig in de 
natuur in de vorm van bijvoorbeeld cellen, organellen en de eiwitmantels van 
virussen. Tegenwoordig kunnen deze compartimenten ook synthetisch gemaakt 
worden, maar niet met dezelfde complexiteit als natuurlijke systemen. Deze 
synthetische microcapsules kunnen worden toegepast in een groot scala aan 
biomedische toepassingen, zoals het toedienen van medicijnen, toevoegingen voor 
slim botcement of als contrastmiddel bij ultrasoon geluid imaging. Omdat deze 
verschillende applicaties verschillende eisen stellen aan de microcapsules kunnen 
niet alle capsules op dezelfde manier of van hetzelfde materiaal gemaakt worden.
Verschillende polymeer gebaseerde capsules die recent ontwikkeld zijn voor 
opslag en afgifte, zijn beschreven in een literatuur overzicht in hoofdstuk 2. Deze 
capsules hebben, in tegenstelling tot de meer traditionele lipide gebaseerde 
capsules, het voordeel dat ze een stabieler membraan hebben, dat hen robuuster 
maakt en daardoor hen ook een betere bescherming biedt tegen invloeden van 
buitenaf. Deze capsules kunnen gemaakt worden via een reeks van verschillende 
methoden, zoals zelf-assemblage, met behulp van een template, in situ 
polymerisatie of het neerslaan van de polymeren. H un applicaties zijn onderzocht 
in verschillende gebieden zoals medicijn afgifte, diagnostiek, sensoren en nano- 
reactoren.
In hoofdstuk 3 zijn bio-afbreekbare polymersomen beschreven die gemaakt zijn 
met behulp van zelf-assemblage. Polymersomen werden gemaakt in polaire en 
apolaire media, gebruik makend van bio-afbreekbare blok-copolymeren van 
poly(ethyleen glycol)-polymelkzuur (PEG-PLLA), poly(ethyleen glycol)- 
polycaprolacton (PEG-PCL) en poly(ethyleen glycol)-poly(melkzuur-co-glycolzuur) 
(PEG-PLGA) om hydrofiele en hydrofobe medicijnen in te sluiten.
Het bleek dat polymersomen alleen gevormd konden worden in een waterige 
omgeving bij gebruik van de kinetische injectie methode als het blok-copolymeer 
poly(ethyleen glycol)-polystyreen (PEG-PS) werd ingemengd. Dit polymeer werkte 
als een mal gedurende de formatie van polymersomen. Het bleek verder dat voor 
afnemende lengtes van de polyester blokken meer van het template polymeer 
nodig was.
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Om hydrofobe stoffen in te sluiten met een hoge mate van efficientie, werden 
omgekeerde polymersomen gemaakt door een oplossing van de bovengenoemde 
bio-afbreekbare polymeren te injecteren in een apolair medium. Ook nu moest 
PEG-PS als een mal worden toegevoegd om stabiele aggregaten te krijgen. Dit 
resulteerde in de formatie van verschillende aggregaten met een specifieke 
morfologie, die ofwel deuken ofwel gaten aan de buitenkant vertoonde. De 
hoeveelheid van deze deuken of gaten was afhankelijk van de hoeveelheid van het 
template polymeer dat gebruikt werd en dit impliceerde een fasescheiding van de 
blok-copolymeren in de aggregaten. Domein formatie en daarmee fasescheiding 
werd bevestigd door middel van hydrolyse van de bio-afbreekbare blok- 
copolymeren in de aggregaten.
Een ander type capsule dat gebruikt kan worden voor afgifte van medicijnen is een 
zogenaamd dubbele emulsie capsule. Deze capsules worden gemaakt met behulp 
van een water-in-olie-in-water (w/o/w) emulsie. Veel parameters kunnen een 
invloed hebben op de morfologie van de capsules en op de efficientie van insluiten. 
In hoofdstuk 4 zijn verschillende van deze parameters onderzocht door het 
combineren van twee mathematische benaderingen om het aantal experimenten in 
goede banen te leiden en om hierdoor de optimale bio-afbreekbare microcapsule te 
maken met betrekking tot de efficiëntie van het insluiten en de grootte van de 
caspule. Als eerste werd een fractioneel factorieel ontwerp uitgevoerd om de meest 
dominante factoren op te sporen. Deze factoren werden verder geoptimaliseerd 
door het toepassen van een D-optimaal ontwerp. Dit resulteerde in het verkrijgen 
van microcaspules die één kern hebben met een grootte van 10 micron en een 
efficientie van insluiten van 78%.
In de vorige twee hoofdstukken werden capsules beschreven die door middel van 
(bio)degradatie hun inhoud kunnen afgeven. In hoofdstuk 5 wordt een andere 
aanpak voor de afgifte van medicijnen gekozen. Een serie van holle bioafbreekbare 
polymere microcapsules werden gemaakt, die door activering met behulp van 
ultrageluid medicijnen kunnen afgeven. Hogesnelheidscamera opnamen lieten een 
sterke correlatie zien tussen de acoutische druk die nodig was om deze 
microcapsules te activeren en de ratio van schildikte tot diameter. De informatie 
die zo verkregen werd, maakte het mogelijk dat een selectieve activering van 
capsules met twee verschillende schildikte tot diameter ratios succesvol kon 
worden volbracht. De capsules werden gemengd en gedispergeerd en werden 
hierna onafhankelijk van elkaar selectief geactiveerd door middel van een verschil
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in acoustische druk. Hiernaast konden ook capsules met dunne schillen 
geactiveerd worden die gefixeerd waren in een agarose gel, gebruik makend van 
een commerciële ultrageluid machine. Dit is een indicatie dat het ook mogelijk is 
om in vivo activatie met deze microcapsules te verkrijgen.
Een veel voorkomende oorzaak van het niet goed werken van een implantaat is het 
mechanisch bezwijken van botcement. De aanwezigheid van microscheuren in het 
botcement versnelt dit proces. Een methode om dit probleem te omzeilen is het 
ontwikkelen van zelf-reparerend botcement zoals beschreven in hoofdstuk 6. 
Standaard botcement werd aangevuld met een reeks aan microcapsules, waarin 
monomeer en initiator was ingesloten. De hypothese was dat wanneer een scheur 
propageert door het botcement en hiermee een capsule breekt, het vrijgekomen 
monomeer en initiator de scheur zouden opvullen en het botcement zou repareren 
door te polymeriseren. Het concept werd aangetoond door eerst manueel het 
monomeer ethyleen glycol dimethacrylaat (EGDMA) met initiator toe te dienen op 
een kapot botcement trekstaafje. Wanneer vervolgens poly(urea formaldehyde) 
(PUF) microcapsules werden getest, die gevuld waren met of methyl methacrylaat 
(MMA) of ethyleen glycol dimethacrylaat (EGDMA) en een initiator, werden geen 
zelf-reparerende eigenschappen gevonden, omdat deze capsules te fragiel waren 
om de bereiding van het botcement te overleven. Daarom werden poly(melamine 
formaldehyde) (PMF) microcapsules gemaakt, die stabieler waren in het 
botcement-MMA mengsel. Trekstaafjes die PMF capsules bevatten met EGDMA en 
een intiator, lieten echter ook geen zelf-reparerende capaciteit zien tijdens 
mechanische belasting. Ook de mechanische eigenschappen van het botcement 
werden minder, wanneer meer capsules door de matrix waren gemengd, alhoewel 
een hogere belading van microcapsules door de matrix wel leidde tot een 
scheurstoppend effect in het cement.
In het laatste hoofdstuk zijn biodegradeerbare poly(L-melkzuur) (PLLA) capsules 
met een kleine grootteverdeling gemaakt met behulp van microsysteem platform. 
Met deze techniek werd een olie-in-water emulsie gemaakt, waarin in een 
vluchtige organische fase het polymeer, een hydrofobe niet-vluchtige verbinding 
waarin het polymeer niet oplost, en een hydrofoob modelmedicijn werden 
opgelost. Het polymeer sloeg neer op de druppel interface wanneer de vluchtige 
fase verdampte, waarbij een capsule werd gevormd waarin de hydrofobe 
verbindingen waren ingesloten. De afgifte van dit modelmedicijn werd 
onderzocht. Deze capsules met een ingesloten organisch oplosmiddel werden ook
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Summary
gebruikt om holle capsules te maken door deze fase te verwijderen met behulp van 
vriesdrogen. Optimale condities voor het maken van deze capsules werden 
gevonden wat betreft de vloeistofsnelheid van de continue fase en het moleculaire 
gewicht van het PLLA polymeer. Deze aanpak van het maken van 
biodegradeerbare capsules is van potentiële interesse voor het veld van medicijn 
afgifte.
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